




Nanofiber-Based Scaffold for Integrative Anterior 











Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy 





































Nanofiber-Based Scaffold for Integrative Anterior Cruciate Ligament Reconstruction 
Siddarth D. Subramony 
 
The anterior cruciate ligament (ACL) is the most frequently injured ligament of the knee, with 
upwards of 100,000 ACL reconstructions performed annually. Current grafting techniques are limited by 
insufficient integration with subchondral bone and donor site morbidity issues related to graft harvest, 
potentially resulting in revision surgery and long-term joint pain. Therefore, significant demand exists for 
alternative grafting solutions that do not require additional surgery and can regenerate the native ACL-to-
bone interface to promote biological fixation of the implanted ACL graft. To address this need, the ideal 
system must be able to withstand the functional demands of the native tissue by demonstrating 
physiologically equivalent mechanical properties, be comprised of compositionally varying phases in 
order to recapitulate the inherent heterogeneity of the native ligament to bone transition and be 
biodegradable such that it is gradually replaced by the regenerated tissue following implantation. It is 
hypothesized that a biomimetic, multi-phased scaffold comprised of optimized bone, interface and 
ligament regions coupled with controlled chemical and/or mechanical stimulation in vitro will guide phase-
specific differentiation of mesenchymal stem cells (MSC) and result in a biologically integrated bone-
ligament-bone complex in vivo. Mesenchymal stem cells are particularly attractive for this application as 
they can be routinely harvested from bone marrow, have been shown to respond to chemical, mechanical 
and structural cues, and are capable of differentiating towards the primary cell types (fibroblasts, 
osteoblasts and chondrocytes) found within ligament, bone and the ligament-to-bone interface. 
To this end, a nanofiber-based synthetic graft was designed with compositionally-varying phases 
to regenerate ligament, bone and interface tissues. The ligament phase was optimized in terms of 
nanofiber alignment, composition, mechanical stimulation and chemical stimulation. It was demonstrated 
that an aligned nanofiber substrate coupled with controlled mechanical stimulation was necessary to 
differentiate MSCs towards a fibroblastic phenotype. The bone phase was optimized in terms of ceramic 
content and it was shown that a threshold of mineral incorporation into nanofibers was necessary to 
differentiate MSCs towards an osteogenic phenotype. Lastly, a mechanoactive nanofiber collar was 
 
 
designed to induce interface formation. It was demonstrated that compressive stimulation applied via 
nanofiber collar contraction induced chondrogenic differentiation of MSCs. Subsequently, the three 
phases were incorporated to form a synthetic graft, for which graft architecture and cell seeding density 
were optimized. The resulting graft was cultured in vitro under the optimized parameters, demonstrating 
the formation of distinct and structurally continuous regions of bone, interface and ligament tissue. The 
graft was implanted in vivo where it was shown to be suitable for ACL reconstruction as it maintained 
knee stability and promoted ligament regeneration. 
In summary, this thesis focuses on the design of a biomimetic, nanofiber-based, integrated bone-
ligament-bone construct, and elucidates chemical, mechanical and scaffold design-related parameters 
that can guide MSC differentiation towards desired tissue types. The impact of these studies extends 
beyond ligament reconstruction as they yield valuable scaffold design criteria, establish scaffold and 
culturing-related parameters to induce stem cell differentiation and can readily be applied to the formation 
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1.1 Specific Aims 
The anterior cruciate ligament (ACL) is the most frequently injured ligament of the knee[4] with 
upwards of 100,000 ACL reconstructions performed annually in the United States alone[5]. Due to the 
ligament’s intrinsically poor healing capability, ACL ruptures require surgical intervention[6-8]. The current 
standard of treatment is ACL reconstruction, which utilizes a biological graft to replace the damaged 
ligament, typically consisting of autologous bone-patellar tendon-bone (BPTB) or hamstring tendon 
tissue. Clinically, there has been a shift towards hamstring tendon grafts due to concerns related to the 
donor site morbidity associated with BPTB grafts, including patellar tendon rupture and persistent anterior 
knee pain[9;10]. However, the integration of hamstring tendon grafts with bone following reconstruction 
has been especially challenging as they lack the intact soft tissue-to-bone transitions inherent to BPTB 
grafts[11]. Studies evaluating graft-to-bone healing have shown that fibrovascular tissue forms within the 
bone tunnel and surrounds the graft following ACL reconstruction[12]. This disorganized tissue results in 
non-anatomical attachment sites that are prone to failure as well as insufficient bone formation within the 
tibial and femoral tunnels, which prevents the re-establishment of the structure-function relationship found 
in the native ligament[13]. In addition, failure rates for the reconstruction procedure, regardless of graft 
source, have been reported to exceed 20% in some instances[14] and frequently fail due to insufficient 
graft integration with bone[15]. As a result, there is a pressing clinical need for functional grafting 
solutions that can enable integrative ACL reconstruction through regeneration of the native ligament and 
ligament-bone interfaces. 
To this end, tissue engineering has emerged as a promising method for integrative ACL 
reconstruction[16]. Recent efforts in ACL tissue engineering have primarily focused on the use of fibrous 
scaffolds[17-19], fabricated from a wide range of polymers, to mimic the structure of the native ligament 
which consists primarily of highly aligned bundles of collagen fibers[20]. These systems have been shown 
to exhibit mechanical properties, in terms of stiffness and failure strength, similar to those of the native 
ACL, and are also capable of directing cell attachment and matrix production[16;18;21]. However, these 
systems fail to promote biological fixation of the ligament to bone via interface regeneration, which is 
essential for long-term functionality of the ACL graft. To date, techniques to simultaneously regenerate 
the ligament as well as the complex femoral and tibial ligament-to-bone transitions have yet to be 
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Figure 1.1. Schematic of 
the proposed integrative 
ACL scaffold. The 
scaffold comprises 
individually optimized 
phases for bone, interface 
or ligament regeneration, 
respectively. A schematic 
of the knee and an MRI 
following ACL 















realized. The native ligament-to-bone interface consists of distinct-yet-continuous regions of mineralized 
and non-mineralized fibrocartilage[22]. This transition is characterized by differences in cell type 
(including osteoblasts, chondrocytes and fibroblasts), matrix composition, mineral content and 
mechanical properties[23] and serves to minimize the formation of stress concentrations and mediate 
load transfer from ligament-to-bone[23]. Given its functional significant, the goal of this thesis project is to 
enable the regeneration of the native ligament as well as the femoral and tibial ligament-to-bone insertion 
sites following ACL reconstruction using a multi-phased scaffold (Fig. 1). With this approach, long-term 
clinical outcomes could be improved by eliminating a secondary surgical procedure plus the associated 
limitations of biological grafts. The primary advantage of this approach is that by engineering an in vitro 
integrated multi-phased scaffold with pre-connected ligament-to-bone interfaces, only osteointegration is 
required in vivo. The proposed techniques are intended to lead to the formation of multiple, distinct-yet-
continuous cellular and matrix regions mimicking the organization of native tissue, with a gradation of 
mechanical and structural properties. 
As this integrative scaffold is intended to replace traditional soft tissue grafts used for ACL 
reconstruction, there are several key design criteria that the ideal system must meet. First, it must be able 
to withstand the functional demands of the native tissue by demonstrating physiologically equivalent 
viscoelastic and elastic mechanical properties as immediate joint stability is required following 
reconstruction. Second, the scaffold must be comprised of compositionally varying phases in order to 
recapitulate the inherent heterogeneity of the native ligament to bone transition. Lastly, the scaffold must 
be biodegradable such that it is gradually replaced by the regenerated tissue following implantation. 
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Collectively, these criteria will support multi-tissue formation and integrative ACL regeneration. 
The strategy described in this thesis for integrative ligament tissue engineering centers on the 
design of a multi-phased, biomimetic scaffold by forming a continuous tissue encompassing the femoral  
bone and interface, ligament proper and tibial interface and bone (Fig. 1.1). To accomplish this, the graft 
will consist of nanofibers with a bone phase and ligament-to-bone interface phase at each end of the 
scaffold along with a central ligament phase to regenerate the ligament proper. Nanofibers are particularly 
advantageous for this application as their nano-architecture emulates the collagenous ultrastructure of the 
native ligament and insertions[24]. Moreover, nanofiber alignment, diameter and composition has also 
been reported to guide cell attachment, orientation, biosynthesis and differentiation[24]. In addition, while 
differentiated primary cells have largely been used for orthopaedic tissue engineering, such an approach 
is not as clinically translative as the ligament, fibrocartilage interface, and bone are populated by distinct 
cell types[25]. Therefore, pluri-potent stem cells represent a more feasible option for the regeneration of 
multiple tissue types using a single cell source. To this end, this thesis will utilize mesenchymal stem cells 
(MSC), which can be routinely harvested from bone marrow[26], have been shown to respond to 
chemical, mechanical and structural cues, and are capable of differentiating towards the primary cell 
types (fibroblasts, osteoblasts and chondrocytes) found within ligament, bone and the ligament-to-bone 
interface. To address the challenge of controlling MSC differentiation and design a clinically translatable 
scaffold, this thesis will focus on using chemical and mechanical cues to guide MSC differentiation on 
each phase. Specifically, fibroblastic differentiation can be stimulated using tensile and torsional 
mechanical loading[27] as well as fibrogenic growth factors[28], osteoblastic differentiation has been 
guided using osteointegrative ceramics[29] and osteogenic induction media[26], and differentiation into 
chondrocytes has been stimulated with compressive loading[30] and chondrogenic induction factors[26]. 
The first three aims will focus on optimizing design and culturing conditions of each phase to guide MSC 
differentiation for the formation of ligament, bone and interface tissue, followed by in vitro culture and in 
vivo evaluation of the integrated ACL scaffold in Aims 4 and 5. The working hypothesis of this thesis is 
that a biomimetic, multi-phased scaffold comprised of optimized bone, interface and ligament regions 
coupled with controlled chemical and/or mechanical stimulation in vitro will guide phase-specific MSC 







Design, characterize and optimize a nanofiber-based phase to direct MSC-mediated 
formation of a ligament-like matrix. 
Ligament formation will be induced by nanofiber composition, nanofiber alignment, 




Design, characterize and optimize a nanofiber-based phase to direct MSC-mediated 
formation of a bone-like matrix. 





Design, characterize and optimize a mechanoactive nanofiber-based collar to direct MSC-
mediated formation of an interface-like matrix. 
Interface formation by MSCs on nanofibers will be induced by compressive loading with 




Fabricate and evaluate a multi-phased, nanofiber-based ACL scaffold in vitro. 
Scaffold mechanical properties will be dictated by architecture and the incorporation of all 
three phases optimized in Aims 1-3 will enable the formation of a biologically integrated 




In vivo evaluation of a multi-phased nanofiber-based scaffold for integrative ACL 
reconstruction. 
The scaffold will enable the formation of a biologically integrated bone-ligament-bone 
complex in vivo. 
  
The overall objective of this thesis is to design a multi-phased, nanofiber-based scaffold for 
integrative ACL reconstruction. To this end, Aims 1-3 encompass the fabrication, characterization and 
optimization of the three phases of the system, with each aim focusing on ligament, interface or bone 
formation, respectively. Following the design of each individual phase, in Aim 4, a stratified scaffold will 
be fabricated by combining these phases and the multi-phased scaffold will then be evaluated in vitro 
and, per Aim 5, in vivo. 
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 More specifically, Aim 1 will focus on the formation of a ligament-like tissue on polymeric 
nanofibers by inducing the differentiation of MSC into the ligament fibroblast-like phenotype. Three 
parameters will be tested in this aim. First, dynamic tensile stimulation will be utilized to induce MSC 
differentiation towards a fibroblastic phenotype, as this is the primary mode of loading experienced by the 
ligament[31] (Chapter 2). Mechanical loading has also been shown to induce MSC differentiation towards 
a fibroblast-like phenotype in published studies[27]. Second, the effect of nanofiber organization will be 
assessed in this aim to determine if aligned nanofibers, which mimic the underlying collagenous structure 
of the native ligament, are necessary for fibroblastic differentiation (Chapter 2). Third, the addition of 
fibrogenic factors[28] will be evaluated to determine if chemical stimulation is necessary in addition to 
mechanical stimulation (Chapter 3). It is expected that mechanical stimulation and nanofiber alignment 
are sufficient to drive ligament-like tissue formation. Lastly, the effect of nanofiber composition will be 
assessed to select the optimal material based on mechanical properties, degradation and cell response 
for the ligament phase (Chapter 4).  
Following development of the ligament phase, Aim 2 addresses the optimization of the bone 
phase by guiding MSC-mediated bone formation. To accomplish this, hydroxyapatite (HA) particles, the 
primary mineral identified in bone[32], will be incorporated into nanofibers to induce MSC differentiation 
towards an osteoblastic phenotype[33]. The osteogenic differentiation of MSCs will be evaluated as a 
function of nanofiber mineral content (Chapter 5) as it has previously been shown that hydroxyapatite can 
induce osteoblastic differentiation[33;34] of stem cells. 
Aim 3 focuses on optimizing the interface phase. As fibrocartilage formation has been shown to 
be induced by compressive loading[35], this aim will incorporate the application of compression to induce 
MSC-mediated formation of a matrix rich in types I and II collagen and proteoglycans. To this end, a 
mechanoactive, nanofiber-based collar composed of polylactide-co-glycolide (PLGA) will be used to apply 
compression to MSCs as it contracts when placed in a physiological environment. Compressive loading 
via a nanofiber collar system has previously been shown to induce upregulation of fibrocartilage-related 
markers when applied to soft tissue in vitro[36]. Similarly, compression has also been shown to enhance 
MSC chondrogenesis[30;37]. The effect of compression via nanofiber collar contraction on MSCs will be 
assessed in vitro (Chapter 6) and the system will be further validated by assessing its ability to induce 
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fibrocartilage formation on biological grafts in vivo (Chapter 7). It is hypothesized that the application of 
compressive loading, via nanofiber scaffold contraction in situ, will initiate fibrocartilage formation and 
enable soft tissue-to-bone interface formation. 
 Incorporating the outcomes of Aims 1-3, Aim 4 encompasses the design, characterization and in 
vitro evaluation of a stratified scaffold that incorporates all three optimized phases to form an integrated 
bone-ligament-bone complex. This multi-phased scaffold will be designed to guide MSC differentiation in 
order to form distinct-yet-continuous regions of bone, interface and ligament tissues in vitro. The effect of 
scaffold architecture on mechanical properties (Chapter 8) will be evaluated and the effect of cell seeding 
density will be evaluated in vitro (Chapter 8) within a bioreactor to provide mechanical stimulation under 
the optimized culture conditions and assess the formation of all three tissue types over time. 
Subsequently, in Aim 5, the system will be evaluated in vivo using a well-established rodent model of 
ACL reconstruction[38] to assess its efficacy for integrative ACL reconstruction (Chapter 9) in terms of 
biomechanical properties and matrix formation, focusing on regenerating a biologically integrated bone-
ligament-bone complex. 
In summary, in order to tissue engineer an integrative and functional anterior cruciate ligament 
graft, the studies discussed in this thesis consist of 1) biomimetic scaffold fabrication and optimization, 2) 
incorporation and differentiation of MSC towards interface-relevant phenotypes and 3) in vitro and in vivo 
evaluation of the novel stratified scaffold. The approach outlined in this thesis is innovative as it focuses 
on the design of a biomimetic, nanofiber-based, integrated bone-ligament-bone construct, and elucidates 
chemical, mechanical and scaffold design-related parameters that can guide MSC differentiation towards 
desired tissue types. The impact of these studies extends beyond ligament reconstruction as they will 
likely yield valuable scaffold design criteria, establish scaffold and culturing-related parameters to induce 
stem cell differentiation and can readily be applied to the formation of interfaces between soft-to-hard 
tissues as well as other complex tissues. 
1.2 Significance 
1.2.1 ACL Injuries and Current Reconstruction Techniques 
 The anterior cruciate ligament (ACL) spans from the anterior tibial plateau to the medial aspect of 
the lateral femoral condyle and primarily serves to resist tibial translation and rotational loads[39]. The 
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ACL is the most frequently injured ligament of the knee, with upwards of 250,000 injuries reported each 
year and over 100,000 ACL reconstructions performed annually in the United States alone[4;5]. Due to 
the avascular nature of the tissue as well as the synovial environment within the joint, the ACL does not 
heal upon injury and requires surgical intervention in the form of the ACL reconstruction procedure[6-8]. 
This procedure is considered the gold standard for ACL rupture and necessitates the use of a graft to 
replace the damaged ligament and restore knee stability. Importantly, the graft must be capable of 
bearing loads almost immediately after surgery and withstand the intensive rehabilitation process that is 
required to regain mobility. This requirement has become even more critical in light of an increasing 
number of ACL injuries due to an aging yet active population. 
While ACL reconstruction has traditionally utilized autologous bone-patellar tendon-bone (BPTB) 
grafts, hamstring tendon grafts have become increasingly popular due to the anterior knee pain and 
patellar tendonitis often associated with BPTB graft harvest[40-42]. Furthermore, hamstring tendon grafts 
have been shown to withstand higher loads at failure as compared to BPTB grafts with similar 
stiffness[43]. Despite this, however, clinical studies have shown that ACL reconstructions utilizing 
hamstring tendon grafts do not result in a complete return to pre-injury activity levels for over 30% of 
patients[44]. This finding is attributed to the inability of hamstring tendon grafts to fully integrate with bone 
and an increase in knee laxity due to insufficient graft fixation[45]. In addition, frequent complaints of 
weakness in knee flexion have been reported following reconstruction with hamstring tendon grafts[46] 
indicating that the harvest of these grafts may result in donor site morbidity issues, such as a significant 
decrease in hamstring muscle strength. 
Whereas BPTB grafts are secured by bone-to-bone healing, fixation of hamstring tendon grafts 
requires healing between soft tissue and bone. Studies evaluating tendon graft-to-bone healing have 
shown that the native insertion site is not reformed following ligament reconstruction with a tendon graft 
as a fibrovascular scar-tissue interface forms between tendon and bone[12;47]. These fixation sites, 
therefore, represent the weakest point during the early postoperative healing period and the lack of 
mechanical stability may lead to graft failure[11;13;47]. As a result, techniques that promote the 




1.2.2 Challenges in ACL Graft Harvest and Fixation 
While advances in surgical technique and rehabilitation have resulted in marked improvement in 
the outcome of ACL reconstruction, the optimal graft for the procedure remains controversial. The BPTB 
grafts require excising the central third of the patellar tendon and therefore have been associated with a 
variety of complications including anterior knee pain and patellar tendon rupture as well as patellar and 
tibial fracture[48]. Hamstring tendon grafts have become a more frequent alternative as they can minimize 
the incidence of these symptoms but have also been reported to cause hamstring weakness as well as 
increased joint long-term joint laxity[48]. Further complicating outcomes is that graft harvesting is highly 
dependent upon the individual surgeon and patient as each graft represents a unique set of technical 
challenges[49]. Allogenic grafts, which have the potential to address these issues, have been shown to 
undergo a slower rate of biologic incorporation and decreased long-term stability as compared to 
autologous grafts[50]. These challenges indicate that alternative grafting solutions that can eliminate the 
variable graft harvesting process and also enable rapid integration with existing tissue would be ideal for 
the ACL reconstruction procedure. 
In addition to graft selection and composition, a variety of factors have been shown to determine 
the long-term performance of ACL grafts, including the initial graft tension[51;52], the intraarticular 
position of the graft[53;54], and graft fixation[13;47]. Graft fixation, specifically, has increasingly gained 
importance as post-surgical rehabilitation methods require the immediate ability to regain full range of 
motion, re-establish neuromuscular function and bear weight[12;55]. The BPTB graft is particularly 
advantageous due to its ability to integrate with the femoral and tibial subchondral bone via the bony ends 
while also possessing intact fibrocartilaginous insertion sites that can serve as functional transitions 
between soft tissue and bone. In contrast, semitendinosus grafts require more extensive mechanical 
fixation within the bone tunnels and, while the physiological range of motion is restored, anatomical graft-
to-bone integration is not achieved as the native insertion site is lost during surgery and fibrous tissue 
forms within the tendon-bone junction [12;47]. Due to this, these fixation sites represent the weakest point 
during the early postoperative healing period and the lack of mechanical stability often results in graft 
failure[11;13;47]. As a result, techniques that promote the regeneration of the native interface on soft 




1.2.3 Graft Fixation Strategies 
 Following ACL reconstruction, tendon-to-bone healing does not result in the regeneration of a 
native fibrocartilaginous transition between soft tissue and bone. Several groups have studied the 
process of tendon-to-bone healing in animal models and have shown that a non-mineralized fibrovascular 
interface forms instead of the native transition[38;56;57]. Initial attempts to improve ligament graft-to-bone 
fixation have focused on augmenting the surgical graft with mineralized components in order to 
encourage bone tissue formation[58-64] as the strength of the tendon-to-bone interface has been shown 
to correlate with the degree of bone in-growth[12].  For example, Tien et al. used calcium phosphate 
cements within the bone tunnels in a rabbit ACL reconstruction study and found that the addition of 
ceramic helped to improve bone tissue growth and organization[58].  Similarly, Mutsuzaki et al. 
demonstrated that hybridization of calcium phosphate onto tendon grafts in a goat ACL reconstruction 
model reduced bone tunnel enlargement and resulted in more organized bone tissue formation than 
compared to the control[64]. These findings indicate that the incorporation of hydroxyapatite is a viable 
strategy for enhancing tendon-to-bone integration. However, although these methods have improved 
osteointegration between the ACL graft and the bone tunnel, they do not result in the regeneration of an 
anatomical fibrocartilage interface between graft and bone which is critical for biological fixation. To this 
end, engineering a biomimetic scaffold to direct cellular response and support multi-tissue formation is a 
key component in functional interface formation. 
 
1.2.4 Biochemical Structure of the ACL and ACL Insertion Sites 
 The anterior cruciate ligament is a dense, collagenous tissue 
that connects the tibia to the femur and serves to resist rotational and 
translational loads[39].  It is primarily composed of types I and III 
collagen along with elastin, fibronectin, decorin, tenascin-C and 
biglycan, with a specific ratio of type I to type III collagen 
(approximately 7:1) that serves to distinguish ligaments from 
tendons[16;65]. It is populated by spindle-shaped fibroblasts that 
Figure 1.2. Collagen alignment. 
The ACL consists of dense 
bundles of collagen fibers 




remain closely attached to the extracellular collagen and follow the 
ultrastructure of the fibrous matrix[66] (Fig. 1.2). Macroscopically, the 
ACL contains a unique helical organization of collagen fibers that is 
thought to be essential for ligaments to perform their stabilizing 
function[20]. In addition, the fibers also have a distinct crimp pattern that 
allows for creep elongation prior to permanent deformation and ligament 
damage[39]. Characterization of the ACL has typically divided the 
ligament into either two functional bundles, the anteromedial bundle and 
posterolateral bundle, or three bundles, with the addition of an 
intermediate bundle between the two[67;68]. These bundles experience 
different patterns of length changes during knee flexion and enable the 
ligament to withstand the multi-axial stresses and varying tensile strains 
that accompany joint motion[69].  
The native ACL insertion sites consist of direct fibrocartilaginous 
interfaces which serve  to minimize stress concentrations and facilitate load transfer between distinct 
tissue types[22;23;70-73]. Variations in cell type and matrix composition occur as the tissue transitions 
from ligament to bone and this interface has been reported to be histologically similar for both the tibial 
and femoral sites[2]. The interface consists of four distinct, yet continuous, tissue regions:  ligament 
proper, non-mineralized fibrocartilage (NFC), mineralized fibrocartilage (MFC), and bone[2] (Fig. 1.3). As 
previously discussed, the ligament region is primarily composed of aligned types I and III collagen 
populated by fibroblasts, along with small amounts of proteoglycans[65]. The non-mineralized 
fibrocartilage region contains ovoid fibrochondrocytes within of a matrix of types I and II collagen present 
within a proteoglycan-rich matrix[74]. The mineralized fibrocartilage zone is composed of hypertrophic 
fibrochondrocytes surrounded by a calcified matrix containing types I, II and X collagen[75]. Lastly, the 
subchondral bone contains osteoblasts, osteocytes, and osteoclasts in a mineralized type I collagen 
matrix[22]. The specific organization and controlled heterogeneity are believed to be important for 
minimizing stress concentrations and facilitating the transfer of complex loads between soft and hard 
tissues[23]. 
Figure 1.3. The ligament-to-
bone interface. The 
interface consists of a 












1.2.5 Current Efforts in ACL Tissue Engineering 
 Synthetic systems have been evaluated for ligament replacement but have met with limited 
clinical success to date, as none are currently FDA approved. These attempts include grafts 
manufactured from carbon fiber[76], polytetrafluoroethylene (PTFE)[77;78], 
polyester[79;80],polypropylene[81], and polyarylamide[82;83]. Among the earliest attempts at a prosthetic 
ligament were the carbon fiber implant and the composite carbon fiber-polyester braid ligament. While 
these ligaments provided initial mechanical stability, long term studies reported the generation and 
migration of carbon wear particles into the joint space following implantation. In addition, frequent 
incidence of implant stretching and rupture led to poor long-term functional outcomes[80].  Alternatively, 
polymer-based grafts have also been evaluated, such as the Gore-Tex ACL, fabricated out of expanded 
PTFE. While the Gore-Tex graft was implanted in more than 18,000 patients worldwide, it ultimately failed 
due to a lack of tissue ingrowth, likely due to the hydrophobicity of the material, and fatigued in response 
to normal cyclic loads[84]. In contrast, synthetic ligaments fabricated from polyester (Dacron) resulted in 
improved outcomes but were still susceptible to failure due to the lack of organized tissue formation over 
time[79;83]. 
In response to the previous failures of synthetic ligaments, tissue engineering has arisen as a 
promising method by which to synthetically regenerate the ACL. Beginning with natural materials, Dunn et 
al. were among the first to evaluate a tissue engineered ACL replacement in vivo[85]. Studies were 
performed using a type I collagen fiber-based prosthesis with polymethylmethacrylate (PMMA) bone 
fixation plugs on the ends. While neo-ligamentous tissue formation was reported, the majority of scaffolds 
ruptured after 20 weeks in a rabbit model[85], demonstrating that this system was insufficient to support 
long-term knee stability. Chvapil et al. similarly evaluated a collagen fiber-based scaffold in vivo using a 
goat model and, after reporting significant decreases in mechanical properties over the course of 11 
months, concluded that a collagen fiber-based scaffold alone was insufficient for ACL replacement[86]. In 
an effort to bolster the mechanical properties of a collagen-based scaffold, Cai et al. investigated a 
composite collagen-polyvinylalcohol (PVA) scaffold in vitro and in vivo in a porcine model[87]. It was 
reported that scaffolds retained 75% of native ACL strength after 24 weeks in vivo and ligament-like 
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tissue was formed within the scaffolds. Dunn et al. have similarly sought to enhance the mechanical 
strength of their collagen scaffold system and recently reported on a composite silk-collagen scaffold [88]. 
While this system has been shown to retain mechanical properties similar to the native ACL after eight 
weeks implantation in a rabbit model, it has yet to be shown to support tissue growth. Altman et al. 
performed a series of studies focusing on the development of a silk-only anterior cruciate ligament 
replacement both in vitro[21;89-91] and in vivo[17]. Specifically, a silk-fiber based scaffold was designed 
and several studies were performed to assess the impact of chemical and mechanical stimulation on the 
differentiation of seeded MSCs. It was demonstrated that individually, soluble chemical factors, such as 
basic fibroblast growth factor (bFGF), as well as tensile and torsional stimulation could drive matrix 
elaboration and fibroblastic differentiation of MSCs on the silk scaffold[21]. In addition, it was also 
reported that chemical and mechanical stimulation could be applied concomitantly and be varied 
temporally to enhance MSC response[89;91]. The system was implanted in an in vivo goat model with 
promising results in terms of histological and mechanical outcomes after 12 months[17] and is currently 
undergoing human clinical trials in Europe[92]. Li et al. optimized the architecture of silk ACL scaffold by 
evaluating wired, braided, and straight fiber scaffold designs[93]. It was reported that the wired system, 
which consists of twisted silk fibers, exhibited biomechanical properties most similar to the native ACL. 
In terms of synthetic approaches, Lin et al. evaluated cylindrical scaffolds composed of 
poly(glycolic acid) (PGA) fibers coated with poly(ε-caprolactone) (PCL) in vitro and reported that they 
supported fibroblast proliferation and matrix deposition[94], demonstrating that polymeric scaffolds are a 
viable alternative to biopolymer systems. Freeman et al. developed a PLLA microfiber system and 
evaluated the effect of both braiding and twisting on scaffold mechanical properties[95;96], demonstrating 
that twisting coupled with braiding could increase scaffold ultimate tensile strength and toe-region length. 
A composite braid-twist scaffold combined with a polyethylene glycol diacrylate (PEDGA) hydrogel was 
also developed and shown to have mechanical properties similar to the native ACL and also support 
fibroblast growth[97]. The braid-twist design has also recently been extended to the development of 
composite collagen and gelatin-based ligament scaffolds[98]. Recently, Barber et al. reported on the 
development of a braided nanofiber-based scaffold for ACL replacement[99]. Scaffold architecture was 
optimized by varying the number of braided bundles and evaluating mechanical properties, with minimal 
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differences in toe-region or elastic modulus as a function of braid number. The system was seeded with 
MSCs and cultured in vitro, demonstrating that it supported cell viability and proliferation. Other than 
scaffold architecture, scaffold composition and fiber diameter also have significant impact on scaffold 
mechanical properties and compatibility. Surrao et al. reported that nanofibrous scaffolds composed of 
poly(L-lactide-co-D,L-lactide) (PLDLA) develop a crimp pattern similar to that of native ligament collagen 
when heated in an aqueous environment and support bovine fibroblast proliferation in vitro[100]. Vaquette 
et al. reported on two hybrid scaffold systems, a knitted PLGA suture system and a knitted silk suture 
system, each coated with electrospun PLA/PCL microfibers[101]. These systems had tensile properties 
similar to native ligaments and resulted in the formation of a ligament-like matrix by rat MSCs in vitro. 
Bach et al. performed a preliminary mechanical evaluation of a PVA hydrogel fiber-based scaffold and 
reported non-linear mechanical characteristics similar to the native ACL[102]. Collectively, these studies 
have established critical design parameters for ligament engineering but do not address one of the 
primary drawbacks of current reconstruction techniques: namely, the inability of grafts to integrate with 
subchondral bone following implantation.  
As tissue engineering approaches have advanced, multi-phased designs focused on regenerating 
bone and the ligament-to-bone interfaces simultaneously with the ligament have been developed. Cooper 
et al. reported on the in vitro[103;104]  optimization and in vivo[18] evaluation of a braided, α-
hydroxyester microfiber-based scaffold for ligament engineering. The architecture and porosity was 
optimized in vitro using a braiding technique to recapitulate the native ligament mechanical properties and 
incorporated a multi-phased design consisting of a denser fiber arrangement at each end of the construct 
for bone formation[103]. Scaffold composition was optimized based on in vitro degradation and cell 
response with poly(L-lactide) (PLLA) selected  based on its ability to maintain structural integrity over the 
eight-week culture duration[104]. Subsequently, the optimized scaffold was evaluated in vivo using a 
rabbit ACL reconstruction model. It was demonstrated that cell seeding of the implanted scaffold resulted 
in a marked improvement in functional outcomes but scaffolds in both groups ruptured after 12 weeks of 
implantation[18]. Kimura et al. evaluated a multi-phased system composed of braided PLLA wrapped with 
collagen for ligament formation and a gelatin hydrogel containing bFGF within the bone tunnels[105]. The 
multi-phased design resulted in distinct regions of bone and ligament formation as well as enhanced 
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mechanical properties compared to single-phase controls. Goh et al. performed a series of studies to 
optimize a knitted silk scaffold which was combined with a microporous silk sponge[106;107]. This bi-
phasic system was designed to mimic the ECM of native tissue and provide sufficient mechanical strength 
for ligament replacement. The scaffold was implanted in vivo using a rabbit model[108] as well as a pig 
model[109]. After 24-weeks in each model, substantial ligament-like tissue was formed on the scaffold 
and an insertion-like structure was regenerated between scaffold and bone. In addition, several in vitro 
studies were performed to further optimize the scaffold, including the use of silk cables to increase tensile 
strength[110], the incorporation of bFGF-releasing PLGA[111] and RADA16 peptide[112] nanofibers to 
enhance cell biosynthesis, and the addition of a silk-based aligned nanofiber topography to direct cell 
orientation and matrix production[113].  
In contrast with these scaffold-based approaches, Ma et al. reported on the in vitro[114] and in 
vivo[115] evaluation of a scaffold-less system for bone-ligament-bone regeneration. The system 
consisted of self-assembled bone constructs co-cultured with a ligament monolayer rolled between them 
to form a bone-ligament-bone replacement. After six months of implantation using a sheep model of ACL 
reconstruction, the constructs increased in cross section, native bone integration, and functional insertion-
like tissue, though with a sample size of only three sheep. Using a similar approach, Paxton et al. 
developed an in vitro model of bone-ligament-bone using calcium phosphate brushite-based anchors 
connected to a fibrin gel-based ligament sinew[116;117].  It was reported that fibroblasts seeded within 
the sinew produced an interface between the anchors and gel that resembled the in vivo tidemark at the 
ligament-to-bone insertion[116]. These studies represent important advancements in the engineering of 
the ligament-to-bone interface but do not represent a functional ligament construct. 
While the aforementioned studies establish the ability of scaffold design as well as chemical and 
mechanical stimulation strategies to direct ligament tissue regeneration, the systems reviewed here do 
not facilitate the formation of the native ligament-to-bone interface. This structure is critical to accomplish 
biological fixation of the regenerated ligament tissue and will be required for long-term clinical success. 
To this end, Spalazzi et al. reported on the development of a multi-phased scaffold for ligament-to-bone 
interface tissue regeneration. Utilizing a tri-phasic design to mimic the ligament, fibrocartilage and bone 
regions of the native transition, phase-specific matrix heterogeneity was demonstrated in vitro by co-
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culturing osteoblasts and fibroblasts on the bone and ligament phases, respectively[118]. In addition, 
using a subcutaneous rodent model, it was demonstrated that fibrocartilage-like tissue could be 
regenerated in vivo by tri-culturing primary cells from each tissue type on each of the phases[119]. These 
studies demonstrate the ability to use stratified scaffold design for multi-tissue regeneration of the ACL-to-
bone interface and this thesis aims to extend upon this work by engineering a system for complete bone-
ligament-bone regeneration.    
    
1.2.6 Mesenchymal Stem Cells  
In addition to scaffold design, cell source is a critical parameter for the clinical translation of tissue 
engineered strategies. While primary cell sources have largely been used to test the feasibility of 
engineered constructs, adult stem cells are considered an ideal cell source due to their versatility and 
clinical translation potential. Mesenchymal stem cells (MSC), in particular, are considered to be 
advantageous for musculoskeletal tissue engineering applications[26;120]. These cells, which reside 
within the bone marrow, can be routinely harvested via conventional biopsy techniques and are able to 
maintain their differentiation capabilities even after long term in vitro culture[26]. Moreover, differentiation 
of MSCs has been shown to be sensitive to chemical, mechanical and structural cues as well as 
combinations of these stimuli[26;91;121]. For the purpose of ligament tissue engineering, it has been 
established that MSCs are capable of differentiating into the primary cell types found within the ligament 
(fibroblasts)[27], bone (osteoblasts)[26], and ligament-to-bone interface (chondrocytes)[26]. More 
specifically, Altman et al. demonstrated that fibroblastic differentiation can be stimulated using tensile and 
torsional stimulation[27] as well as fibrogenic growth factors[28]. Osteoblastic differentiation has been 
guided using osteogenic induction medium containing dexamethasone[26],  osteointegrative ceramics 
such as hydroxyapatite[34] and tricalcium phosphate[122] as well as shear stress[123]. Lastly, 
chondrogenic differentiation has been induced with chondrogenic induction factors including transforming 





Despite advances in surgical techniques, the failure rates of biological grafts and donor site 
morbidity issues related to conventional graft harvesting techniques remain a significant clinical problem. 
In addition, the native ligament-to-bone interface is not re-established following ACL reconstruction and is 
critical for long term knee stability and functionality. Therefore, a significant demand exists for alternative 
grafting solutions that do not require additional surgery and can regenerate the native ACL-to-bone 
interface to promote biological fixation of the implanted ACL graft. In order to tissue engineer an 
integrative and functional anterior cruciate ligament graft, the studies outlined in this thesis consist of 1) 
biomimetic scaffold fabrication and optimization, 2) incorporation and differentiation of MSC towards 
relevant phenotypes and 3) in vitro and in vivo evaluation of the novel stratified scaffold. A ligament 
(Chapters 2-4), bone (Chapter 5) and interface (Chapters 6-7) phase will be individually optimized and a 
scaffold incorporating all the phases will be fabricated and evaluated in vitro (Chapter 8). Subsequently, 
the optimized scaffold will be implanted in vivo (Chapter 9) to evaluate its functional and integrative 
potential. The findings of these studies will yield valuable scaffold design criteria, establish scaffold and 
culturing-related parameters to induce stem cell differentiation and, further, can readily be applied to the 




CHAPTER 2: LIGAMENT PHASE: THE EFFECT 
OF NANOFIBER ORGANIZATION AND 
MECHANICAL STIMULATION ON FIBROBLASTIC 






 This thesis begins by focusing on the ligament phase of the ACL scaffold in order to determine 
the cues necessary to direct fibroblastic differentiation of mesenchymal stem cells. Stem cells have been 
shown to respond to both physical and chemical cues in order to guide differentiation. In particular, this 
study will evaluate the effects of tensile mechanical stimulation and nanofiber organization on the 
fibroblastic differentiation of MSCs. The findings from this study will provide the physical parameters 
necessary to direct differentiation of MSCs into a ligament fibroblast phenotype on the ligament phase of 
the scaffold.  
 
2.1.1 Background and Motivation 
 An emerging trend in biomaterial and scaffold design has been the incorporation of strategic 
biomimicry in order to more effectively guide MSC differentiation and accelerate the healing process. 
Specifically, nanofibers been investigated for the regeneration of connective tissues, such as 
bone[124;125], meniscus[126], intervertebral disk[127], cartilage[128], tendons and 
ligaments[24;129;130], as they are biomimetic and can be fabricated to replicate the structural 
organization of the collagenous matrix that dominates these tissues. Moreover, nano-scale fibers have 
been shown to direct cell attachment and matrix deposition[24;99;106;131] and represent an ideal system 
to model the collagenous matrices present within native tissue structures. These fibers exhibit high aspect 
ratio, surface area, permeability and porosity, making them advantageous for tissue engineering 
applications. Furthermore, they can be fabricated from a variety of polymers, both natural and synthetic, 
with tunable fiber diameter and matrix alignment[132;133].  
Given their similarity to the native extracellular matrix (ECM), nanofibers have been used to 
promote MSC response and differentiation. For example, Ma et al. studied the effect of poly(L-lactic) acid 
(PLLA) nanofiber alignment on the osteogenic differentiation of rat MSC in conjunction with osteogenic 
medium[134]. It was found that total calcium content was the highest on aligned nanofibers albeit no 
difference in cell proliferation or osteogenic markers was observed between cells cultured on aligned and 
unaligned nanofibers.  Similarly, Baker et al. investigated the impact of poly(ε-caprolactone) (PCL) 
nanofiber alignment on bovine MSC fibrochondrogenesis when coupled with chondrogenic induction 
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medium[126].  It was reported that a greater increase in construct mechanical properties was measured 
when MSCs were cultured on aligned nanofibers in contrast to cells on unaligned controls after 10 weeks. 
Notably, the majority of these studies have employed chemical factors along with scaffold cues, making it 
difficult to decouple the effects of these distinct stimuli[135]. Recently, Schofer et al. reported that 
culturing MSCs on type I collagen or PLLA nanofibers modulated cell proliferation and expression of 
osteogenic markers, even in the absence of osteogenic induction medium[136]. Similarly, Jiang et al. 
reported that culture on PCL nanofibers upregulated the expression of neural markers by MSCs, as 
compared to monolayer controls[137].  
In addition to matrix-guided cues, mechanical stimulation has been found to direct MSC 
differentiation[27;123;138]. For example, dynamic tensile (10%) and torsional (25%) strains applied at 1 
cycle/minute upregulated types I and III collagen expression by human MSCs in collagen gels and direct 
these cells towards a fibroblastic phenotype without the use of chemical induction medium[27]. In 
addition, Terranciano et al. demonstrated that 10% compressive strain applied at a frequency of 1 Hz to 
MSC-encapsulated poly(ethylene glycol)-diacrylate hydrogels resulted in the upregulation of cartilaginous 
markers and greater matrix production when combined with chemical stimulation[138]. Recently, Grayson 
et al. also reported that osteogenic differentiation and mineral production by MSCs correlated to the 




Collectively, the aforementioned studies suggest that mechanical loading and nanofiber 
architecture are important in guiding MSC differentiation. Therefore, the purpose of this study is to 
investigate the role of nanofiber matrix alignment and mechanical stimulation on MSC differentiation 
towards a fibroblastic phenotype for the ligament phase of the synthetic ACL graft. To this end, this study 
will evaluate the fibroblastic differentiation of human MSCs on nanofibers as a function of fiber alignment 
and mechanical stimulation. It is hypothesized that tensile stimulation combined with a biomimetic nano-
scale substrate will direct MSC differentiation towards a ligament fibroblast-like phenotype and the 
subsequent production of a ligament-like matrix. To test this hypothesis, the attachment, proliferation, 
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biosynthesis and differentiation of MSCs stimulated by dynamic tensile loading will be evaluated on 
aligned and unaligned nanofibers over a four-week culturing period. It is expected that the results of this 
study will elucidate fundamental substrate and culture environment-related rules to systematically control 
MSC differentiation and determine if loading or matrix alignment is a more dominant determinant of cell 
behavior, without confounding effects from concurrent chemical stimulation. These outcomes of this study 
will establish the nanofiber alignment and mechanical stimulation parameters for the ligament phase of 
the synthetic ACL graft. 
 
2.2 Materials and Methods 
2.2.1 Nanofiber Mesh Fabrication  
Unaligned and aligned nanofiber meshes composed of poly(lactide-co-glycolide) (PLGA, 85:15, 
Mw = 123.6 kDa; Lakeshore Biomaterials, Birmingham, AL) were produced via electrospinning[24;139]. 
Briefly, 35% PLGA (v/v) was solubilized in 55% N,N-dimethylformamide (Sigma-Aldrich, St. Louis, MO) 
and 10% ethyl alcohol. The solution was loaded into a syringe with an 18.5-gauge stainless steel blunt tip 
needle and electrospun at 8-10kV and 1 mL/hour using a custom electrospinning device. Polymer was 
dispensed via a syringe pump (Harvard Apparatus, Holliston, MA; 1 ml/hr) and unaligned meshes were 
fabricated using a static collector plate whereas the aligned meshes were produced by electrospinning 
onto rotating mandrel (20 m/s). With the exception of fiber alignment, the resultant meshes were identical 
with respect to fiber diameter, pore size and porosity[24]. 
 
2.2.2 Cells and Cell Culture 
Human mesenchymal stem cells (MSC) were obtained commercially (Lonza, Walkersville, MD) 
and maintained in culture with fully supplemented (FS) DMEM containing 10% FBS (stem cell certified, 
Atlanta Biologicals, Atlanta, GA), 1% penicillin-streptomycin, 1% non-essential amino acids, 0.1% 
amphotericin B and 0.1% gentamicin. Cells were cultured to 80% confluence and then passaged using 
0.25% trypsin/1 mM ethylenediaminetetraacetate (EDTA) and re-plated at a density of 5x103 cells/cm2. 
Cells from passage two were seeded on meshes for all studies. Prior to cell seeding, the stemness of 
these cells was ascertained using flow cytometry (BD FACSCalibur, Franklin Lakes, NJ) to confirm 
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characteristic MSC surface markers, with cells determined to be positive for markers CD29, CD71, 
CD106 (BD Biosciences) and negative for markers CD14, CD31 and CD34 (BD Biosciences). 
Meshes were secured in a custom high-throughput bioreactor to apply uniaxial tensile strain. 
Briefly, electrospun meshes (5x6cm) were excised after fabrication and subsequently sterilized via 
ultraviolet irradiation (15minutes/side). meshes were secured in loading cartridges via teflon clamps, 
sectioned into 5 cm x 1 cm strips and pre-incubated in FS medium at 37ºC and 5% carbon dioxide for 16 
hours. Cells were seeded on the meshes at a density of 3x104 cells/cm2 and allowed to attach for 15 min 
before the addition of FS DMEM. Following an initial five-day period of static culture to allow for matrix 
elaboration, the effects of a loading physiologically relevant regimen[140], similar to previous 
studies[141], consisting of 1% strain at 1 Hz for 90 minutes twice daily (10.5 hours rest between cycles) 
on MSC morphology, attachment, proliferation, gene expression and matrix production were determined 
after 1, 7, 14 and 28 days of mechanical stimulation. Aligned and unaligned meshes cultured in identical 
bioreactor cartridges without loading served as controls. 
 
2.2.3 Cell Attachment and Alignment 
Cell attachment and alignment were imaged via scanning electron microscopy (SEM, 1.0kV, 
Hitachi S-4700, Pleasanton, CA). Following fixation, samples were dehydrated in an ethanol series and 
then sputter-coated with gold-palladium to reduce charging effects.  
Cell viability and morphology (n=3/group) were evaluated using Live/Dead staining (Invitrogen, 
Carlsbad, CA) following the manufacturer’s suggested protocol. The samples were imaged under 
confocal microscopy (Leica Microsystems TCS-SP5, Bannockburn, IL) at excitation wavelengths of 
488nm and 594nm. Cell penetration was evaluated by taking a z-series of confocal images over a depth 
of 20μm, equivalent to 15 to 20 layers of nanofibers. 
The effects of mechanical loading and nanofiber architecture on MSC alignment were quantified 
following the methods of Costa et al. Briefly, confocal images (n=3/group) of cell-seeded meshes were 
analyzed using circular statistics software customized for evaluating fiber alignment (Fiber 3). The circular 
statistics parameters determined included mean vector angle, which represents the average fiber 
alignment in the matrix (-90º < θ < 90º; 0º indicates horizontal orientation); mean vector length, which 
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ranges from zero for a randomly distributed sample to unity for an aligned sample (0 < r < 1); and angular 
deviation, which characterizes the dispersion of the non-Gaussian angle distribution of the nanofibers (0-
40.5º). Specifically, an angular deviation of 0º represents an aligned sample, and 40.5º is indicative of 
random distribution. 
 
2.2.4 Cell Proliferation  
Total DNA content was measured using the PicoGreen dsDNA assay (Invitrogen).  At each time 
point, the samples (n=5/group) were homogenized in 0.1% Triton-X (Sigma-Aldrich) and subjected to 20 
seconds of ultrasonication at 5W.  Fluorescence was measured using a microplate reader (Tecan, 
Research Triangle Park, NC) at an excitation wavelength of 485 nm and an emission wavelength of 535 
nm.  A standard curve was derived and used to correlate DNA concentration to fluorescence intensity, 
and cell number was determined based on a conversion factor of 8pg DNA/cell[104].   
 
2.2.5 Matrix Deposition 
Total collagen content per sample (n=5/group) was calculated using the hydroxyproline 
assay[142].  Briefly, the samples were first desiccated for 24 hours and then digested for 16 hours at 65°C 
with papain (600 µg protein/ml) in 0.1M sodium acetate (Sigma), 10 mM cysteine HCl (Sigma), and 50 
mM ethylenediaminetetraacetate (Sigma).  A 40 µl aliquot of the digest was hydrolyzed with 10 µl 10 M 
sodium hydroxide and autoclaved for 25 minutes.  The hydrolyzate was then oxidized by a buffered 
chloramine-T reagent for 25 minutes before the addition of Ehrlich’s reagent.  Sample absorbance was 
measured at 550nm (Tecan), and the collagen content was obtained by interpolation along a standard 
curve of bovine type I collagen (Sigma). 
Collagen distribution was also visualized using picrosirius red staining of frozen sections 
(n=2/group). Briefly, after fixation, samples were embedded in 5% polyvinyl alcohol (PVA, Sigma-Aldrich) 
and 7-micrometer thick sections (spanning the depth and width of the mesh) were obtained using a 
cryostat (Hacker-Bright OTF model, Hacker Instruments and Industries, Winnsboro, SC). Collagen 
distribution was visualized with picrosirius red staining under light microscopy (Axiovert 25, Zeiss). 
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Elaboration of type I and type III collagen (n=3 samples/group) on nanofibers was evaluated 
using immunohistochemistry. After rinsing with PBS, samples were fixed with 10% neutral buffered 
formalin for 24 hours. Monoclonal antibodies for type I collagen (1:20 dilution in serum-free Protein Block, 
Dako Cytomation, Carpinteria, CA) and type III collagen (1:100 dilution in serum-free Protein Block) were 
obtained from Abcam (Cambridge, MA) and Sigma-Aldrich, respectively. Samples were treated with 1% 
hyaluronidase for 30 min at 37ºC and incubated with primary antibody overnight. After a PBS wash, Alexa 
Fluor 488-conjugated secondary antibody (Invitrogen) was added and incubated for 1 hour. Propidum 
iodide (Invitrogen) was used as a nuclear counterstain. Images were obtained using a confocal 
microscope (Leica TCS SP5) with 488 nm and 594 nm excitation wavelengths.  
  
2.2.6 Fibroblastic Markers 
Gene expression (n=5/group) was measured using quantitative real-time reverse transcriptase 
polymerase chain reaction (qPCR). Expression of fibroblastic markers type I collagen, type III collagen, 
fibronectin, tenascin-C, tenomodulin and scleraxis as well as integrins α2, αV, α5 and β1 was determined 
with GAPDH as the house-keeping gene using custom-designed primers as follows: 
Gene Sense Anti-Sense 
GAPDH 5’- GGCGATGCTGGCGCTGAGTA-3’ 5’-ATCCACAGTCTTCTGGGTGG-3’ 
Collagen I 5’-TGGTCCACTTGCTTGAAGAC-3’ 5’-ACAGATTTGGGAAGGAGTGG-3’ 
Collagen III 5’-GGCTACTTCTCGCTCTGCTT-3’ 5’-CATATTTGGCATGGTTCTGG-3’ 
Fibronectin 5’-TTGAACCAACCTACGGATGA-3’ 5’-AAATGACCACTTCCAAAGCC-3’ 
Tenascin-C 5’-TGCCCATTACAGGAGGTACA-3’ 5’-CACTTTCCTCAAAGCCCTTC-3’ 
Scleraxis 5’-CAGCGGCACACGGCGAAC-3’ 5’-CGTTGCCCAGGTGCGAGATG-3’ 
Tenodmoulin 5’-TTTGAGGAGGAGGGAGAAGA-3’ 5’-TTCCTCACTTGCTTGTCTGG-3’ 
α2 5’-CAGAATTTGGAACGGGACTT-3’ 5’- CAGGTAGGTCTGCTGGTTCA-3’ 
αV 5’-GATGGACCAATGAACTGCAC-3’ 5’-TTGGCAGACAATCTTCAAGC-3’ 
α5 5’-GTGGCCTTCGGTTTACAGTC-3’ 5’-AATAGCACTGCCTCAGGCTT-3’ 




Total RNA was isolated using the TRIzol reagent (Invitrogen, Carlsbad, CA) extraction method. The 
isolated RNA was reverse-transcribed into cDNA via the SuperScript III First-Strand Synthesis System 
(Invitrogen) following the manufacturer's suggested protocol. The cDNA product was amplified and 
quantified through real-time PCR using iQ SYBR Green Supermix (BioRad, Hercules, CA). All reactions 
were run for 50 cycles using the iCycler iQ Real-Time PCR Detection System (BioRad). Normalized 
expression levels reported were calculated based on difference between threshold cycles, namely, the 
difference in threshold cycle values between the gene of interest and the housekeeping gene GAPDH. 
 
2.2.7 Statistical Analysis 
Results are presented in the form of mean ± standard deviation, with n equal to the number of 
samples per group. Two-way ANOVA was used to determine the effects of loading and time on cell 
alignment, proliferation, gene expression and matrix deposition. The Tukey-Kramer post-hoc test was 
used for all pair-wise comparisons and significance was attained at p<0.05. Statistical analyses were 
performed with JMP IN (4.0.4, SAS Institute, Inc., Cary, NC). 
 
2.3 Results 
2.3.1 Cell Attachment and Alignment 
The MSCs were cultured on aligned and unaligned nanofiber meshes in a custom designed 
loading bioreactor (Fig. 2.1). It was observed that cells remained viable and proliferated on both aligned 
and unaligned nanofibers. On unaligned nanofibers, a significantly greater number of cells were 
measured after 28 days of loading (Fig. 2.2). Similarly, significantly more cells were found on loaded 
aligned nanofibers by day 7, with cell number plateauing after 28 days. In terms of cell attachment, on 
unaligned nanofibers, as expected, random orientation of cells was observed without loading and this cell 
morphology was maintained over time. Interestingly, upon loading, the cells adopted a markedly different 
morphology and aligned in the direction of applied strain by day 28. In contrast, a characteristic elongated 
fibroblast-like morphology was maintained on aligned nanofibers with no change observed due to either 
mechanical loading or culture duration.   
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To further investigate these apparent differences between groups, cell alignment on loaded and 
unloaded nanofibers was quantified using circular statistical analysis, focusing on changes in mean vector 
angle (MVA), angular deviation (AD) and mean vector length (MVL)[24;143] (Fig. 2.3). In general, values 
for the MVL range from 0 to 1, with the upper bound indicating greater horizontal alignment whereas the 
MVA (-90° < θ < 90°) represents the angle of cells with respect to the horizontal axis, with a lower angle 
indicating horizontal alignment. Values for AD characterize the dispersion of the non-Gaussian angle of 
distribution (0-40.5°) with 0° representing horizontal alignment and 40.5° indicating random distribution. In 
this study, it was observed that on unaligned nanofibers, loading resulted in a significantly greater MVL 
(loaded: 0.94; unloaded: 0.33) and a significant decrease in AD after 28 days of culture as well as a 
distinct cell alignment profile (p<0.05), represented as a histogram of cell orientation measured in each 
group (Fig. 2.3), all indicating a greater degree of horizontal alignment with respect to the unloaded 
group. In contrast, on aligned nanofibers, no difference in the MVL (0.91 vs. 0.93; unloaded vs. loaded) or 
AD (11.74° vs. 9.21°; unloaded vs. loaded) was found between the loaded and unloaded group.  
 
2.3.2 Matrix Deposition 
In terms of collagen production (Fig. 2.4), on both aligned and unaligned nanofibers, a significant 
increase in total collagen content was found after 28 days of loading. Further analysis revealed that on a 
per-cell basis, mechanical loading upregulated cellular biosynthesis on both unaligned and aligned 
nanofibers, with significantly greater collagen production per-cell measured for both groups after 28 days 
of loading when compared to unloaded controls. Moreover, immunohistochemistry revealed that, 
independent of loading, the matrix formed on unaligned nanofibers consisted primarily of type I collagen. 
Similarly, a predominantly type I collagen matrix was seen on aligned nanofibers in the absence of 
loading. Interestingly, upon the application of loading, a matrix of both types I and III collagen was 
produced by the cells only on aligned nanofibers while the matrix deposited on the unaligned nanofibers 




2.3.3 Cell Differentiation 
To further ascertain MSC differentiation, markers characteristic of the ligament fibroblast 
phenotype, including types I and III collagen, fibronectin, tenascin-C, scleraxis and tenomodulin, were 
assessed using quantitative real-time RT-PCR. On unaligned nanofibers, a mean increase in type I 
collagen was observed after seven days of loading and expression remained elevated after 28 days. The 
expression of type III collagen increased (6.1±1.0 fold higher with respect to the unloaded control) after 
seven days of loading but returned to control levels by day 28. Fibronectin expression was upregulated 
after 14 days (2.0±1.2 fold increase relative to unloaded control) and remained upregulated after 28 days 
in the loaded group. Notably, key fibroblastic markers tenascin-C, scleraxis and tenomodulin remained at 
basal level and were not upregulated by loading over time on unaligned nanofibers (Fig. 2.5). In contrast, 
on aligned nanofibers, type I collagen expression remained statistically similar both between groups and 
over time, although a three-fold increase in mean expression was observed after 28 days of loading 
compared to the unloaded group. Expression of type III collagen (4.1±1.1 fold increase relative to 
unloaded control), fibronectin (5.1±1.2 fold increase relative to unloaded control) and tenascin-C (4.3±1.0 
fold increase relative to unloaded control) was significantly upregulated after 14 days of mechanical 
stimulation, with the higher expression level maintained after 28 days of loading. (Fig. 2.5). While no 
change in tenomodulin expression was observed over time on aligned nanofibers regardless of loading, 
scleraxis was downregulated after 28 days of static culture whereas its expression was maintained over 
time in the loaded group (Fig. 2.5). In addition, phenotype specificity was evaluated by measuring the 
expression of various osteogenic (Runx-2, osteocalcin) and chondrogenic markers (sox9, type II 
collagen). No upregulation of any of these markers was observed over time or with loading on either 
unaligned or aligned nanofibers.  
 
2.3.4 Integrin Expression  
Next, to better understand the mechanisms behind MSC mechanotransduction and the observed 
cell-matrix interactions, the expression of key integrins (α2, αV, α5, β1) was assessed as these surface-
membrane receptors have been shown to mediate cell response to physical stimulation as well as matrix 
alignment[24;144-148]. It was observed that on unaligned nanofibers, both α2 and β1 were upregulated 
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after 14 days of loading and expression levels were maintained thereafter, while the expression of α5 
became significantly higher after seven days and plateaued thereafter (Fig. 2.6).  On the aligned 
nanofibers, similar to the response on unaligned nanofibers, αV expression did not change in response to 
loading. However, distinct expression profiles, as compared to the unloaded control, were measured with 
integrin subunits α2, α5 and β1 being upregulated after 14 days of culture, and expression levels were 
maintained after 28 days on the loaded nanofibers(p<0.05, Fig. 2.6).  
 
2.4 Discussion 
The objectives of this study are to investigate the role of nanofiber matrix alignment and 
mechanical stimulation on MSC differentiation, focusing on elucidating the relative contribution of each 
parameter as well as their interaction. It is shown that fibroblastic differentiation of MSCs is only possible 
when cultured on aligned nanofibers and co-stimulated with mechanical loading. In contrast, when 
loading was applied to MSCs cultured on unaligned nanofibers, while cells adapted their morphology to 
align in the direction of loading, they fail to undergo fibroblastic differentiation and do not deposit a 
ligament-like matrix. The findings of this study provide the first evidence that there is an interactive effect 
between matrix alignment and mechanical loading, and co-stimulation is required for the induction of 
MSC differentiation into fibroblasts.  
In terms of cell alignment and morphology, it was observed in this study that cells aligned in the 
direction of strain on the unaligned nanofibers whereas no change in alignment occurred over time on the 
aligned nanofibers in response to tensile stimulation. These findings suggest that the underlying nanofiber 
organization is the primary determinant of cellular alignment and that contact guidance drives long-term 
cellular organization. However, similar to what has been previously reported for fibroblasts on non-
patterned substrates[149;150], cell alignment can also be modulated by exogenous factors such as the 
direction of applied strain and oriented in a more physiologically relevant arrangement. 
In evaluating cell proliferation, the significant increase in cell number on unaligned nanofibers in 
response to loading, despite similar numbers of initially seeded cells on both the unloaded and loaded 
groups, may be due to a greater cell density that could be achieved with linear cell alignment in the 
direction of applied strain, as opposed to the random fiber-directed adhesion of cells on control 
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nanofibers. Though alternatively, mechanical loading may also enhance nutrient diffusion through the 
culture medium and promote cell survival over the unloaded groups. Notably, however, a consistently 
greater number of cells were measured on aligned nanofibers at all time points after day 1 as compared 
to unaligned nanofibers, supporting the implication that linear matrix alignment may allow for greater cell 
density on nanofibers.  
Total matrix deposition by MSCs was found to increase significantly with tensile stimulation on 
both aligned and unaligned nanofiber nanofibers. These observations corroborate previous reports of 
elevated MSC biosynthesis, such as in studies performed by Baker et al. who applied both tensile and 
chemical stimulation to MSCs cultured on PCL nanofibers[151] as well as for human fibroblasts cultured 
on polyurethane nanofibers[152] and subjected to tensile strain. However, in contrast to these reports, the 
results of this study reveal that mechanical stimulation alone can enhance MSC matrix deposition in the 
absence of growth factors as per-cell collagen production was enhanced on both aligned and unaligned 
nanofibers after 28 days of loading. 
In addition to enhanced matrix production, the production of type III collagen by MSCs in 
response to tensile strain only occurs on aligned nanofibers. The production of type III collagen is 
essential for the fibroblastic differentiation of cells as this protein represents approximately 12% (by dry 
weight) of the native ligament matrix[65] and provides tendons and ligaments with their strength and 
elasticity by forming heterotypic fibers incorporating type I collagen[153] while also playing a critical role in 
the healing processes of connective tissues[66]. These results indicate that only loading in conjunction 
with nanofiber alignment can stimulate the production of type III collagen. In short, for MSC to differentiate 
towards the ligament fibroblast phenotype, it is observed that a combination of physiologically-relevant 
cell-material interactions and mechanical stimulation is required. 
Analysis of MSC differentiation revealed that several key fibroblastic markers were upregulated 
only with the combination of nanofiber alignment and dynamic tensile loading. On unaligned nanofibers, 
an increase in type III collagen expression was observed after seven days of loading, accompanied by an 
increase in fibronectin expression after 14 days. Though type III collagen deposition was not found on 
unaligned nanofibers, the increase in expression may arise due to the similarity of the unaligned matrix to 
the disorganized collagen matrix of scar tissue, as five- to ten-fold increases in type III collagen content 
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have been reported at the Achilles’ tendon rupture sites during healing[154]. The changes in gene 
expression on aligned nanofibers are similar to those reported by Altman et al. who evaluated the effect 
of tensile strain and torsion on MSCs in type I collagen gels[27] and on silk fibers[91], reporting a similar 
upregulation of types I and III collagen as well as tenascin-C. Upregulation of both types I and III collagen 
expression is in agreement with the increase in total collagen deposition as well as the production of type 
III collagen by MSCs on aligned nanofibers in response to loading. Hsieh et al. also observed elevated 
type I collagen expression in fibroblasts cultured on silicone elastomer membranes and subjected to 
tensile strain[155]. The results of this study, however, represent a comprehensive characterization of 
fibroblastic differentiation of MSCs as a function of scaffold architecture and mechanical stimulation. 
Additionally, as no specific marker serves to distinguish ligament fibroblasts from other fibroblasts present 
in connective tissues, the type I:III collagen ratio is an important indicator of cell phenotype as it varies 
significantly between ligaments (~7:1) and tendons (~20:1)[65] and is substantially decreased in scar 
tissue (~1:1)[156]. In this study, cells on unaligned nanofibers demonstrated a type I:III collagen ratio of 
0.51±1.26 without loading and 1.03±0.99 with loading. In contrast, cells on aligned nanofibers measured a 
type I:III collagen expression ratio of 8.35±2.12 after 28 days of loading, as opposed to approximately 
2.07±1.11 for the unloaded group, thereby suggesting that cells assumed a ligament fibroblast-like 
phenotype in response to mechanical stimulation only on the aligned nanofibers.  
Furthermore, scleraxis, a transcription factor that has been shown to be critical for tendon and 
ligament formation during development in both avian and murine models[157;158], was maintained on 
nanofibers subjected to mechanical stimulation while decreasing in unloaded scaffolds, a trend similar to 
that reported by Kuo et al. using a collagen gel system seeded with human MSCs[159]. However, 
tenomodulin, a transmembrane glycoprotein induced by scleraxis and implicated in collagen 
organization[160;161], was not upregulated with stimulation in this study. Tenomodulin, a late marker of 
tendon and ligament formation, is regulated by scleraxis[162] and will likely be upregulated in long term 
culture.  
In addition, mechanical stimulation, on both substrates, leads to significant changes in integrin 
expression, indicating that these receptors mediate both cell-matrix interaction and mechanotransduction. 
The upregulation of α2, α5 and β1 on both unaligned and aligned nanofibers, though with distinct 
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temporal patterns, in response to loading indicates that these integrins play a role in MSC 
mechanotransduction. Integrin upregulation has also been observed for MSCs cultured on silk fibers and 
subjected to dynamic torsion, whereby a significant increase in α2 expression was found albeit without a 
concurrent upregulation of β1[89]. The elevated expression of these integrins is likely in response to 
mechanical loading, ensuring that there are sufficient numbers of surface receptors to translate the 
physical stimulation. Interestingly, a similar enhancement of integrin expression was reported for 
differentiated cells in response to nanofiber alignment. Moffat et al. observed α2 upregulation by tendon 
fibroblasts when cultured on aligned versus unaligned PLGA nanofibers[24] and it was proposed that 
fibroblasts may signal recognition of fiber alignment with upregulated integrin expression. Therefore, the 
biomimetic aligned nanofibers, which resembles the native collagenous ECM, may also contribute to the 
observed increase in α2 expression as the β1 subunit complexes with α2 to bind to collagen[163]. As 
such, no upregulation in α2 expression was observed for MSCs on unaligned or aligned nanofibers in the 
absence of loading, indicating that for MSCs, upregulation of such a key collagen-binding molecule is 
linked primarily to mechanical stimulation.  
Upregulation of the α5 and β1 subunits has also been associated with mechanotransduction by 
Hannafin et al. who observed α5 and β1 subunit upregulation by canine ligament fibroblasts cultured in 
tethered and strained collagen gels[149;164].  Additionally, the α5 integrin complexes with β1 to bind to 
fibronectin[165] and has been demonstrated to be upregulated by MSCs upon binding to fibronectin 
functionalized surfaces[166]. The concomitant increase in fibronectin expression observed here may be 
coupled with the upregulation of these integrins as fibronectin plays a central role in cell adhesion and 
also can influence a variety of downstream pathways. For example, binding to the α5β1 receptor has 
been shown to activate the Shc pathway which promotes cell proliferation and is potentially responsible 
for the observed increase in cell number on meshes subjected to mechanical stimulation this study[167]. 
In addition, Song et al. reported that rat MSC proliferation on silicone elastomers was enhanced with 
mechanical loading and postulated that such a response may be due to activation of the focal adhesion 
kinase (FAK) pathway via integrin signaling[168]. The downstream effects of these cell-matrix interactions 
will be investigated in future studies. 
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In addition to systematically elucidating the role of scaffold architecture and mechanical 
stimulation in stem cell differentiation, the findings of this study have broad implications for scar-less 
wound healing and guided soft tissue repair. All three of the integrin subunits upregulated in this study 
have been implicated in ligament and tendon healing and published studies have shown that α5, αV and 
β1 integrin production increases in injured rabbit medial collateral ligaments (MCL)[165]. Moreover, 
mechanical stimulation has been demonstrated to accelerate the wound healing process, such as that of 
skin wounds using a rabbit model[169].  The α2β1 integrin, specifically, is known to be utilized by cells to 
contract collagen fibrils during matrix reorganization and wound healing[170], and the upregulation of 
these integrins suggest a nanofiber-driven matrix remodeling response by these stem cells. In addition, 
by modulating alignment, the nanofiber matrix can be used to model both the healthy tissue (aligned) and 
a disorganized wound site (unaligned) during repair. Specifically, the ability of mechanical loading to 
‘rescue’ cell alignment towards a more physiologically relevant organization is significant as these 
observations demonstrate that controlled physical stimulation may be a more potent driver of MSC 
differentiation than substrate morphology. However, the lack of fibroblastic differentiation by MSCs on the 
unaligned substrate and the statically cultured aligned substrate indicates that neither mechanical loading 
nor substrate alignment alone is sufficient to drive MSCs towards a fibroblastic phenotype, thereby 
demonstrating that both biomimetic architecture and physiologic mechanical stimulation are needed to 
control MSC differentiation and guide tissue healing. Clinically, it is envisioned that a strategy of 
concurrent stimulation with a biomimetic ECM and physiological loading could be utilized to direct the 
differentiation of MSCs on scaffolds for connective tissue engineering as well as extended applications in 
scar-less wound repair. Future work will more closely investigate the effects of cellular deformation on the 
aligned and unaligned nanofibers, as previous work has established that actin and myosin stress-fibre 
alignment is substrate-dependent and can influence differentiation[171], while also evaluating further 
optimization of the loading regiment for both differentiation and matrix production.  
 
2.5 Conclusions 
 This study investigated the coupled effects of nanofiber matrix alignment and mechanical 
stimulation on stem cell differentiation. It was demonstrated that MSCs differentiate into ligament 
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fibroblast-like cells when cultured on aligned nanofibers and subjected to tensile loading.  In contrast, on 
unaligned nanofibers, mechanical loading only modulates cell attachment morphology without 
subsequent induction of fibroblastic differentiation. These results demonstrate the deterministic role 
biomaterial substrate alignment plays in stem cell response to mechanical loading, as both biomimetic 
alignment and tensile loading are required for the induction of MSCs into ligament fibroblasts. As a result, 
the ligament phase of the graft should consist of aligned nanofibers subjected to dynamic tensile loading 
to drive fibroblastic differentiation of seeded MSCs. Next, the effect of combined chemical and 
mechanical stimulation will be evaluated to determine if fibroblastic differentiation on aligned nanofibers 




Figure 2.1. Modular bioreactor system for applying tensile strain to nanofiber meshes. A) Scanning 
electron micrographs of unaligned and aligned PLGA nanofibers. B) Nanofiber meshes are cultured in a 
custom bioreactor with load applied via a linear actuator and stepper motor. C) Five nanofiber meshes 
are cultured in each individual bioreactor. The apparatus is housed within a cell culture incubator for the 







Fiber Diameter (nm) 667 ± 128 615 ± 152 
Pore Size (μm) 4.91 ± 0.78 4.23 ± 1.06  




Figure 2.2. Effect of alignment and mechanical stimulation on cell attachment and proliferation. On 
unaligned nanofibers, a significantly greater number of MSC were found after 28 days of loading. Cells 
attachment conformed to the underlying nanofiber architecture in the control group but appeared to align 
in the direction of loading with the application of mechanical stimulation. On aligned nanofibers, an 
increase in total cell number was observed after seven days with equal numbers of cells present after 28 





















































































Figure 2.3. Effect of alignment and mechanical stimulation on cell alignment. A distinct difference in 
MSC alignment was observed on unaligned nanofibers after 28 days of loading with cells predominantly 
aligned in the direction of loading on strained nanofibers, as quantified via circular statistical analysis. 
Analysis via SEM indicated that cells spanned across fibers as opposed to following individual fibers. No 
difference in alignment was observed on aligned nanofibers due to loading.   
Day 28 (n=3) MVA ± AD (°) MVL 
Unloaded MSC 3.69 ± 11.74 0.93 ± 0.07 
Loaded MSC 4.01 ± 9.21 0.91 ± 0.08  






















Mean Vector Angle (MVA): -90° ≤ θ ≤ 90°, 0° = horizontal orientation   
Angular Deviation (AD): 0° = aligned, 40.5° = random 
Mean Vector Length (MVL): 0 = random, 1 = aligned 
Day 28 (n=3) MVA ± AD (°) MVL 
Unloaded MSC 6.78 ± 28.98 0.33 ± 0.09 
Loaded MSC 4.44 ± 7.26 0.94 ± 0.03  
Scaffold 9.12 ± 37.19 0.26 ± 0.12 
Day 1 Day 14 Day 28 

































































Figure 2.4. Effect of alignment and mechanical stimulation on matrix deposition. A significant 
increase in total collagen was measured, using the hydroxyproline assay, on both aligned and unaligned 
nanofibers after 28 days of dynamic loading. Immunohistochemistry after 28 days of culture also indicated 
that the ECM was primarily composed of type I collagen on unaligned nanofibers with type III collagen 





































































Red: collagen Red: type I collagen; Yellow: type III collagen; 
Blue: cell nuclei 
Red: collagen Red: type I collagen; Yellow: type III collagen;  




























Figure 2.5. Effect of alignment and mechanical stimulation on cell differentiation. Gene expression 
of fibroblast makers by MSCs on unloaded and loaded nanofibers versus time (*p<0.05). On unaligned 
nanofibers, type III collagen was upregulated after 7 days of loading but returned to control levels after 14 
days. Fibronectin expression was upregulated after 14 days and remained elevated after 28 days of 
loading. In contrast, on aligned nanofibers, types I and III collagen, fibronectin, tenascin-C and scleraxis 
were all upregulated. The ratio of collagen type I:III was 8.35 ± 2.12 by cells on loaded nanofibers after 28 
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Figure 2.6. Effect of alignment and mechanical stimulation on integrin expression. Gene expression 
of integrin subunit by MSCs on unaligned nanofibers revealed the upregulation of integrin subunits α2, α5 
and β1. (*p<0.05). Similarly, on aligned nanofibers upregulation of integrin subunits α2, α5 and β1 was 












































































































































































































CHAPTER 3: LIGAMENT PHASE: THE EFFECT 
OF FIBROGENIC CULTURE CONDITIONS ON 
FIBROBLASTIC DIFFERENTIATION OF 





Based on the previous study in Chapter 2, fibroblastic differentiation of MSCs requires 
physiologically-relevant mechanical stimulation coupled with an aligned nanofiber substrate. It has also 
been demonstrated that chemical stimulation, using growth factors such as basic fibroblast growth factor 
(bFGF) and transforming growth factor-beta can induce fibrogenic differentiation of MSCs and that 
differentiation can be further enhanced when coupled with mechanical loading. This chapter aims to 
determine the synergistic effects of chemical and mechanical stimulation to determine if adding growth 
factors prior to applying the mechanical strain regimen, identified in Chapter 2, is necessary to enhance 
fibrogenesis. 
 
3.1.1 Background and Motivation 
Despite the versatility of MSCs for tissue engineering purposes, standardized methods to 
differentiate these cells towards a fibroblastic lineage have not been well established. To this end, several 
groups have demonstrated that mechanical stimulation can be used to drive fibroblastic differentiation of 
MSCs. Among the earliest to evaluate fibrogenic differentiation of MSC were Altman et al. who 
demonstrated that MSCs could be induced into a fibroblastic phenotype when seeded in type I collagen 
gels and subjected to a combination of tensile and rotational strain. Specifically, It was reported that the 
application of mechanical stress upregulated the expression of ligament fibroblast markers, resulted in the 
production of type III collagen and guided cell alignment in the direction of applied load[27]. Studies 
performed by Butler et al. evaluating a range of mechanical stimulation parameters using a type I 
collagen sponge system have similarly demonstrated that tensile strain can upregulate the expression of 
fibroblastic markers and enhance MSC matrix deposition[172-175]. Recently, it was demonstrated that 
the application of dynamic mechanical stimulation to human MSCs cultured on aligned nanofibers results 
in fibroblastic differentiation and the production of a ligament-like matrix[176] Mechanical loading resulted 
in the upregulation of several fibroblastic genes including type III collagen, fibronectin, tenascin-C and 
scleraxis while also resulting in the production of a matrix rich in types I and III collagen. 
To augment ligament engineering strategies, methods to further enhance MSC response and 
biosynthesis have been explored in order to facilitate the formation of functional ligament tissue. Mitogens 
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such as the transforming growth factor-beta (TGF-β) family, basic fibroblast growth factor (bFGF) and 
epidermal growth factor (EGF) have been shown to induce proliferation both in vitro and in vivo for cell 
types including fibroblasts and MSCs and have also been shown to affect MSC differentiation and 
biosynthesis. In particular, bFGF has been shown to maintain MSC differentiation potential, stimulate 
proliferation, and induce fibroblastic differentiation. Studies performed by Hankemier et al. demonstrated 
that low-dose (3ng/ml) bFGF increased MSC proliferation as measured after 7 days and, on days 14 and 
28, upregulated the expression of type I and III collagen, fibronectin and smooth muscle actin[177]. 
Furthermore, chemical stimulation has been shown to synergistically enhance cell response when 
combined with mechanical stimulation. For example, Moreau et al. evaluated the sequential application of 
biochemical and mechanical stimulation to MSCs cultured on silk fiber-based scaffolds. It was reported 
that stimulating cells with bFGF or EGF for five days prior to the application of mechanical load modulated 
matrix protein expression and cell activity[91].  
 
3.1.2 Objectives 
Building upon previous results, bFGF was selected for further investigation to enhance MSC-
based ligament engineering for the ligament phase of the synthetic ACL graft. Specifically, the objective 
of this study is to evaluate the synergistic effect of chemical and mechanical stimulation on the fibroblastic 
differentiation of human MSC when seeded on nanofiber meshes. It is hypothesized that chemical 
priming of MSCs with bFGF prior to the application of mechanical stimulation will enhance MSC matrix 
production and upregulate the expression of relevant fibroblastic genes. 
 
3.2 Materials and Methods 
3.2.1 Nanofiber Mesh Fabrication  
Aligned nanofiber meshes composed of PLGA (85:15, Mw = 123.6 kDa; Lakeshore Biomaterials, 
Birmingham, AL) were produced using electrospinning[24;139]. Briefly, PLGA nanofibers were fabricated 
by producing a solution composed of 35% PLGA (v/v) in 55% N,N-dimethylformamide (Sigma-Aldrich, St. 
Louis, MO) and 10% ethyl alcohol. The solution was loaded into a syringe with an 18.5-gauge stainless 
steel blunt tip needle and electrospun at 8-10kV and 1 mL/hour using a custom electrospinning device. 
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Aligned fibers were produced by electrospinning onto a custom rotating mandrel (20 m/s) with polymer 
dispensation via a syringe pump (Harvard Apparatus, Holliston, MA; 1 ml/hr). 
 
3.2.2 Cells and Cell Culture 
Human mesenchymal stem cells (MSC) were obtained commercially (Lonza, Walkersville, MD) 
and maintained in culture with DMEM containing 10% fetal bovine serum (FBS, embryonic stem cell 
certified, Atlanta Biologicals, Atlanta, GA), 1% penicillin-streptomycin, 1% non-essential amino acids, 
0.1% amphotericin B and 0.1% gentamicin. Cells were cultured to 80% confluence and then passaged 
using 0.25% trypsin/1 mM ethylenediaminetetraacetate (EDTA) and re-plated at a density of 5x103 
cells/cm2. Passage 2 cells were used for nanofiber mesh seeding. 
All studies were performed using low-serum medium as adapted from previously published 
studies. This medium was identical to MSC maintenance media but contained 5% FBS and was utilized 
for the duration of the culture period. To evaluate chemical stimulation, the low-serum medium was 
supplemented with 10ng/mL bFGF (Invitrogen). 
 Meshes were secured in a custom bioreactor to apply uniaxial tensile strain. Briefly, electrospun 
meshes (5x6cm) were excised after fabrication and subsequently sterilized via ultraviolet irradiation 
(15minutes/side). Meshes were secured in loading cartridges via teflon clamps, sectioned into 5 cm x 1 
cm strips and pre-incubated in culture medium at 37ºC and 5% carbon dioxide for 16 hours. Cells were 
seeded on the meshes at a density of 3x104 cells/cm2 and allowed to attach for 15 min before the addition 
of culture medium.  
 
3.2.3 Cell Attachment and Alignment 
Cell viability and morphology (n=3/group) was evaluated using Live/Dead staining (Invitrogen, 
Carlsbad, CA) following the manufacturer’s suggested protocol. The samples were imaged under 
confocal microscopy (Leica TCS SP5, Bannockburn, IL) at excitation wavelengths of 488nm and 594nm. 
Cell penetration was evaluated by taking a z-series of confocal images over a depth of 20μm, equivalent 




3.2.4 Cell Proliferation  
Total DNA content was measured using the PicoGreen dsDNA assay (Invitogen).  At each time 
point, the samples (n=5/group) were homogenized in 0.1% Triton-X (Sigma-Aldrich) and subjected to 20 
seconds of ultrasonication at 5W.  Fluorescence was measured using a microplate reader (Tecan) at an 
excitation wavelength of 485 nm and an emission wavelength of 535 nm.  A standard curve was derived 
and used to correlate DNA concentration to fluorescence intensity, and cell number was determined 
based on a conversion factor of 8pg DNA/cell[104].  
 
3.2.5 Matrix Deposition 
Total collagen content per sample (n=5/group) was calculated using the hydroxyproline 
assay[142].  Briefly, the samples were first desiccated for 24 hours and then digested for 16 hours at 65°C 
with papain (600 µg protein/ml) in 0.1M sodium acetate (Sigma), 10 mM cysteine HCl (Sigma), and 50 
mM ethylenediaminetetraacetate (Sigma).  A 40 µl aliquot of the digest was hydrolyzed with 10 µl 10 M 
sodium hydroxide and autoclaved for 25 minutes.  The hydrolyzate was then oxidized by a buffered 
chloramine-T reagent for 25 minutes before the addition of Ehrlich’s reagent.  Sample absorbance was 
measured at 550nm (Tecan), and the collagen content was obtained by interpolation along a standard 
curve of bovine type I collagen (Sigma). 
 Collagen penetration was also visualized using picrosirius red staining of frozen sections 
(n=2/group) after 28 days of culture. Briefly, after fixation, samples were embedded in 5% polyvinyl 
alcohol (PVA, Sigma-Aldrich) and 7-micrometer thick sections (spanning the depth and width of the 
mesh) were obtained using a cryostat (Hacker-Bright OTF model, Hacker Instruments and Industries, 
Winnsboro, SC). Collagen distribution was visualized with picrosirius red staining under light microscopy 
(Axiovert 25, Zeiss). 
 
3.2.5 Cell Differentiation 
 Gene expression (n=5/group) was measured using quantitative real-time reverse transcriptase 
polymerase chain reaction (qPCR) at 1, 7, 14 and 28 days. Total RNA was isolated using the Trizol 
extraction method (Invitrogen). Isolated RNA was then reverse-transcribed into complementary DNA 
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using the SuperScript First-Strand Synthesis System (Invitrogen), and the cDNA product was amplified 
using recombinant Taq DNA polymerase (Invitrogen). Expression of fibroblastic markers type I collagen, 
type III collagen, fibronectin tenascin-C, tenomodulin and scleraxis was determined. GAPDH served as 
the house-keeping gene. Primer sequences were as follows: 
Gene Sense Anti-Sense 
GAPDH 5’- GGCGATGCTGGCGCTGAGTA-3’ 5’-ATCCACAGTCTTCTGGGTGG-3’ 
Collagen I 5’-TGGTCCACTTGCTTGAAGAC-3’ 5’-ACAGATTTGGGAAGGAGTGG-3’ 
Collagen III 5’-GGCTACTTCTCGCTCTGCTT-3’ 5’-CATATTTGGCATGGTTCTGG-3’ 
Fibronectin 5’-TTGAACCAACCTACGGATGA-3’ 5’-AAATGACCACTTCCAAAGCC-3’ 
Tenascin-C 5’-TGCCCATTACAGGAGGTACA-3’ 5’-CACTTTCCTCAAAGCCCTTC-3’ 
Scleraxis 5’-CAGCGGCACACGGCGAAC-3’ 5’-CGTTGCCCAGGTGCGAGATG-3’ 
Tenodmoulin 5’-TTTGAGGAGGAGGGAGAAGA-3’ 5’-TTCCTCACTTGCTTGTCTGG-3’ 
 All genes were amplified for 50 cycles in a thermocycler (Bio-Rad iCycler, Hercules, CA) with a 
fluorescent probe (SYBR Green, Invitrogen). Quantitative analysis of gene expression was performed 
using the delta-delta CT method. 
 
3.2.6 Mechanical Properties 
Mechanical properties of the loaded and unloaded meshes (n = 5 samples/group) were 
determined at 1, 7, 14 and 28 days after priming. At each time point, samples were tested to failure under 
uniaxial tension. Meshes were secured with custom clamps tested to failure at a strain rate of 
5mm/minute (Instron, Model 8841, Norwood, MA) with an average gauge length of 3cm. Samples were 
evaluated to failure at a strain rate of 5mm/min with load applied in the direction of fiber alignment. Mesh 
yield strength and ultimate tensile stress were determined, and elastic modulus was calculated from the 
linear region of the stress-strain curve. 
 
3.2.7 Experimental Design & Bioreactor Culture 
The effect of exogenous bFGF stimulation on MSC response was first evaluated in a two-week 
study in which cell viability, proliferation, matrix deposition and differentiation were assessed. 
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Subsequently, a four-week study was conducted in which MSCs were primed statically for 5 days with 
bFGF and then subjected to dynamic tensile stimulation in a custom bioreactor. Loaded samples were 
subjected to 1% strain at 1Hz for 90 minutes twice daily and evaluated over a period of 28 days. Control 
meshes, cultured in identical bioreactor cartridges, were subjected to the same growth factor priming 
regimen without subsequent mechanical stimulation. 
 
3.2.8 Statistical Analysis 
Results are presented in the form of mean ± standard deviation, with n equal to the number of 
samples per group. Two-way ANOVA was used to determine the effects of chemical stimulation and 
mechanical loading on cell proliferation, matrix deposition, gene expression and mechanical properties. 
The Tukey-Kramer post-hoc test was used for all pair-wise comparisons and significance was attained at 
p<0.05. Statistical analyses were performed with JMP IN (4.0.4, SAS Institute, Inc., Cary, NC). 
 
3.3 Results 
3.3.1 MSC Response to Chemical Stimulation 
 Cell viability and attachment morphology was visualized using confocal microscopy. The MSCs 
displayed an elongated fibroblastic morphology that conformed to the alignment of the underlying 
nanofibers (Fig. 3.1). Similarly viable cells were observed both with and without the treatment of bFGF. 
Cell number was quantified for both groups at each time point. Chemical stimulation resulted in a 
significant difference in the number of cells per mesh after 7 days of culture, with a significantly greater 
number of cells present on nanofibers subjected to bFGF stimulation. The total number of cells was also 
significantly greater than that measured after 1 day of culture for both groups (Fig. 3.1). After 14 days of 
culture, there remained significant difference in number of cells present in the control and bFGF 
stimulated group. Total collagen deposition was evaluated for both groups over time. Total collagen 
deposited by cells was similar after 1 day of culture with a significant increase in the bFGF stimulated 
group after 7 days of culture (Fig. 3.1). A significantly greater amount of collagen was measured on 
nanofibers subjected to bFGF stimulation after 14 days. No significant change in total collagen was 
measured over time in the control group.  
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 Differentiation of MSCs in both groups was assessed over the 14 day culture period by 
measuring the expression of types I and III collagen, fibronectin, tenascin-C, scleraxis and tenomodulin. 
Significant changes in gene expression occurred only after 14 days in the bFGF stimulation group. 
Specifically, types I and III collagen, fibronectin and tenascin-C were all upregulated after 14 days of 
chemical stimulation as compared to the control group (Fig. 3.2). The expression of these genes did not 
change over time in the control group. In both the control and bFGF stimulated groups, the mean 
expression of scleraxis and tenomodulin decreased over time though no significant change was 
measured.  
 Nanofiber mesh mechanical properties were measured over the duration of the study via uniaxial 
tensile testing. No differences in mechanical properties were measured between the unloaded and loaded 
groups in terms of elastic modulus, yield strength, ultimate tensile strength or ductility. A significant 
decrease in elastic modulus and ductility were observed after 28 days of culture in both groups. 
 
3.3.2 MSC Response to Sequential Chemical and Mechanical Stimulation 
 After determining the effect of chemical stimulation on MSC response, a four-week study was 
conducted to assess MSC response to sequential chemical and mechanical stimulation. Confocal 
microscopy of cells seeded revealed no differences in cell viability or morphology between the loaded and 
unloaded control group as cells aligned in the direction of the underlying nanofibers and remained viable 
over the duration of the study (Fig 3.3). A significant increase in total cells was observed after 7 days of 
culture in both the loaded and unloaded group. Total cell number on nanofiber meshes was significantly 
greater in the loaded group after 7 days of mechanical stimulation, as compared to unloaded controls. No 
significant difference between groups was measured after 14 days, though significantly greater cells were 
once again measured on the loaded group after 28 days. 
 Matrix deposition was evaluated both quantitatively to determine total collagen content and 
qualitatively to evaluate matrix morphology and penetration. Total collagen deposition increased over the 
duration of the culture period with significantly greater collagen deposited by cells subjected to dynamic 
loading as compared to loaded controls after 28 days (Fig. 3.4). In addition, histological analysis of matrix 
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deposition via Picrosirius Red staining revealed deeper matrix penetration into loaded meshes after 28 
days.  
 To evaluate MSC differentiation, the expression of several key fibroblastic genes was measured 
using quantitative PCR (Fig. 3.5). In the unloaded group, type I collagen expression was unregulated 
significantly 7 days after the priming culture period but decreased significantly after 28 days. In contrast, 
type I collagen was upregulated to a greater extent in the loaded group after 7 days of mechanical 
stimulation and remained elevated after 28 days. The expression of type III collagen was significantly 
upregulated after 14 days in both groups though the expression levels on mechanically stimulated 
nanofiber meshes were significantly higher at both 14 and 28 days. Fibronectin expression increased 
over time in both the unloaded and loaded groups with expression levels remaining similar regardless of 
the application of mechanical stimulation. Tenascin-C expression increased over time in both groups over 
the first 14 days following priming. A significant decrease in tenascin-C expression was measured in the 
unloaded group after 28 days whereas the expression level was maintained with mechanical stimulation. 
Expression of scleraxis remained similar in both groups over the duration of the study though expression 
of tenomodulin increased significantly after 28 days of loading. 
 The effect of combined chemical and mechanical stimulation on nanofiber mesh mechanical 
properties was assessed over the duration of the culture period (Fig 3.6). No difference in mesh 
mechanical properties was measured between groups at any time point. A significant decrease in yield 
strength, ultimate tensile strength (UTS) and ductility were measured 4 weeks after priming in both groups 
as compared to day 1 (p<0.05). 
 
3.4 Discussion 
This study focuses on the differentiation of mesenchymal stem cells into fibroblast-like cells on 
nanofiber meshes using a combination of chemical and mechanical stimulation. In this study, the effects 
of treating MSCs seeded on nanofibers with bFGF alone and also sequentially with bFGF followed by 
dynamic tensile strain were systematically investigated. It is observed that bFGF stimulation alone can 
enhance MSC proliferation and matrix deposition and that mechanical stimulation can synergistically 
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enhance these effects to drive MSCs towards a fibroblastic phenotype. Based on these findings, it is 
apparent that combinatorial stimulation techniques could be used to engineer ligament tissue in vitro.  
 In this study, biochemical stimulation of MSCs with bFGF resulted in an increase in the total 
number of cells and collagen on nanofiber meshes after 14 days as well as an increase in the expression 
of types I and III collagen, fibronectin and tenascin-C. It has previously been established that bFGF is a 
mitogen which can enhance the proliferation of MSCs. Pitaru et al. reported that bFGF in conjunction with 
osteogenic medium containing dexamethasone stimulated proliferation. Hankemeier et al. also reported 
that bFGF stimulation results in dose-dependent effects on MSCs and low doses (3ng/ml) stimulated cell 
proliferation while upregulating the expression types I and III collagen, fibronectin and alpha-smooth 
muscle actin (α-SMA).  In contrast, high doses (30ng/ml) decreased proliferation and ECM protein 
expression. The dose used in this study (10ng/ml) is closer in magnitude to the low-dose condition. In 
addition, an increase in total collagen was observed on nanofibers with chemical stimulation as compared 
to unstimulated controls after 14 days. This difference is likely due to the increased number of cells, as 
normalizing collagen content per-cell indicated no difference in per-cell collagen production. Previous 
groups have reported similar findings when utilizing bFGF to stimulate MSCs on tissue engineered 
scaffold systems. For example, Sahoo et al. extended upon this and evaluated the incorporation of bFGF 
into a silk/PLGA hybrid fiber scaffold for ligament tissue engineering{5313}. Local release from the 
biohybrid scaffold resulted in an increase in cell number and total collagen and also increased scaffold 
mechanical properties after three weeks of culture in vitro.  
 Based upon the ability of bFGF to enhance cell response and elicit the upregulation of fibroblast-
related matrix proteins, chemical priming of MSCs with bFGF prior to mechanical stimulation was 
investigated. Notably, in this study, it was shown that applying mechanical stimulation following chemical 
priming resulted in a greater number of cells and total collagen present on nanofiber meshes after 28, as 
compared to applying a bFGF priming regimen alone. These findings indicate that mechanical stimulation 
can synergistically enhance cell proliferation and biosynthetic response on nanofibers. In addition, 
mechanical stimulation maintained the expression of types I and III collagen over the four week period 
following priming. This finding indicates that that chemical stimulation may not result in cells fully 
obtaining a fibroblastic phenotype, whereas mechanical stimulation could maintain differentiation or 
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potentially result in cells committing to fibrogenesis. Interestingly, combined mechanical and chemical 
stimulation resulted in the upregulation of tenomodulin 28 days after chemical priming. Tenomoduling ia 
an anti-angiogenic transmembrane protein that has been shown to be predominantly expressed in 
tendons and ligaments. While previous work evaluating mechanical stimulation without chemical priming 
of MSCs on nanofibers did not show any effect on tenomodulin expression, this finding indicates that 
bFGF priming may result in MSCs further differentiating towards a ligament or tendon fibroblast 
phenotype.  
The effect of combined bFGF and mechanical stimulation has been previously investigated on 
other tissue engineered constructs with similar results. Petrigliano et al. reported on the development of a 
bFGF-eluting porous polycaprolactone-based construct[178]. It was shown that cells subjected to both 
chemical and mechanical stimulation resulted in the greatest upregulation of types I and III collagen and 
tenascin-C. Moreau et al. demonstrated that bFGF priming followed by mechanical stimulation enhanced 
matrix development and better supported overall tissue development, as compared to EGF priming[91].  
It has previously been shown that mechanical stimulation may result in increased cell 
responsiveness to growth factors, potentially due to mechanical forces initiating enhanced matrix 
production and remodeling. In a study performed by Shin et al., bFGF signaling was investigated as a 
mechanotransduction pathway for human umbilical vein endothelial cells (HUVEC) subjected to cyclic 
pressure[179]. It was shown that the enhanced proliferation of cells was associated with rapid tyrosine 
phosphoryliation of the bFGF receptor, fibroblast growth receptor 2 (FGFR-2), but not with increased 
synthesis of bFGF. Studies performed by Vincent et al. also demonstrated that cyclic loading of porcine 
cartilage resulted in the rapid activation of the bFGF-dependent extracellular signal-regulated kinase 
(ERK) mitogen-activated protein (MAP) kinase pathway[180;181]. These findings collectively implicate 
bFGF in mechanical signaling and suggest that priming of cells with this protein may increase cell 
response to mechanical stimulation.  
 Sequential chemical and mechanical stimulation resulted in no difference in nanofiber mesh 
mechanical properties as compared to chemical priming alone. It is likely that longer-term culture or 
further strategies to enhance matrix deposition may be necessary in order for cells to produce sufficient 
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ECM to augment nanofiber mesh mechanical properties. Previous studies using electrospun nanofibers 
have shown increases in cell-seeded mechanical properties as late as 10 weeks post-seeding[126]. 
One limitation of this study is the use of serum-containing medium in conjunction with growth 
factor stimulation. This parameter was determined based on previous work in which low-serum levels in 
conjunction with growth factors elicited a favorable response[28;91]. While these conditions may be 
suitable for ligament tissue engineering strategies, a further investigation of growth factor stimulation on 
MSC response requires serum-free condition as the proteins present in serum may mask or 
synergistically enhance the effects of bFGF. In addition to bFGF, other growth factors, such as TGF-
β[28;182] or growth/differentiation factor-5 (GDF-5)[182;183], may be able to further enhance cell 
response, either simultaneously or in sequence, as these proteins have been shown to enhance MSC 
biosynthesis as well as ligament and tendon tissue formation.  
While this study produced several promising findings, significant further investigation is required 
to understand the temporal effects of chemical and mechanical stimulation on MSC response. 
Specifically, future work should assess dose-dependent response, priming duration and variations in 
mechanical stimulation parameters are necessary to optimize MSC differentiation into a fibroblast-like 
phenotype. These studies represent a foundation upon which further investigation can be performed and 
it is anticipated that combined stimulation techniques of mesenchymal stem cells on tissue engineered 
scaffolds will enable functional ligament regeneration. 
 
3.5 Conclusions 
 In summary, it is shown that bFGF stimulation of MSCs can enhance MSC proliferation and 
matrix deposition and that applying chemical stimulation prior to mechanical stimulation can 
synergistically enhance these effects to drive MSCs towards a fibroblastic phenotype. Based on these 
findings, it is apparent that combinatorial stimulation techniques could be used to engineer ligament 




Figure 3.1. Effect of bFGF on MSC Proliferation and Matrix Production. Treatment with exogenous 
bFGF resulted in significantly greater cells on nanofibers after 7 days of culture. Growth factor treatment 




Figure 3.2. Effect of bFGF on MSC Differentiation. Growth factor treatment resulted in the upregulation 
of types I and III collagen, fibronectin and tenascin-C. In contrast, the mean expression of scleraxis and 





Figure 3.3. Effect of chemical and mechanical stimulation on cell attachment and proliferation. 
Cells remained similarly viable on both unloaded and loaded scaffolds. A significantly greater number of 





Figure 3.4. Effect of chemical and mechanical stimulation on MSC biosynthesis. Mechanical 
stimulation in conjunction with growth factor priming resulted in enhanced collagen deposition after 28 
days of loading, as compared to unloaded controls. Histological analysis indicated deeper matrix 
penetration into loaded meshes after 28 days.  
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Figure 3.5. Effect of chemical and mechanical stimulation on MSC differentiation. Mechanical 
stimulation in conjunction with chemical priming resulted in a significant upregulation of types I and III 




Figure 3.6. Effect of chemical and mechanical stimulation on nanofiber mesh mechanical 
properties. No difference in mesh mechanical properties was measured between groups over time. A 
significant decrease in yield strength, ultimate tensile strength (UTS) and ductility were measured 4 




CHAPTER 4: LIGAMENT PHASE: THE EFFECT 





 In the previous chapters, cues to induce fibroblastic differentiation of MSCs were investigated. In 
chapter 2, it was demonstrated that mechanical stimulation alone on an aligned nanofiber substrate could 
induce the expression of fibroblastic markers and the deposition of a ligament-like matrix by MSCs. 
Subsequently, in chapter 3, it was shown that these effects could be enhanced when combined with 
chemical stimulation. However, in addition to supporting fibroblastic cell response, the ligament phase of 
the ACL scaffold must be sufficiently mechanically suitable for ligament replacement. This chapter 
investigates the optimal nanofiber composition for the ligament phase of the scaffold to select a material 
that mimics the mechanical properties of the native ligament and supports long-term ligament tissue 
formation. 
 
4.1.1 Background and Motivation 
A number of synthetic ACL prosthetic devices have been previously investigated with limited 
clinical success to date, as none are currently FDA approved. These attempts include grafts 
manufactured from carbon fiber[76], polytetrafluoroethylene (PTFE)[77;78], polyester[79;80] and 
polypropylene[81]. Among the earliest attempts at a prosthetic ligament were the carbon fiber implant and 
the composite carbon fiber-polyester braid ligament. While these ligaments provided initial mechanical 
stability, long term studies reported the generation and migration of carbon wear particles into the joint 
space following implantation. In addition, frequent incidence of implant stretching and rupture led to poor 
long-term functional outcomes[80].  Alternatively, polymer-based grafts have also been evaluated, such 
as the Gore-Tex ACL, fabricated out of expanded PTFE. While the Gore-Tex graft was implanted in more 
than 18,000 patients worldwide, it ultimately failed due to a lack of tissue ingrowth, likely due to the 
hydrophobicity of the material, and fatigued in response to normal cyclic loads[84]. In contrast, synthetic 
ligaments fabricated from polyester (Dacron) resulted in improved outcomes but were still susceptible to 
failure due to the lack of organized tissue formation over time[79;83]. In response to the previous failures 
of synthetic ligaments, tissue engineering has arisen as a promising method by which to synthetically 
regenerate the ACL. A number of approaches have been reported in the literature, including poly(methyl 
methacrulate)[85], silk[17;21;89-91;107-109] and PLLA-based[18;95;96;99;103;104] systems.  
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In terms of material selection, nanofibers have been fabricated from a wide variety of polymers. 
These include poly(lactide-co-glycolide) (PLGA)[24], poly(ε-caprolactone) (PCL)[126;128], 
polyurethane[152], silk[112], and collagen[184], among others. As the elastic modulus of the human ACL 
are reported to be within the range of 49-163 MPa[185;186], the ideal ACL scaffold must have 
mechanical properties within this range. Two suitable polymers for this purpose are PLGA and PCL as 
these materials have been widely investigated for tissue engineering applications[24;126;128]. An alpha-
hydroxyester, PLGA degrades via bulk erosion on the order of six months to one year in vivo[187], and 
can be used to form nanofibers with an elastic modulus on the order of 400 MPa[24]. In contrast, PCL, 
also a polyester, degrades via surface erosion on the order of one to two years[188] with PCL nanofibers 
exhibiting an elastic modulus of approximately 50-100 MPa[126]. Due to the wide range of mechanical 
properties and degradation characteristics represented by these two polymers, it is anticipated that an 
ideal ligament scaffold, in terms of mechanical properties, degradation characteristics, and cell response 
could be fabricated by blending these two materials together. 
 
4.1.2 Objectives 
 This study focuses on the fabrication of nanofibers from PLGA and PCL and assesses fibroblast 
response as a function of nanofiber composition in order to determine the optimal composition for a 
synthetic nanofiber-based ligament. The objective of this study is to evaluate the response of human ACL 
fibroblasts (hACL Fb) on PCL, PLGA and blends of PCL/PLGA nanofibers in order to determine the 
optimal composition for the ligament phase of the multi-phased ACL scaffold. It is hypothesized that 
blending the two polymers will allow for the fabrication of nanofibers with tunable mechanical and 
degradation characteristics and that changes in the underlying nanofiber composition will dictate cell 
response. 
 
4.2 Materials and Methods 
4.2.1 Nanofiber Mesh Fabrication 
Nanofiber meshes were fabricated via electrospinning. For PLGA mesh fabrication, a 35% (v/v) 
solution of PLGA (85:15, DL, High IV, Lakeshore Biomaterials, Birmingham, AL) was mixed with 55% 
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N,N-dimethylformamide (DMF, Sigma-Aldrich) and 10% ethyl alcohol. To fabricate the PCL nanofibers, a 
mixture of 16% (w/v) PCL (Sigma-Aldrich, Mw=70,000-90,000) was dissolved in a mixture of 60/40 
dichloromethane (DCM, Sigma-Aldrich) and DMF. Blend PLGA-PCL nanofibers fabricated by varying the 
ratio of PLGA and PCL in the solution, while using a 60/40 DCM/DMF mixture as a solvent. Each polymer 
solution was loaded into a 5 mL syringe with a 18.5-gauge stainless steel blunt tip needle, and 
electrospun at 8-10kV using a custom electrospinning device.  The polymer solution was deposited (1 
mL/hour) using a syringe pump (Harvard Apparatus, Holliston, MA) onto a custom rotating mandrel (20 
m/s) to produce aligned fibers.  
 
4.2.2 Nanofiber Characterization 
The structural and material properties of the nanofibers were characterized post-fabrication. 
Nanofiber morphology and organization was imaged using scanning electron microscopy (SEM, 1.0 kV, 
S-4700, Hitachi, Japan). For SEM analysis, the nanofibers were sputter-coated (108Auto, Cressington 
Scientific, Watford, UK) with a gold-palladium coating to reduce charging effects. Fiber diameter was 
quantified using image analysis of SEM micrographs (2000x, n=3 images/group, ImageJ, National 
Institutes of Health, Bethesda, MD).  
 Fourier Transform Infrared Spectroscopy (FTIR, FTS 3000MX Excalibur Series, Digilab, 
Randolph, MA) was performed on as-fabricated nanofibers to further investigate composition. Briefly, 
FTIR spectra were collected in Attenuated Total Reflectance (ATR) mode (200 scans, resolution at 4 
cm−1) and analyzed for characteristic peaks to confirm the presence of both polymers: PLGA (C=O, 1780 
cm-1), PCL (C=O, 1724 cm-1). 
The mechanical properties of the as-fabricated nanofibers were evaluated under uniaxial tensile 
testing. Briefly, the meshes (6cm x 1 cm, n=5/group) were secured with custom clamps and mounted on a 
mechanical testing device (Instron, Model 8841, Norwood, MA) with an average gauge length of 3 cm. 
The samples were evaluated to failure at a strain rate of 5mm/min along the nanofiber long axis. 
Nanofiber mesh yield strength and ultimate tensile stress were determined, and elastic modulus was 
calculated from the linear region of the stress-strain curve. 
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 Polymer degradation was examined in vitro after 1, 7, 14, 28, and 56 days of culture in fully 
supplemented medium. At each time point, total weight loss (n=5) was determined for each sample. After 
incubation in plain DMEM, the samples were rinsed with deionized water, allowed to dry under vacuum 
using a lyophilizer for 24 h and the dry weight was measured over time. 
 
4.2.3 Cells and Cell Culture 
 Human ACL fibroblasts were derived from explant culture of tissues obtained from a patient 
(male, aged 24) undergoing ACL reconstruction surgery. Briefly, the tissue samples were rinsed in 
phosphate buffered saline (PBS, Sigma-Aldrich), plated in tissue culture dishes, and maintained in 
Dulbecco’s modifies Eagle medium supplemented with 10% fetal bovine serum, 1% non-essential amino 
acids, 1% penicillin/streptomycin, 0.1% amphotericin B and 0.1% gentamicin sulfate. The cells from the 
first migration were subsequently discarded, and the tissue was re-plated in fresh fully supplemented 
medium. Only cells obtained from the second and third migrations were used in this study because this 
method has been shown to yield a relatively homogenous fibroblast population. All medium and 
supplements were purchased from Mediatech (Herndon, VA). 
 Nanofiber meshes were secured using custom-made clamps to prevent contraction. After 
ultraviolet sterilization, the nanofibers were pre-incubated in fully supplemented medium at 37C and 5% 
carbon dioxide for 16 hours. Human ACL fibroblasts (passage 2) were seeded on the nanofiber meshes 
at a density 3x104 cells/cm2 and allowed to attach for 15 minutes before the addition of fully 
supplemented medium. The cells were cultured on the nanofibers for four weeks and the effects of 
nanofiber composition on cell morphology, gene expression, proliferation, and matrix production were 
determined throughout the culturing period. In addition, the effects of in vitro culture on nanofiber 
mechanical properties were evaluated over time. 
 
4.2.4 Cell Proliferation and Matrix Production 
Total DNA content was measured using the PicoGreen dsDNA assay (Invitrogen).  At each time 
point, the samples (n=5/group) were homogenized in 0.1% Triton-X (Sigma-Aldrich) and subjected to 20 
seconds of ultrasonication at 5W.  Fluorescence was measured using a microplate reader (Tecan, 
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Research Triangle Park, NC) at an excitation wavelength of 485 nm and an emission wavelength of 535 
nm.  A standard curve was derived and used to correlate DNA concentration to fluorescence intensity, 
and cell number was determined based on a conversion factor of 8pg DNA/cell[104].   
Total collagen content per sample (n=5/group) was calculated using the hydroxyproline 
assay[142].  Briefly, the samples were first desiccated for 24 hours and then digested for 16 hours at 65°C 
with papain (600 µg protein/ml) in 0.1M sodium acetate (Sigma), 10 mM cysteine HCl (Sigma), and 50 
mM ethylenediaminetetraacetate (Sigma).  A 40 µl aliquot of the digest was hydrolyzed with 10 µl 10 M 
sodium hydroxide and autoclaved for 25 minutes.  The hydrolyzate was then oxidized by a buffered 
chloramine-T reagent for 25 minutes before the addition of Ehrlich’s reagent.  Sample absorbance was 
measured at 550nm (Tecan), and the collagen content was obtained by interpolation along a standard 
curve of bovine type I collagen (Sigma). 
Collagen distribution was visualized using picrosirius red staining of frozen sections (n=2/group). 
Briefly, after fixation, samples were embedded in 5% polyvinyl alcohol (PVA, Sigma-Aldrich) and 7-
micrometer thick sections (spanning the depth and width of the mesh) were obtained using a cryostat 
(Hacker-Bright OTF model, Hacker Instruments and Industries, Winnsboro, SC). Collagen distribution was 
visualized with picrosirius red staining under light microscopy (Axiovert 25, Zeiss). 
 
4.2.5 Nanofiber Mechanical Properties 
The effects of in vitro fibroblast culture on the mechanical properties of nanofiber mehses were 
determined at day 1, 7, 14, 28 and 56. For tensile testing, the meshes (6 cm x 1 cm, n=5/group) were 
secured with custom clamps and mounted on an Instron (Model 8841, Norwood, MA), equipped with a 25 
lb load cell. The samples had an average gauge length of 3 cm and were tested to failure along the 
nanofiber long axis at a strain rate of 5 mm/min. Nanofiber yield strength and ultimate tensile stress were 
determined, and elastic modulus was calculated from the linear region of the stress-strain curve.    
 
4.2.6 Cell Differentiation 
 Fibroblastic phenotype was assessed quantitative real-time reverse transcriptase polymerase 
chain reaction (n=5/group) after 28 days of culture. Total RNA was isolated using the Trizol extraction 
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method (Invitrogen). Isolated RNA was then reverse-transcribed into complementary DNA using the 
SuperScript First-Strand Synthesis System (Invitrogen), and the cDNA product was amplified using 
recombinant Taq DNA polymerase (Invitrogen). Expression of fibroblastic markers type I collagen, type III 
collagen, fibronectin, tenascin-C, tenomodulin and scleraxis was determined. GAPDH served as the 
house-keeping gene. All primer sequences were as follows:  
Gene Sense Anti-Sense 
GAPDH 5’-GGCGATGCTGGCGCTGAGTA-3’ 5’-ATCCACAGTCTTCTGGGTGG-3’ 
Collagen I 5’-TGGTCCACTTGCTTGAAGAC-3’ 5’-ACAGATTTGGGAAGGAGTGG-3’ 
Collagen III 5’-GGCTACTTCTCGCTCTGCTT-3’ 5’-CATATTTGGCATGGTTCTGG-3’ 
Fibronectin 5’-TTGAACCAACCTACGGATGA-3’ 5’-AAATGACCACTTCCAAAGCC-3’ 
Tenascin-C 5’-TGCCCATTACAGGAGGTACA-3’ 5’-CACTTTCCTCAAAGCCCTTC-3’ 
Scleraxis 5’-CAGCGGCACACGGCGAAC-3’ 5’-CGTTGCCCAGGTGCGAGATG-3’ 
Tenodmoulin 5’-TTTGAGGAGGAGGGAGAAGA-3’ 5’-TTCCTCACTTGCTTGTCTGG-3’ 
All genes were amplified for 50 cycles in a thermocycler (Bio-Rad iCycler, Hercules, CA) with a 
fluorescent probe (SYBR Green, Invitrogen). Quantitative analysis of gene expression was performed 
using the delta-delta CT method. 
 
4.2.7 Statistical Analysis 
Results are presented in the form of mean ± standard deviation, with n equal to the number of 
samples per group. Two-way ANOVA was used to determine the effects of nanofiber composition on cell 
degradation, proliferation, matrix deposition, gene expression and mechanical properties. The Tukey-
Kramer post-hoc test was used for all pair-wise comparisons and significance was attained at p<0.05. 
Statistical analyses were performed with JMP IN (4.0.4, SAS Institute, Inc., Cary, NC). 
 
4.3 Results 
4.3.1 Nanofiber Characterization 
 The structural and material properties of the nanofiber meshes were characterized post-
fabrication. The nanofibers displayed a characteristic aligned morphology when examined via SEM 
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regardless of composition (Fig 4.1). Nanofibers with greater PCL content exhibited a more evident crimp 
pattern in the fibers. Fiber diameter was also measured for each composition (Table 4.1) with no 
significant difference between groups.  
The presence of PLGA and PCL within each composition was verified via FTIR-ATR. The 1724 
cm-1 carbonyl peak attributed to PCL was present only within blend and pure PCL nanofibers (Fig 4.1). 
Similarly, the 1780 cm-1 carbonyl peak of PLGA is present only within blend and pure PLGA nanofibers. 
The relative intensity of these peaks also qualitatively reflects the amount of each polymer present within 
the blends. 
Analysis of blend nanofiber mechanical properties via uniaxial tensile testing revealed a gradient 
of moduli and a composition-dependent elastic stress-strain curve (Fig 4.2). The stress-strain curve of 
PLGA nanofibers displayed no toe-region whereas the PCL nanofibers demonstrated a toe-region from 
approximately 0-2.5% strain. The curves of blend nanofibers displayed composition-dependent 
characteristics, more closely mimicking PLGA in the 1:1 PLGA:PCL blend as opposed to PCL in the 1:5 
PLGA:PCL blend.  The nanofibers also exhibited composition-dependent elastic moduli (Table 4.1). Yield 
strength was similar regardless of composition, except for the 1:5 PLGA:PCL group for which a 
significantly higher yield stress (16.6±3.0 MPa) was measured. Ultimate tensile strength increased with 
increasing PCL content, though 1:5 PLGA:PCL nanofibers exhibited the highest UTS (58.3±7.4 MPa). 
The ductility of PCL and blend nanofibers was significantly greater than that of PLGA nanofibers.  
 Composition-dependent degradation was assessed by measuring dry weight over the course of a 
56 day in vitro culture period (Fig 4.3). As shown in Figure X, the PLGA nanofibers exhibited the greatest 
degradation, with 56.09±3.51% remaining after 56 days. Greater mass was retained with increasing PCL 
content as PCL nanofibers retained 96.04±0.57% of their initial mass after 56 days. 
 
4.3.2 Cell Attachment and Proliferation 
The attachment morphology and growth of human ACL fibroblasts on the nanofiber meshes were 
visualized using confocal microscopy (Fig 4.4). The fibroblasts attached and assumed similar 
morphologies on all compositions. The cells adopted a phenotypic elongated morphology and aligned in 
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the direction of the underlying fiber arrangement. This cell shape and organization was maintained over 
the duration of culture in all groups.  
Cell number on all compositions was similar on day one and day seven of culture (Fig 4.4). A 
significantly greater number of cells was measured on the 1:5 PLGA:PCL nanofibers as compared to the 
1:1 PLGA:PCL and 1:2 PLGA:PCL groups after 14 days. This trend was maintained after 28 days with the 
PLGA, PCL and 1:5 PLGA:PCL groups all have a significantly greater number of cells than the 1:1 and 
1:2 PLGA:PCL blends. 
 
4.3.3 Matrix Deposition 
 Total collagen deposition was measured over the duration of the study (Fig 4.5). Significantly 
greater total collagen deposition was measured in the 5:1 and PCL groups after 28 days as compared to 
that of cells on the 1:1 and 1:2 blend nanofibers. Significantly greater total collagen was also deposited by 
cells on the 1:5 and PCL nanofibers on day 28 as compared to day 1, with only a mean increase over 
time observed for the other groups. Collagen distribution as visualized by picrosirius red staining showed 
similar matrix deposition on all compositions. The greatest matrix penetration into the mesh was observed 
for the PCL nanofibers. 
 
4.3.5 Mechanical Properties 
 The mechanical properties of ACL fibroblast-seeded nanofiber meshes were determined over 
time and compared as a function of composition and culturing time (Fig 4.6). A significant decrease in 
elastic modulus, yield strength, ultimate tensile strength and ductility were measured over time for the 
PLGA nanofibers. The elastic modulus, ultimate tensile stress and ductility remained statistically similar 
over the duration of the culture period for blend nanofiber groups as well as the PCL group, except for a 
significant increase in yield strength measured for the PCL group at day 28 which was maintained 
through day 56. Nanofibers retained mechanical properties similar to their as fabricated characteristics 
until day 28. At day 56, the PLGA nanofibers had a significantly lower yield strength, ultimate tensile 




4.3.4 Fibroblastic Phenotype 
 The fibroblastic phenotype of cells was evaluated after 28 days by determining the expression of 
several characteristic markers, specifically types I and III collagen, fibronectin, tenascin-C and 
tenomodulin (Fig 4.7). The expression of type III collagen, fibronectin and tenascin-C remained similar on 
all nanofiber compositions. A mean increase in type I collagen expression was measured with increasing 
PCL content and a significant upregulation in type I collagen expression was measured for cells on PCL 
nanofibers as compared to those on PLGA nanofibers. A similar trend was observed for tenomodulin 
expression with greater expression on the PCL nanofibers as compared to PLGA. 
  
4.4 Discussion 
This study aimed to identify the optimal composition for the ligament phase of a nanofiber-based 
synthetic ACL scaffold. In this study, nanofibers with controlled mechanical properties were fabricated 
using blends of PCL and PLGA to determine the effect of nanofiber composition on human ACL fibroblast 
response. These nanofibers exhibit mechanical properties within range of the human ACL, with tunable 
linear elastic and toe-regions, and were found to support the proliferation and biosynthesis of human ACL 
fibroblasts.  
 The mechanical properties of the blend nanofibers varied as a function of PLGA and PCL 
content. Specifically, it was shown that a higher PLGA to PCL ratio resulted in an increase elastic 
modulus, lower yield strength and greater toe-region, as expected when comparing the mechanical 
properties of pure PLGA and PCL nanofibers. Baker et al. reported similarly tunable characteristics for 
blended PLGA and PCL nanofibers containing approximately 60% PLGA and 40% PCL[189]. 
Interestingly, in this study, blending also resulted in nanofibers with unique characteristics such as the 5:1 
PLGA:PCL nanofibers which exhibited the greatest ultimate tensile strength and the 1:1 PLGA:PCL 
nanofibers which had the greatest ductility. These findings suggest interactive effects between PLGA and 
PCL that result in unique mechanical properties when the two polymers are blended together. 
Degradation kinetics of the nanofibers was also modulated by PLGA and PCL content. As expected, 
increasing PLGA content resulted in a more rapid degradation rate though the inclusion of PCL resulted 
in a significantly greater residual mass after 56 days of culture in all blend nanofibers, as compared to 
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PLGA nanofibers. These findings demonstrate that nanofiber degradation can be controlled to suit 
specific tissue engineering applications. Collectively, these findings suggest that a blend nanofiber 
system is optimal for ACL tissue engineering as all of the compositions had mechanical properties within 
range of the native tissue and allows for modulation of the degradation rate to match neo-tissue 
formation. 
In terms of ACL fibroblast response, while similar numbers of cells attached on all compositions, 
a significantly greater number of cells was measured on the 1:5 PLGA:PCL nanofibers as compared to 
the 1:1 PLGA:PCL and 1:2 PLGA:PCL groups after 14 days. Further, this trend was maintained after 28 
days with the PLGA, PCL and 1:5 PLGA:PCL groups all having a significantly greater number of cells 
than the 1:1 and 1:2 PLGA:PCL blends. These findings suggest composition-based effects on fibroblast 
proliferation but do not elucidate a composition-based trend between groups. Baker et al. investigated 
PLGA and PCL foams on urinary tract stromal cells for bladder tissue engineering[189]. It was reported 
that cell attachment and proliferation was increased on the PCL foams as compared to PLGA foams. It 
was hypothesized that this occurred because the PCL foams more closely mimicked the mechanical 
properties of the native bladder. In this study, the 1:5 PLGA:PCL and PCL nanofibers were also more 
within range of the native human ACL, with elastic moduli of 205±41 MPa and 170±15 MPa respectively, 
as compared to the native ACL modulus of 49-163 MPa[186].   
Total collagen deposition was measured to assess matrix production on each nanofiber 
composition. Interestingly, we observed that nanofibers incorporating greater amounts of PCL resulted in 
the highest total collagen deposition indicating that PCL directs human ACL fibroblasts towards a matrix 
deposition response as compared to PLGA. These findings were also supported by a significant increase 
in type I collagen expression after 14 days on PCL nanofibers and may again be attributable to the lower 
rigidity associated with increasing PCL content. Substrate rigidity modulating cell response has been 
extensively investigated on a variety of cell types[121], in particular for human mesenchymal stem cells, in 
which differentiation has shown to be regulated by matrix rigidity[121] and indicates that ligament 
fibroblasts may be similarly responsive to their culture environment. In addition to type I collagen 
upregulation, the upregulation of tenomodulin was also reported on the PCL nanofibers. The upregulation 
of this protein, a late marker of tendon and ligament formation[162], may indicate a long-term tissue 
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formation response as the PCL nanofibers more closely mimic the native ACL environment. The 
increased matrix synthesis on the 5:1 blend and PCL nanofibers and marker upregulation suggest that, in 
terms of cell response, nanofibers primarily composed of PCL may be optimal for ACL tissue engineering. 
Collectively, the results of this study suggest that a 1:5 PLGA:PCL blend is the optimal 
composition for nanofibers used for ligament tissue engineering. However, further studies will be required 
in order to further investigate these findings. In particular, in vivo studies are required to determine the 
degradation rate of each composition within a physiologic environment and also to select the optimal 




 This study focused on determining the optimal nanofiber composition for the ligament phase of 
the ACL scaffold. Two biodegradable polymers, PCL and PLGA, were blended to fabricate nanofibers 
with tunable mechanical properties and degradation characteristics. Mechanical properties of all 
compositions remained within range of the native human ACL. Although cells remained viable and 
proliferated regardless of composition, the greatest matrix deposition and fibroblastic marker expression 
was measured on nanofibers composed primarily of PCL. In contrast, the slow degradation rate of PCL 
may hinder long-term matrix formation within the scaffold, there by indicating that incorporation of PLGA 
is necessary to balance degradation kinetics and cell response. These findings suggest that a 1:5 
PLGA:PCL blend is optimal for the ligament phase of the scaffold. The findings of Chapters 2-4 
demonstrate that an aligned nanofiber matrix composed of a 1:5 PLGA:PCL blend coupled with 
mechanical stimulation is suitable for ligament regeneration. In the following chapter, the bone phase will 
be optimized.  
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Table 4.1.Structural and mechanical characteristics of nanofibers as function of composition. 





UTS (MPa) Ductility (%) 
Fiber Diameter 
(nm) 
PLGA 373 ± 99* 10.7 ± 2.4 13.5 ± 2.4 39 ± 1.6* 615 ± 152 
1:1 PLGA:PCL 326 ± 31* 8.87 ± 1.0 16.3 ± 1.5  85 ± 3.9* 663 ± 156 
1:2 PLGA:PCL 330 ± 37 10.3 ± 0.7  36.6 ± 4.2 69 ± 3.8 678 ± 109 
1:5 PLGA:PCL 227 ± 45 16.6 ± 3.0 58.3 ± 7.4* 67 ± 1.8 691 ± 181 
PCL 170 ± 15 11.6 ± 0.8 43.5 ± 6.7* 65 ± 3.5 712 ± 146 





Figure 4.1. Blend nanofiber characterization. Incorporation of PLGA and PCL was verified via FTIR 
analysis. Blends displayed peaks at 1172, 1361, and 1724 cm-1 attributable to PCL and at 1780 cm-1 for 
PLGA. Fiber morphology was also verified via SEM with scaffolds displaying characteristic aligned 






















Figure 4.2. Effect of nanofiber composition on mechanical properties. Nanofiber mechanical 
properties were modulated by the ratio of PLGA to PCL. Elastic modulus decreased with increasing PCL 








































































































Figure 4.3. Effect of nanofiber composition on degradation. Degradation was characterized by 
measuring dry weight over time after incubating nanofiber meshes in culture media. Dry weight was the 




























Figure 4.4. Effect of nanofiber composition on cell attachment and proliferation. Cell attachment 
was similar on all compositions with cells displaying a characteristic elongated morphology and 
conforming to the alignment of the underlying nanofibers. Cells proliferated on all compositions over time 
with a significantly greater number of cells present on PLGA, 1:5 PLGA:PCL and PCL scaffolds after 28 







































Figure 4.5. Effect of nanofiber composition on collagen deposition. Significantly greater total 
collagen deposition was measured in the 5:1 and PCL groups after 28 days as compared to that of cells 
on the 1:1 and 1:2 blend nanofibers. Significantly greater total collagen was also deposited by cells on the 
1:5 and PCL nanofibers on day 28 as compared to day 1, with only a mean increase over time observed 
for the other groups. Matrix deposition as visualized via picrosirius red staining (red=collagen) indicated 






































Figure 4.6. Effect of in vitro culture on nanofiber mechanical properties. A significant decrease in 
elastic modulus, yield strength, ultimate tensile strength and ductility were measured over time for the 
PLGA nanofibers. The elastic modulus, ultimate tensile stress and ductility remained statistically similar 
over the duration of the culture period for blend nanofiber groups as well as the PCL group, except for a 
significant increase in yield strength measured for the PCL group at day 28 which was maintained 
through day 56. At day 56, the PLGA nanofibers had a significantly lower yield strength, ultimate tensile 














































































































Figure 4.7. Effect of nanofiber composition on fibroblastic phenotype at day 28. A mean increase in 
type I collagen expression was measured with increasing PCL content and a significant upregulation in 
type I collagen expression was measured for cells on PCL nanofibers as compared to those on PLGA 



































CHAPTER 5: BONE PHASE: THE EFFECT OF 
NANOFIBER MINERAL CONTENT ON HUMAN 





 While the previous chapters focused on the design and optimization of the ligament phase, 
demonstrating that fibroblastic differentiation of MSCs can be induced using mechanical stimulation as 
well as chemical stimulation. In addition, it was shown that nanofibers composed of a blend of PLGA and 
PCL are suitable for ligament tissue formation. This chapter focuses on the next phase of the multi-
phased synthetic ACL scaffold, the bone phase.  
The bone phase of the ACL scaffold must be osteconductive in order to integrate with 
subchondral bone within the femoral and tibial tunnels after ACL reconstruction. In addition, it must also 
be osteoinductive in order to induce osteoblastic differentiation of MSCs and thereby enable cell-
mediated bone formation. To this end, composite polymer-ceramic nanofibers containing hydroxyapatite 
will be investigated for the bone phase. Hydroxyapatite is particularly advantageous for this purpose as it 
is the primary mineral found in bone and has been widely used for commercial bone regeneration 
products[190-192]. To optimize the composition of the bone phase, this chapter investigates the effect of 
nanofiber mineral content on osteogenic differentiation of MSCs. 
 
5.1.1 Background and Motivation 
Polymer and polymer-ceramic nanofibers have been widely investigated for bone tissue 
engineering. Composite polymer-ceramic nanofibers have been reportedly fabricated by incorporating 
nanoparticles of hydroxyapatite (HA)[33;193-195], beta tricalcium phosphate (TCP)[33;196] or 
demineralized bone powder directly into the fibers[197]. Hydroxyapatite is particularly advantageous for 
this purpose as it is the primary mineral found in bone and has been widely used for commercial bone 
regeneration products[190-192]. In addition, composite nanofibers incorporating HA have been shown to 
promote osteoblast proliferation and enable mineralized tissue formation both in vitro and in 
vivo[33;196;197].   
In addition to scaffold parameters, the incorporation of cells into tissue engineered systems has 
been established a method to augment tissue formation. Mesenchymal stem cells (MSCs) are considered 
an ideal cell source for this purpose as they can be easily obtained from the bone marrow, as well as 
other tissues, and can readily differentiate into an osteoblastic phenotype using chemical induction 
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medium or scaffold-based cues[26;198]. Dexamethasone and bone morphogenetic protein-2 (BMP-2) are 
among the most common chemical supplements used to induce osteogenic differentiation[26]. In 
contrast, the precise scaffold-based cues to drive osteogenic differentiation have not been determined. 
Reports have indicated that cues such as scaffold mineral incorporation[33;197;199] and surface 
roughness[200] can induce the MSC mineralization. However, many studies investigating the use of 
MSCs for bone tissue engineering have been performed in conjunction with osteogenic induction 
medium, making it difficult to identify the independent effects of scaffold-based and chemical cues. 
This study focuses on identifying the optimal nanofiber mineral content for the osteogenic 
differentiation of MSCs, in the absence of osteogenic chemical factors, in order to identify parameters to 
direct osteogenic differentiation of MSCs on nanofibers. To this end, HA nanoparticles will be 
incorporated into nanofibers to fabricate a composite polymer-ceramic system. Ostegenesis will be 
evaluated in terms of cell mineralization potential, mineralized matrix production and osteogenic marker 
expression. It is hypothesized that increasing nanofiber mineral content, in terms of hydroxyapatite 
nanoparticle weight-percent, will increase the expression of osteogenic markers and enhance mineralized 
matrix deposition.  
 
5.1.2 Objectives 
The objective of this study is to determine the optimal nanofiber mineral content to support bone 
formation and induce MSC osteogenesis. Previous studies have reported that the incorporation of 
ceramics, such as HA and tricalcium phosphate, into polymer nanofibers can modulate the proliferation 
and osteoblastic activity of stem cells[199]. In addition, it has been shown that the effect of ceramic 
presence can be content dependent, such as in studies performed by He et al. with composite PLGA 
microspheres incorporating various ratios of hydroxyapatite[201], where greater mineral content resulted 
in increased mineralized tissue formation. It is hypothesized that increasing nanofiber mineral content, in 
terms of hydroxyapatite nanoparticle weight-percent, will increase the expression of osteogenic markers 




5.2. Materials and Methods 
5.2.1 Nanofiber Mesh Fabrication 
Composite polymer-ceramic nanofibers were fabricated via electrospinning. Briefly, a 5:1 mixture 
of PLGA and PCL was dissolved in a 60:40 mixture of dichloromethane and dimethyl formamide (DMF) 
and mixed for one hour. Simultaneously, a suspension of HA nanoparticles (Nanocerox, Ann Arbor, MI) 
and DMF was sonicated for one hour. The nanoparticle suspension and polymer solution were then 
mixed rigorously to produce an 18% (wt%) polymer solution containing 0%, 15%, 25% or 35% (wt 
ceramic/wt polymer) HA. To produce the nanofibers, each polymer solution was loaded into a 5 mL 
syringe with a 18.5-gauge stainless steel blunt tip needle, and electrospun at 8-10kV using a custom 
electrospinning device. The polymer solution was deposited (1 mL/hour) using a syringe pump (Harvard 
Apparatus, Holliston, MA) onto a rotating mandrel (20m/s) to produce the aligned fibers.   
 
5.2.2 Nanofiber Characterization 
As-fabricated nanofibers were imaged with secondary scanning electron microscopy (SEM, 1-2 
kV, Hitachi 4700, Hitachi Ltd.) to evaluate nanofiber morphology.  Nanofibers were sputter-coated (108 
Auto, Cressington Scientific, Watford, UK) with gold-palladium to reduce charging effects. Nanofiber 
diameter was quantified via image analysis of SEM micrographs (2000x, n=3 images/group, ImageJ, NIH, 
Bethesda, MD).  The elemental composition of as-fabricated nanofibers was evaluated with 
backscattered SEM coupled with energy dispersive x-ray analysis (EDAX).  After coating, the samples 
were imaged in the backscattered mode and EDXA was performed at 2 kV.   
To further assess nanofiber mineral presence, Fourier Transform Infrared Spectroscopy (FTIR, 
FTS 3000MX Excalibur Series, Digilab, Randolph, MA) was performed on as-fabricated nanofibers. 
Briefly, FTIR spectra were collected in Attenuated Total Reflectance (ATR) mode (200 scans, resolution 
at 4 cm−1) and analyzed for characteristic peaks: PLGA (C=O, 1780 cm-1), PCL (C=O, 1724 cm-1) and 
HA (PO4 bending, 605 cm-1 and 560 cm-1). 
The mineral content (n=5/group) of the as-fabricated nanofibers was evaluated with 
thermogravimetric analysis (TGA, Q50, TA Instruments, New Castle, DE).  The sample was loaded into a 
calibrated platinum pan, heated to 100oC, followed by a 20ºC/minute ramp to 700ºC, and the residual 
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weight was then determined. The degradation temperature of PLGA and PCL is approximately 400°C, 
therefore the residual weight corresponded to the weight percent of mineral in the nanofibers.   
 
5.2.3 Cells and Cell Culture 
Human mesenchymal stem cells (MSC) were obtained commercially (Lonza, Walkersville, MD) 
and maintained in culture with DMEM containing 10% fetal bovine serum (FBS, embryonic stem cell 
certified, Atlanta Biologicals, Atlanta, GA), 1% penicillin-streptomycin, 1% non-essential amino acids, 
0.1% amphotericin B and 0.1% gentamicin. All media supplements were purchased from Cellgro-
Mediatech unless otherwise specified.  Cells were cultured to 80% confluence and then passaged using 
0.25% trypsin/1 mM ethylenediaminetetraacetate (EDTA) and re-plated at a density of 5x103 cells/cm2. 
Passage 2-3 cells were used for nanofiber mesh seeding. 
 
5.2.4 Cell Proliferation  
Total DNA content was measured using the PicoGreen dsDNA assay (Invitrogen).  At each time 
point, the samples (n=5/group) were homogenized in 0.1% Triton-X (Sigma-Aldrich) and subjected to 20 
seconds of ultrasonication at 5W.  Fluorescence was measured using a microplate reader (Tecan, 
Research Triangle Park, NC) at an excitation wavelength of 485 nm and an emission wavelength of 535 
nm.  A standard curve was derived and used to correlate DNA concentration to fluorescence intensity, 
and cell number was determined based on a conversion factor of 8pg DNA/cell[104].   
 
5.2.5 Matrix Production and Mineralization 
Total collagen content per sample (n=5/group) was calculated using the hydroxyproline 
assay[142].  Briefly, the samples were first desiccated for 24 hours and then digested for 16 hours at 65°C 
with papain (600 µg protein/ml) in 0.1M sodium acetate (Sigma), 10 mM cysteine HCl (Sigma), and 50 
mM ethylenediaminetetraacetate (Sigma).  A 40 µl aliquot of the digest was hydrolyzed with 10 µl 10 M 
sodium hydroxide and autoclaved for 25 minutes.  The hydrolyzate was then oxidized by a buffered 
chloramine-T reagent for 25 minutes before the addition of Ehrlich’s reagent.  Sample absorbance was 
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measured at 550nm (Tecan), and the collagen content was obtained by interpolation along a standard 
curve of bovine type I collagen (Sigma). 
Collagen distribution (n=2/group) was also visualized using picrosirius red staining of frozen 
sections. Briefly, after fixation, samples were embedded in 5% polyvinyl alcohol (PVA, Sigma-Aldrich) and 
7-micrometer thick sections (spanning the depth and width of the mesh) were obtained using a cryostat 
(Hacker-Bright OTF model, Hacker Instruments and Industries, Winnsboro, SC). Collagen distribution was 
visualized with picrosirius red staining under light microscopy (Axiovert 25, Zeiss). 
Mineralization potential was determined by measuring ALP activity (n=5) using an colorimetric 
assay based on the hydrolysis of p-nitrophenyl phosphate (pNP-PO4) to p-nitrophenol (pNP)[202].  Briefly, 
the samples were lysed in 0.1% Triton-X solution, then added to pNP-PO4 solution (Sigma) and allowed 
to react for 30 min at 37°C. The reaction was terminated with 0.1 N NaOH (Sigma), and sample 
absorbance was measured at 415nm using a microplate reader (Tecan).  In addition, mineral distribution 
(n=2/group) was evaluated by von Kossa staining of frozen sections with 5% silver nitrate, followed by 30 
minutes of UV exposure[203].  Media calcium concentrations (n=5) were quantified using the Arsenazo III 
dye (Pointe Scientific, Lincoln Park, MI) and a malachite green, ammonium molybdate based phosphate 
colorimetric assay (BioVision, San Francisco, CA) was used to assess media phosphate concentration. 
Both assays were read at an absorbance wavelength of 620nm.using a microplate reader[204].  
 
5.2.6 Cell Differentiation 
Osteoblastic differentiation of MSCs was assessed via quantitative real-time reverse transcriptase 
polymerase chain reaction (qPCR, n=5/group) after 14 and 28 days. Total RNA was isolated using the 
Trizol extraction method (Invitrogen). Isolated RNA was then reverse-transcribed into complementary 
DNA using the SuperScript First-Strand Synthesis System (Invitrogen), and the cDNA product was 
amplified using recombinant Taq DNA polymerase (Invitrogen). Expression of osteogenic markers type I 
collagen, RUNX-2, bone sialoprotein (BSP), osteocalcin, osteopontin, and osteonectin was determined. 
GAPDH served as the house-keeping gene. All primer sequences are listed in Table 2. All genes were 
amplified for 50 cycles in a thermocycler (Bio-Rad iCycler, Hercules, CA) with a fluorescent probe (SYBR 
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Green, Invitrogen). Quantitative analysis of gene expression was performed using the delta-delta CT 
method. 
 
5.2.7 Statistical Analysis 
Results are presented in the form of mean ± standard deviation, with n equal to the number of 
samples per group. Two-way ANOVA was used to determine the effects of nanofiber mineral content on 
cell proliferation, matrix deposition and differentiation. The Tukey-Kramer post-hoc test was used for all 
pair-wise comparisons and significance was attained at p<0.05. Statistical analyses were performed with 
JMP IN (4.0.4, SAS Institute, Inc., Cary, NC). 
 
5.3 Results 
5.3.1 Nanofiber Characterization 
 A distinct aligned nanofiber morphology was observed using SEM for all groups. The addition of 
ceramic nanoparticles resulted in visible nodules on the surface of the fibers, evident at higher 
magnifications (Fig. 5.1). The elemental composition of the fibers was also determined using EDAX (Fig 
5.1). The incorporation of was confirmed for the 15%, 25% and 35% HA groups with the presence of 
calcium (Ca) and phosphorous (P) peaks. No such peaks were observed for the 0% HA group, confirming 
the lack of ceramic content. The chemical composition of the nanofibers, further investigated via FTIR-
ATR, confirmed the presence of ceramic within the nanofibers (Fig 5.2). Typical infrared bands for the 
PCL and PLGA stretching modes were observed in the ceramic-free (0% HA) and ceramic-containing 
(15%, 25%, 35% HA) groups. The composite nanofibers showed characteristic peaks corresponding to 
the PO43- absorption bands at 564, 603 and 1031 cm-1 attributable to hydroxyapatite, as has been 
reported previously[33;205;206]. Ceramic content was verified using TGA to confirm mineral content of 
the composite nanofibers. Residual weight of the 0% HA nanofibers was 0.96±0.41% and 16.4±1.20%, 




5.3.2 Cell Proliferation and Collagen Deposition 
 Cells remained similarly viable on all groups over time as evident in the confocal microscopy 
images, with green staining for live cells (Fig 5.3). The cells also displayed a characteristic spindle-
shaped aligned morphology in the direction of the underlying fiber alignment. In terms of cell proliferation, 
no significant difference in cell number was measured between groups at any of the time points (Fig 5.3). 
However, a significant increase in cell number was measured in all groups between day 1 and day 7 as 
well as between days 7 and 14, indicating that cells proliferated over time.  
  Total collagen content was measured to assess cell matrix deposition over time. No significant 
difference in total collagen was measured between groups at any time points (Fig 5.4). A mean increase 
in total collagen was observed over time in all groups and significantly greater total collagen was present 
on all groups after 28 days as compared to day 1. Collagen distribution was also visualized via picrosirius 
red staining, which stains for collagen types I, II and III, of histological sections (Fig 5.4). Similar collagen 




 Alkaline phosphatase activity was quantified to measure MSC mineralization potential over time 
(Fig. 5.5). A significant increase in ALP activity was measured after 12 hours of culture on the 25% and 
35% HA groups as compared to the 0% and 15% HA groups. Significantly elevated ALP activity in these 
groups persisted through day 7, after which it returned to basal levels similar to the 0% and 15% HA 
groups. Mineral deposition visualized via von Kossa staining showed similar mineral distribution on the 
composite nanofibers and no mineral present in the 0% HA group (Fig 5.5). 
 Media calcium and phosphate concentration was also measured over the duration of the study to 
better understand mineralization mechanics on the nanofibers (Fig. 5.6). Significantly lower media 
calcium content was measured in the 35% HA group after 7 days of culture and this difference was 
maintained through the 28 day culture period. Significantly lower media calcium content was also 
measured in the 25% HA though only at day 28. Measurement of media phosphate concentration showed 
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no significant differences between groups, though a mean decrease in phosphate content was observed 
with increasing nanofiber ceramic content at all time points.    
 
5.3.4 Cell Differentiation 
 The expression of several key osteogenic markers was evaluated after 28 days to determine if 
MSCs underwent osteogenic differentiation (Fig. 5.7). While type I collagen expression was not 
upregulated for any groups, the expression of ALP, RUNX-2 and osteocalcin was increased by cells on 
the 25% and 35% HA nanofibers. In addition, osteopontin and osteonectin were upregulated on the 35% 
HA nanofibers only. A mean increase in BSP expression was also measured on the 35% HA nanofibers 
as compared to all other groups. 
 
5.4 Discussion 
The objective of this study was to determine the optimal nanofiber mineral content to induce 
osteoblastic differentiation of MSCs in the absence of osteogenic chemical factors. To this end, the 
response of MSCs was evaluated over time on nanofibers both with and without hydroxyapatite 
nanoparticles. It was found that MSCs underwent osteogenic differentiation in response to nanofiber 
mineral content alone. Interestingly, differentiation, in terms of ALP activity and osteogenic marker 
expression, was only observed on the nanofibers with the greatest mineral content and osteogenic 
response increased with increasing nanofiber mineral content, indicating that a minimum threshold of 
mineral is required to elicit a response. 
 In terms of mineralization, an increase in ALP activity early within the culture period on the 25% 
and 35% HA nanofibers, beginning at the 12 hour time point and remaining elevated until 7 days of 
culture. This finding likely indicates a rapid mineralization response by the cells as ALP is known to 
increase inorganic phosphate concentration and thereby promote mineralization[207]. This response also 
suggests that the composite nanofibers quickly induce a mineralization response by the cells, potentially 
attributable to the increase surface roughness of the mineral-containing fibers. It has been reported that 
nano-scale surface roughness regulates osteoblast response[208;209] and can also induce an 
osteogenic response by stem cells[210-213]. For example, Balloni et al. reported the upregulation of 
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RUNX-2, BMP-2 and osterix by MSCs cultured on an acid-etched titanium surfaces as compared to a 
machined titanium surface. Similarly, the nodules visible on the surface of the composite nanofibers may 
represent a rougher, osteoinductive surface for attached MSCs. 
 In addition, in this study, a sustained decrease in media calcium content was measured for MSCs 
cultured on the 35% HA nanofibers after 7 days, which persisted through the remainder of the 28 day 
culture period. A significant decrease in media calcium content was also measured for the 25% HA group, 
through only after 28 days. These finding suggests that cell-mediated mineralization is occurring as 
calcium and phosphate are precipitating from the media for mineralized matrix formation, as it has been 
shown that large quantities of these ions are accumulated during the cellular mineralization 
process[214;215]. Though, only a mean decrease in phosphate concentration was measured with 
increasing nanofiber mineral content.  It is also notable that the decrease in calcium concentration occurs 
earlier on the 35% HA nanofibers, indicating that greater nanofiber content elicits a more rapid 
mineralization response. 
 Analysis of MSC differentiation reveled that several osteogenic markers were upregulated after 
28 days on the 25% and 35% HA nanofibers. Specifically, ALP and RUNX-2, a transcription factor 
essential for osteoblastic differentiation, along with osteocalcin, a pro-osteoblastic protein characterized 
as a late marker of bone formation were upregulated on the 25% and 35% HA nanofibers. Interestingly, 
osteopontin, a protein which plays a role in anchoring osteoclasts, and osteonectin, an important factor in 
bone mineralization, both of which are characterized as early markers of bone formation, were only 
upregulated on the 35% HA nanofibers. These results could be attributed to different temporal sequence 
of osteoblastic marker expression by MSCs on the 25% HA nanofibers as compared to the 35% HA 
nanofibers, with a more complete phenotype assumed by cells in the 35% HA group.  
 Previous studies exploring the effects of nanofiber mineral content have also found that ceramic 
incorporation can induce MSC osteogenesis in the absence of osteogenic chemical factors. Peng et al. 
reported increased ALP activity as well as upregulation of ALP and osteocalcin by murine MSC on 
composite chitosan-HA nanofibers containing 30% HA[216]. Similarly, Lu et al. reported the upregulation 
of ALP and osteocalcin by rat MSC cultured on poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) 
nanofibers containing 10% HA[217]. Phipps et al. reported that a composite PCL, collagen and 10% HA 
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mesh can increase phosphorylate FAK production, a signaling molecule in osteogenic differentiation, in 
human MSC[218]. Other ceramics have also been shown to be capable of directing osteogenesis when 
incorporated into nanofibers. For example, Polini et al. demonstrated that nanofibers containing 
approximately 35% tricaclium phosphate (TCP) nanoparticles upregulate BSP and RUNX-2 expression in 
human MSC[33]. However, unlike previous reports, this study represents a systematic investigation into 
the requirements to drive osteoblastic differentiation of MSCs on nanofibers without concurrent chemical 
factors, elucidating that a threshold of ceramic particles is required. 
  Several groups have also demonstrated that osteogenesis of MSC on composite nanofibers can 
be further enhanced when combined with osteogenic medium, typically containing dexamethasone or 
BMP-2. Chen et al. reported elevated ALP activity by MSCs on unaligned PCL nanofibers incorporating 
50% HA and also similarly demonstrated that a threshold of mineral was required, as no difference in ALP 
activity was measured on nanofibers containing 25% HA. Lee et al. reported upregulation of ALP and 
osteocalcin on PLGA nanofibers containing approximately 28% HA. Lastly, Ko et al. reported increased 
human MSC calcium deposition composite poly(L-lactide) (PLA) and demineralized bone powder (DBP) 
nanofibers containing approximately 17% DBP.  
In summary, the composite polymer-ceramic nanofiber system presented here represents a 
promising system for bone tissue engineering. The results of this study demonstrate that composite 
nanofibers can result in osteogenic differentiation of MSCs, in the absence of chemical stimulation, 
provided a sufficient threshold of mineral is incorporated. These findings indicate that bone tissue 
engineering scaffolds will benefit from increased mineral content that more closely mimics the 
composition of native bone.  
  
5.5 Conclusions 
 Collectively, the results of this study provide the optimal design specifications for the bone phase 
of the multi-phased ACL scaffold. A nanofiber-based system incorporating 35% HA results in a 
mineralization response by MSCs as well as the upregulation of several osteoblastic markers. Therefore 
the bone phase of the synthetic ACL scaffold will consist of composite polymer-ceramic nanofibers 




Figure 5.1. Composite polymer-ceramic nanofiber morphology and composition. Nanofibers were 
examined under SEM and displayed a characteristic aligned nanofiber morphology. More visible nodules 
were evident on the surface of the fibers with increasing mineral content. EDAX analysis confirmed the 


































Figure 5.2. Composite polymer-ceramic nanofiber composition and mineral incorporation. FTIR-
ATR was used to assess nanofiber chemical composition. Infrared bands for the PCL and PLGA 
stretching modes were observed in the ceramic-free (0% HA) and ceramic-containing (15%, 25%, 35% 
HA) groups. The composite nanofibers showed characteristic peaks corresponding to the PO43- 
absorption bands at 564, 603 and 1031 cm-1. Ceramic content was verified using TGA to confirm mineral 
content. Residual weight of the 0% HA nanofibers was 0.96±0.41% and 16.4±1.20%, 26.2±0.39% and 














































Figure 5.3. Effect of nanofiber mineral content on cell attachment and proliferation. Cells displayed 
an elongated morphology aligned in the direction of the underlying fiber organization. Cells also remained 
similarly viable on all groups over time. No significant difference in cell number was measured between 
groups at any of the time points. However, a significant increase in cell number was measured in all 
groups between day 1 and day 7 as well as between days 7 and 14.  





































Figure 5.4. Effect of nanofiber mineral content on collagen deposition. A mean increase in total 
collagen was observed over time in all groups and significantly greater total collagen was present on all 
groups after 28 days as compared to day 1. Collagen distribution at day 28 was also visualized via 
picrosirius red staining, which displayed similar collagen distribution in all groups, with collagenous matrix 
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Figure 5.5. Effect of nanofiber mineral content on mineralization. A significant increase in ALP 
activity was measured after 12 hours of culture on the 25% and 35% HA groups as compared to the 0% 
and 15% HA groups. Elevated ALP activity in these groups persisted through day 7, after which it 
returned to basal levels. Mineral distribution visualized via von Kossa staining showed similar mineral 





































Figure 5.6. Cell-mediated mineralization mechanism on polymer-ceramic nanofibers. Significantly 
lower media calcium content was measured in the 35% HA group after 7 days of culture and this 
difference was maintained through day 28. Significantly lower media calcium content was also measured 
in the 25% HA group, though only at day 28. Measurement of media phosphate concentration showed no 
significant differences between groups, though a mean decrease in phosphate content was observed with 












































Figure 5.7. Effect of nanofiber mineral content on MSC differentiation. At day 28, the expression of 
ALP, RUNX-2 and osteocalcin was increased by cells on the 25% and 35% HA nanofibers. In addition, 
osteopontin and osteonectin were upregulated on the 35% HA nanofibers only. A mean increase in BSP 































CHAPTER 6: INTERFACE PHASE: EFFECT OF 
NANOFIBER COLLAR CONTRACTION ON 






 In the previous chapters, the ligament and bone phases of the multi-phased ACL scaffold were 
optimized in terms of composition and cell response. This chapter focuses on the final phase of the 
scaffold, the interface phase. As the scaffold must integrate tissue on the ligament and bone phases via 
the formation of a fibrocartilage interface, a system to induce cartilage-like tissue formation by MSCs will 
be investigated. To this end, a nanofiber-based collar system to apply compression and induce 
fibrocartilage formation will be investigated and evaluated in vitro. 
  
6.1.1 Background and Motivation 
At the ACL-bone interface, there exists a gradual transition from soft tissue-to-bone.  With the 
exception of the mode of collagen fiber insertion into the subchondral bone, the transition from ACL-to-
bone is histologically similar for the femoral and tibial insertion sites.  The interface consists of four 
different zones: ligament (L), non-mineralized fibrocartilage (NFC), mineralized fibrocartilage (MFC), and 
bone (B)[219-223].  The ligament proper is composed of fibroblasts embedded in a type I and type III 
collagen matrix.  The NFC is composed of ovoid chondrocytes, and type II collagen is detectable within 
the pericellular matrix.  The primary sulfated proteoglycan is aggrecan.  The next zone is the MFC, with 
hypertrophic chondrocytes surrounded by a large pericellular matrix[221].  Type X collagen, a specific 
marker for hypertrophic chondrocytes, is detected only within this zone[220].  The last zone is the 
subchondral bone and the cells present are osteoblasts, osteocytes and osteoclasts embedded in a type I 
collagen matrix.  The principal function of the fibrocartilage interface is to minimize stress concentrations 
and to facilitate load transfer between distinct tissue types[23;72]. 
The majority of current interface regeneration efforts centers on the formation of ligament-
interface-bone[36;224] or tendon-interface-bone[24] complexes for orthopaedic tissue engineering.  In 
terms of improving the osteointegration potential of tendon grafts, early attempts focused on augmenting 
the surgical graft with a material that would encourage bone tissue growth.  For example, Tien et al. used 
calcium phosphate cements to fill the tendon-to-bone junction in a rabbit ACL reconstruction study and 
found that the addition of this ceramic helped to improve bone growth and organization[58].  Using a 
different approach, Mutsuzaki et al. soaked tendon grafts in a series of solutions which coated the 
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tendons with a calcium phosphate layer prior to implantation[60].  The modified graft was tested using a 
rabbit ACL reconstruction model, and it was found that the pre-coated tendons enhanced healing and 
promoted integration.  Although these methods have improved osteointegration between the ACL graft 
and the bone tunnel, they do not result in the regeneration of the fibrocartilage interface.  Thus there 
exists a significant clinical need for integrative fixation devices that will promote interface formation and 
osteointegration.   
The mechanisms governing the formation of this interface are not well understood; though it has 
been reported that metaplasia of tendon or ligament tissue plays a role in this process[225;226]. 
Specifically, Nawata et al., using a rodent model, reported that ACL insertion fibrochondrocytes arise from 
ligament fibroblasts[226]. Similarly, Gao et al. used a rodent model to show that ligament fibroblasts begin 
to synthesize type II collagen during the development of the ligament-bone enthesis[225]. In addition, 
mechanical stimulation has been implicated in the process of enthesis development and fibrocartilage 
formation[75]. Vogel et al. investigated this process extensively in a bovine model, focusing on the effect 
of compressive loading on fibrocartilage formation in flexor tendons[227-231]. It was reported that 
compressive loading induced metaplasia of tendinous matrix and initiated its transformation into 
fibrocartilage-like tissue as gene expression of fibrocartilage markers, such as aggrecan and type II 
collagen, was not observed in the wrap-around regions of fetal and neonatal bovine flexor tendons, but 
was strongly expressed in those of mature animals[229], thereby suggesting that physiological 
compressive loading induces post-natal fibrocartilage formation. Extending this work, it was reported that 
translocation of rabbit flexor digitorum profundus tendon to remove compressive loading resulted in a 
decrease in the size of the fibrocartilage region, looser collagen organization and a lower 
glycosaminoglycan content in the tissue[228].  It was also reported that re-establishing cyclic 
compression in vitro enhanced the expression of aggrecan, biglycan and versican in bovine flexor 
tendons[230]. Collectively, these findings suggest that compressive loading modulates fibrocartilage 





Based on the aforementioned studies, compression will be evaluated as a stimulus to induce 
fibrocartilage formation by MSCs. To this end, a novel mechanoactive collar will be investigated for the 
interface phase of the synthetic ACL scaffold. This collar, composed of an aligned poly(lactic-co-glycolic) 
acid (PLGA) nanofiber mesh, undergoes anisotropic contraction when placed in a physiological 
environment[24;36;232]. The efficacy this mechnoactive collar has previously been demonstrated in vitro 
as it was reported to upregulate the gene expression of fibrocartilage markers, such as transforming 
growth factor-beta 3 (TGF-β3), aggrecan and type II collagen when applied to bovine patellar tendons in 
vitro[36]. To mimic the heterogeneity of the native ligament-to-bone interface, the collar will consist of two 
phases: a PLGA phase, to induce and support non-mineralized fibrocartilage formation, and a composite 
PLGA-HA phase incorporating hydroxyapatite to support mineralized fibrocartilage formation. The first 
objective of this study is to characterize the contractile properties of the bi-phasic nanofiber collar while 
the second is to evaluate the use of the mechanoactive system in vitro to apply compression to MSCs 
and induce fibrocartilage-like tissue formation. It is hypothesized that collar-mediated compression will 
result in the upregulation of cartilage-related markers and the production of a cartilage-like matrix. 
  
6.2 Materials and Methods 
6.2.1 Scaffold Fabrication 
Bi-phasic nanofiber collars were produced via electrospinning. Briefly, a polymer solution 
consisting of 35% PLGA (w/v, 85:15, Mw=123.6 kDa; Lakeshore Biomaterials) in 55% N,N-
dimethylformamide (Sigma-Aldrich, St. Louis, MO) and 10% ethanol (Pharmco-AAPER, Brookfield, CT) 
was loaded into a syringe fitted with an 18.5-gauge blunt tip needle (Becton Dickinson, Franklin Lakes, 
NJ). Composite PLGA-hydroxyapatite (PLGA-HA) nanofibers were fabricated similarly by adding a 
suspension of HA nanoparticles immersed in DMF to the PLGA solution, resulting in a 15% HA (w/w) 
polymer-ceramic suspension. Aligned fibers were obtained using an aluminum mandrel rotating at a 
velocity of 20m/s with a constant polymer flow rate of 1 mL/hr maintained via a syringe pump (Harvard 
Apparatus, Holliston, MA)[233]. An electrical potential was applied between the needle and the drum 
using a high-voltage DC power supply (Spellman, Hauppauge, NY). The bi-phasic collar system was 
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fabricated by electrospinning parallel regions of PLGA and PLGA-HA nanofibers. After depositing a layer 
of aligned PLGA nanofibers on the mandrel, a custom masking system was applied upon which a layer of 
PLGA-HA nanofibers was deposited. The resulting multi-phase collar consisted of a PLGA region, a 
PLGA/PLGA-HA overlapping region (1mm in length) and a PLGA-HA region. 
Braided nanofiber constructs, around which the collars were secured prior to cell seeding, were 
fabricated via electrospinning. A mixture of 18% (w/v) poly(ε-caprolactone) (PCL, Sigma-Aldrich, 
Mw=70,000-90,000) and PLGA (85:15, Lakeshore) was dissolved in a mixture of 60/40 dichloromethane 
(DCM, Sigma-Aldrich) and DMF. The polymer solution was loaded into a 5 mL syringe with a 18.5-gauge 
stainless steel blunt tip needle, and electrospun at 8-10kV using a custom electrospinning device.  The 
polymer solution was deposited (1 mL/hour) using a syringe pump (Harvard Apparatus, Holliston, MA) 
onto a custom rotating mandrel (20 m/s) to produce aligned fibers. To standardize the amount of fibers in 
each construct, the solution was electrospun for 45 minutes to create a 20μm-thick nanofiber mesh. The 
resulting meshes were rolled into bundles 0.8mm in diameter and three fibrous bundles were then 
braided together. Once braided, the three bundles were cut into 1 cm length sections and melted at the 
ends to form a construct. Collars were secured to the braided constructs using a 7-0 Prolene suture 
(Ethicon, Somerville, NJ). 
  
6.2.3 Collar Contraction 
 The effect of mineral content and incubation time on nanofiber collar contraction was measured in 
vitro by comparing length and width changes of the bi-phasic collar with those of single phase PLGA and 
PLGA-HA collars. Briefly, collars (1cm x 2cm) were incubated in phosphate buffered saline (PBS) and 
cultured for 72 hours. Collar dimensions were measured by taking digital images after 1, 2, 24 and 72 
hours and measuring length and width using ImageJ image analysis software.  
 
6.2.4 Cells and Cell Culture 
Human mesenchymal stem cells were obtained commercially (Lonza, Walkersville, MD) and 
maintained in culture with DMEM containing 10% fetal bovine serum (FBS, embryonic stem cell certified, 
Atlanta Biologicals, Atlanta, GA), 1% penicillin-streptomycin, 1% non-essential amino acids, 0.1% 
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amphotericin B and 0.1% gentamicin. All media supplements were purchased from Cellgro-Mediatech 
unless otherwise specified.  Cells were cultured to 80% confluence and then passaged using 0.25% 
trypsin/1 mM ethylenediaminetetraacetate (EDTA) and re-plated at a density of 5x103 cells/cm2. Passage 
2-3 cells were used for scaffold seeding. 
Constructs were seeded dynamically using an orbital shaker. Briefly, after sterilization, constructs 
were placed in conical tubes (BD Biosciences) containing cell suspension with a density of 1 million 
MSC/ml. Tubes containing constructs were placed on an orbital shaker, rotating at a rate of 100 RPM, for 
four hours in a cell culture incubator which was shown in optimization studies to result in approximately 
1x106 cells attached to each construct. Following the seeding process, constructs were placed in 
individual tubes for culture. To study the effect of nanofiber contraction on mesenchymal stem cell (MSC) 
response, braided nanofiber constructs with and without nanofiber collars were evaluated. 
 
6.2.5 Cell Proliferation 
Total DNA content was measured using the PicoGreen dsDNA assay (Invitrogen).  At each time 
point, the samples (n=5/group) were homogenized in 0.1% Triton-X (Sigma-Aldrich) and subjected to 20 
seconds of ultrasonication at 5W.  Fluorescence was measured using a microplate reader (Tecan, 
Research Triangle Park, NC) at an excitation wavelength of 485 nm and an emission wavelength of 535 
nm.  A standard curve was derived and used to correlate DNA concentration to fluorescence intensity, 
and cell number was determined based on a conversion factor of 8pg DNA/cell[104].  
 
6.2.6 Matrix Production 
Total collagen content per sample (n=5/group) was calculated using the hydroxyproline assay.  
The assay was performed following a 16-hour sample digestion in Papain (Sigma-Aldrich) to solubilize 
ECM proteins. Absorbance was measured using a microplate reader (Tecan) at 555 nm. A standard 
curve was generated and used to correlate total collagen content to absorbance. 
Sample glycosaminogylcan content (GAG, n=5) was determined with a modified 1, 9-
dimethylmethylene blue (DMMB) binding assay[234-236], with chondrotin-6-sulfate (Sigma) as the 
standard.  To account for the anionic nature of the carboxyl groups on the alginate hydrogel, the pH of the 
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DMMB dye solution was adjusted to 1.5 with concentrated formic acid (Sigma) so that only the sulfated 
GAG-DMMB complexes were detectable.  Additionally, the absorbance difference between 540nm and 
595nm was used to improve the sensitivity in signal detection.   
 
6.2.7 Cell Differentiation 
The phenotype of MSCs was assessed quantitative real-time reverse transcriptase polymerase 
chain reaction (n=5/group). Total RNA was isolated using the Trizol extraction method (Invitrogen). 
Isolated RNA was then reverse-transcribed into complementary DNA using the SuperScript First-Strand 
Synthesis System (Invitrogen), and the cDNA product was amplified using recombinant Taq DNA 
polymerase (Invitrogen). The oligonucleotide primer sequences were: type I collagen: 
TGGTCCACTTGCTTGAAGAC (sense), ACAGATTTGGGAAGGAGTGG (antisense); type II collagen: 
GGACATAGGGCCTGTCTGTT (sense), CCGGACTGTGAGGTTAGGAT (antisense); aggrecan: 
CAGATCTGCATGGAATCACC (sense); AAGTGCCTGCATCTATGTCG (antisense); and transforming 
growth factor beta-3 (TGF-β3): AAACTCCAGCTCTCTTCCCA (sense); ACGAAGTAGCGGACTGTGTG 
(antisense) was determined. GAPDH served as the house-keeping gene. All genes were amplified for 50 
cycles in a thermocycler (Bio-Rad iCycler, Hercules, CA) with a fluorescent probe (SYBR Green, 
Invitrogen). Quantitative analysis of gene expression was performed using the delta-delta CT method. 
 
6.3 Results 
6.3.1. Collar Contraction 
 Prior to performing the cell-seeded, collar contraction was characterized as the effect of 
incubation on nanofiber collar contraction was evaluated over time and compared as a function of collar 
composition (Fig. 6.1). All compositions contracted in length to less than 45% of original length within 12 
hours of incubation with no significant change in length over the remainder of the study. In addition, no 
significant difference in change in length was measured as a function of nanofiber composition. Similarly, 
in terms of width, the PLGA and PLGA-HA collars contracted to approximately 60% of original width 
within 12 hours of incubation with no significant change over the remainder of the incubation period. In 
addition, no difference was observed between these groups.  In contrast, the bi-phasic collar contracted 
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to only 80% of original width. No delamination was observed between the PLGA and PLGA-HA phases of 
the bi-phasic collar over time. 
 
6.3.2 Cell Proliferation and Matrix Deposition 
 Total cell number was measured for constructs without and without nanofibers collars at days 1, 3 
and 7  (Fig 6.2) No difference in cell number was measured between groups at any time points, though a 
mean increase was observed over time in both groups. 
 Matrix deposition was quantified in terms of total collagen content and sulfated GAG content (Fig. 
6.3) No significant difference in collagen content was measured between groups or over time, though a 
mean increase was observed over time in both groups. In contrast, a significant increase in total GAG 
content was measured after 7 days with the nanofiber collar as compared to the control group. 
 
6.3.3 Cell Differentiation 
 Stem cell differentiation was assessed by measuring the expression of several fibrocartilage-
related proteins, specifically type II collagen, aggrecan and TGF-β3 (Fig 6.4). At day 1, the expression of 
type II collagen, aggrecan, and TGF-β3 was significantly upregulated with the nanofiber collar. At day 3, 
only TGF-β3 was upregulated in the nanofiber collar group and, at day 7, no difference in the expression 
of these genes was measured between groups.  In addition, type I collagen expression was measured at 
each time point to determine phenotype specificity (Fig 6.4). No change in type I collagen expression was 
observed over time in either group. 
 
6.4 Discussion 
 This study focused on the evaluation of a novel mechanoactive nanofiber collar system to apply 
in situ compression to tissue engineering scaffold systems. The first objective of this study was to 
characterize the contractile behavior of the nanofiber collar system and the second was to evaluate its 
ability to induce chondrogenic differentiation of MSCs in vitro. It was hypothesized that collar-mediated 
contraction would result in the upregulation of fibrocartilage-related markers by MSCs and the deposition 
of a cartilaginous matrix. To this end, a braided nanofiber construct, simulating a synthetic ACL graft, was 
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wrapped with the nanofiber collar and then seeded with MSCs. The MSC-seeded constructs were 
cultured for 7 days and evaluated in terms of cell proliferation, matrix deposition and differentiation.   
 In this study, MSCs were subjected to compression via nanofiber collar contraction which resulted 
in the short-term upregulation of fibrocartilage-related markers. In particular, TGF-β3, aggrecan and type 
II collagen were all upregulated after 1 day of culture. However, the lack of long-term marker upregulation 
in this study potentially suggests an adaptive response by MSCs to the static compressive loading 
provided by the collar thereby indicating that continued compression or dynamic loading may be 
necessary to sustain a response. Alternatively, sustained chondrogenic chemical factors could also, 
absent in the culture medium used in this study, could also help further drive cells towards a 
fibrochondrogenic lineage.  
 In this study, aggrecan expression by MSCs was upregulated after 1 day of compression and 
returned to basal levels at subsequent time points. However, despite this short-term upregulation in 
marker expression, a significant increase in GAG production was measured after 7 days of compression. 
This is of particular importance because proteoglycans are one of the principal types of proteins found in 
cartilaginous tissues and serve to help these structures retain water and resist compressive loading[237]. 
Compressive loading has previously been shown to increase proteoglycan production by MSCs and is 
widely used in cartilage tissue engineering applications[238-240] to enhance the biochemical and 
mechanical properties of cartilage constructs. In addition, compressive loading of the enthesis regions of 
tendons has been demonstrated to enhance aggrecan gene expression and increase the synthesis of 
and large proteoglycans[35;227].  
 Of the fibrocartilage markers investigated in this study, TGF-β3 expression was upregulated the 
longest. Studies investigating the function of TGF-β3 have reported that it has a range of functions in cell 
differentiation and development[241;242]. In terms of tissue engineering, this protein is widely used to 
differentiate MSCs towards a cartilaginous lineage[243]. Exogenous addition of TGF- β3 has also been 
shown to increase aggrecan expression and subsequent proteoglycan production, suggesting a possible 
mechanism for the GAG findings observed in this study[244]. In addition, He et al. developed a co-culture 
silk scaffold system and reported fibrocartilaginous differentiation of MSCs when stimulated with TGF-β3, 
similar to their response when co-cultured with chondrocytes[245]. Collectively, these results imply that 
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the upregulation of TGF-β3 coupled with aggrecan upregulation and increased proteoglycan production 
indicate the differentiation of MSCs towards a cartilage or fibrocartilage-like lineage.   
 The nanofiber collar system developed in this study also has the potential to enable biological 
fixation by being applied to soft tissue grafts. Spalazzi et al. reported on the use of a combined nanofiber 
mesh and microsphere collar system to upregulate the expression of the same fibrocartilage markers 
after 24 hours of compression in vitro indicating that connective tissues containing viable cells may 
respond similarly[36]. It is anticipated that autografts, typically utilized for ACL reconstruction surgeries 
could be augmented using this system by applying the collar to the proximal and distal ends of the graft 
prior to securing it within the bone tunnels during surgery. 
 
6.5 Conclusions 
 In summary, this study demonstrates that the nanofiber collar system can be applied to induce 
chondrogenic differentiation of MSCs in vitro, in terms of cartilaginous matrix deposition and the 
expression of fibrocartilage-related proteins. These findings indicate that the collar represents a promising 
system for the interface phase of the synthetic ACL graft. However, due to the lack of sustained marker 
expression, the system will be evaluated in vivo in the next chapter to determine if it can induce long-term 





Figure 6.1. Mechanoactive nanofiber collar contraction. Nanofiber collars were fabricated via 
electrospinning. The collars underwent anisotropic contraction when incubated in a physiological 
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Figure 6.2. Effect of nanofiber collar contraction on MSC attachment and proliferation. No 
significant difference in cell number was measured between groups or over time indicating that the 

























Figure 6.3. Effect of nanofiber collar contraction of MSC matrix deposition. No difference in total 
collagen content was measured between groups or over time though a mean increase was observed over 
time in both groups. A mean increase in GAG content was measured at day 3 and GAG content was 














































Figure 6.4. Effect of nanofiber collar contraction on MSC differentiation. The application of the 
nanofiber collar resulted in the upregulation of type II collagen, aggrecan and TGF-β3 at day 1 as 
compared to the control group. Only TGF-β3 remained upregulated at day 3 and no difference in marker 































































































CHAPTER 7: INTERFACE PHASE: IN VIVO 






 In Chapter 6, a nanofiber collar system was designed and it was demonstrated that using this 
system to apply compression to MSCs resulted in the upregulation of fibrocartilage-related markers and 
the production of a cartilaginous extracellular matrix. However, due to the lack of sustained fibrocartilage 
market expression, the collar system will be validated in vivo using a rodent model to determine if it can 
induce fibrocartilage formation on soft tissue grafts. 
 
7.1.1 Background and Motivation 
 Initial attempts to improve ligament graft-to-bone fixation have focused on augmenting the 
surgical graft with mineralized components in order to encourage bone formation[58-63] as the strength of 
the tendon-to-bone interface has been shown to correlate with the degree of bony in-growth[12].  For 
example, Tien et al. used calcium phosphate cements within the bone tunnels in a rabbit ACL 
reconstruction study and found that the addition of this ceramic helped to improve osseous tissue in-
growth and organization[58].  Similarly, the injection of tricalcium phosphate cement to the tendon-bone 
junction within the bone tunnel in a canine ACL reconstruction model resulted in more organized bone 
tissue formation compared to the uncemented control[59].  Using an alternative approach, Mutsuzaki et 
al. soaked tendon grafts in a series of solutions which coated the tendons with a calcium phosphate layer 
prior to surgery[60;61].  The modified graft displayed enhanced healing and promoted tendon-to-bone 
integration when tested in a rabbit ACL reconstruction model.  These findings indicate that the inclusion of 
calcium phosphate is a viable strategy for enhancing tendon-to-bone integration. However, although 
these methods have improved osteointegration between the ACL graft and the bone tunnel, they do not 
result in the regeneration of the fibrocartilage interface.   
The native ACL-to-bone enthesis consists of a fibrocartilaginous transition which serves to 
minimize stress concentrations and facilitates load transfer between two distinct tissue types[22;23;70-
73]. The mechanisms governing the formation of this interface are not well understood; though it has 
been reported that metaplasia of tendon or ligament tissue plays a role in this process[225;226]. 
Specifically, Nawata et al., using a rodent model, reported that ACL insertion fibrochondrocytes arise from 
ligament fibroblasts[226]. Similarly, Gao et al. used a rodent model to show that ligament fibroblasts begin 
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to synthesize type II collagen during the development of the ligament-bone enthesis[225]. In addition, 
mechanical stimulation has been implicated in the process of enthesis development and fibrocartilage 
formation[75]. Vogel et al. investigated this process extensively in a bovine model, focusing on the effect 
of compressive loading on fibrocartilage formation in flexor tendons[227-231]. It was reported that 
compressive loading induced metaplasia of tendinous matrix and initiated its transformation into 
fibrocartilage-like tissue as gene expression of fibrocartilage markers, such as aggrecan and type II 
collagen, was not observed in the wrap-around regions of fetal and neonatal bovine flexor tendons, but 
was strongly expressed in those of mature animals[229], thereby suggesting that physiological 
compressive loading induces post-natal fibrocartilage formation. Extending this work, it was reported that 
translocation of rabbit flexor digitorum profundus tendon to remove compressive loading resulted in a 
decrease in the size of the fibrocartilage region, looser collagen organization and a lower 
glycosaminoglycan content in the tissue[228].  It was also reported that re-establishing cyclic 
compression in vitro enhanced the expression of aggrecan, biglycan and versican in bovine flexor 
tendons[230]. Collectively, these findings suggest that compressive loading modulates fibrocartilage 
formation and may be responsible for matrix remodeling in tendon tissue. 
 
7.1.2 Objectives 
 To address the challenge of achieving biological fixation of soft tissue grafts, the goal of this study 
is to develop functional methods to regenerate an anatomic fibrocartilage transition on ACL reconstruction 
grafts.  To this end, a novel mechanoactive graft collar will be evaluated. This collar is composed of an 
aligned poly(lactic-co-glycolic) acid (PLGA) nanofiber mesh which is biodegradable and undergoes 
anisotropic contraction when placed in a physiological environment[24;36;232]. This collar is designed to 
be secured to the proximal and distal ends of the graft during surgery and remain in the bone tunnels 
during the healing process (Fig. 7.1). Furthermore, to mimic the heterogeneity of the native ligament-to-
bone interface, a multi-phasic collar with both PLGA and composite PLGA-hydroxyapatite nanofiber 
components has been developed to provide region-specific enhancement of fibrocartilage and 
mineralized tissue formation.  The efficacy of the mechnoactive collar was previously demonstrated in 
vitro as it was report to upregulate the expression of fibrocartilage markers, such as transforming growth 
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factor-beta 3 (TGF-β3), aggrecan and type II collagen when applied to bovine patellar tendons in vitro[36]. 
The objective of the current study is to evaluate the use of a mechanoactive collar system in vivo using a 
rat ACL reconstruction model. It is hypothesized that the composite nanofiber collar will promote 
fibrocartilage formation, enhance osteointegration and improve graft fixation strength following ACL 
reconstruction. It is anticipated that the impact of this work will extend beyond orthopaedic repair 
techniques as similar approaches could be developed to apply mechanical stimulation in situ to improve a 
variety of surgical procedures and also enhance the clinical potential of tissue engineering strategies. 
 
7.2 Materials and Methods 
7.2.1 Collar Fabrication 
Aligned nanofiber collars composed of polylactide-co-glycolide (PLGA, 85:15, Mw = 123.6 kDa; 
Lakeshore Biomaterials) were produced via electrospinning[24;246]. Briefly, a polymer solution consisting 
of 35% PLGA (w/v) in 55% N,N-dimethylformamide (Sigma-Aldrich, St. Louis, MO) and 10% ethanol 
(Pharmco-AAPER, Brookfield, CT) was loaded into a syringe fitted with an 18.5-gauge blunt tip needle 
(Becton Dickinson, Franklin Lakes, NJ). Composite PLGA-hydroxyapatite (PLGA-HA) nanofiber collars 
were fabricated similarly by adding a suspension of HA nanoparticles immersed in DMF to the PLGA 
solution, resulting in a 15% HA (w/w) polymer-ceramic suspension. Aligned fibers were obtained using an 
aluminum mandrel rotating at a velocity of 20m/s with a constant polymer flow rate of 1 mL/hr maintained 
via a syringe pump (Harvard Apparatus, Holliston, MA)[233]. An electrical potential was applied between 
the needle and the drum using a high-voltage DC power supply (Spellman, Hauppauge, NY). The bi-
phasic (BP) collar was fabricated by electrospinning parallel regions of PLGA and PLGA-HA nanofibers. 
After depositing a layer of aligned PLGA nanofibers on the mandrel, a custom masking system was 
applied upon which a layer of PLGA-HA nanofibers was deposited. The resulting multi-phase collar 
consisted of a PLGA region, a PLGA/PLGA-HA overlapping region (1mm in length) and a PLGA-HA 




7.2.2 ACL Reconstruction Procedure 
The ACL reconstruction procedure was performed on male Lewis rats (weight, 275–300 g) using 
a flexor digitorum longus tendon graft[247] following approval by the Institutional Animal Care and Use 
Committee. The rats were kept in soft-bedding cages with free access to food and water. Animals were 
anesthetized with a mixture of 80 mg/kg ketamine hydrochloride and 5 mg/kg xylazine administered 
intraperitoneally through a 25-gauge needle. A longitudinal incision was first made on the medial aspect 
of the right distal leg and ankle. The flexor digitorum longus tendon was identified and cut just distal to the 
ankle in order to harvest the full length of the flexor digitorum longus tendon (average length, 30 mm). A 
second incision was made over the knee and a medial parapatellar arthrotomy was performed to open 
the joint and excise the ACL. Bone tunnels 1.6mm in diameter were made in the proximal tibia and the 
distal femur by entering the joint at the attachment sites of the ACL. In the experimental groups (PLGA, 
PLGA-HA, and bi-phasic), a nanofiber collar was wrapped once around a 5 mm section of each end of 
the tendon graft, corresponding to the regions inserted into the bone tunnels (Fig 7.1). The collar was 
secured to the graft using 7-0 Prolene suture (Ethicon, Somerville, NJ) and a 4–0 Ethibond suture 
(Ethicon, Somerville, NJ) was passed through each end of the graft. Control groups received a graft 
without a nanofiber collar. The graft was passed through the bone tunnels to replace the ACL and the 
proximal and distal ends were secured to the femur and tibia, respectively. Wounds were closed in 
standard fashion. No negative effects of the autologous graft harvest were observed other than expected 
swelling and all animals resumed normal gait by 2 to 3 days after surgery. The animals remained healthy 
and infection-free throughout the duration of the study. All animals resumed normal cage activity by the 
first postoperative day. Careful inspection of the articular surfaces after euthanasia revealed no arthritis or 
advanced joint degeneration. 
 
7.2.3 Matrix Deposition & Fibrocartilage Formation 
Two animals per group were euthanized at 4 and 8 weeks after surgery via carbon dioxide 
inhalation and prepared for histologic analysis. At each time point, one specimen was decalcified and 
embedded in paraffin for histology and immunohistochemistry. The remaining specimen for each time 
point was embedded in methacrylate.  
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Harvested tissues for decalcified histology were fixed for 4 days in 10% neutral buffered formalin 
and then decalcified for 48 hours in a solution of formalin, formic acid and ion exchange beads (Dowex 
HCS-5, Dow Chemical, Midland, MI). Excess bone and soft tissue surrounding the femoral and tibial 
tunnels was removed and the tissues were dehydrated in serial alcohol concentrations (70%–100%), 
cleared thrice in xylenes and then embedded in paraffin (Fisher Scientific) at 60ºC. Seven-micrometer-
thick sections were cut perpendicular to the axes of the bone tunnels and stained with a Modified 
Goldner’s Masson trichrome stain and picrosirius red to visualize collagen distribution, and alcian blue to 
visualize sulfated glycosaminoglycans (GAG). Images were obtained using a light microscope (Zeiss 
Axiovert 25, Zeiss, Germany) and a polarized light microscope (Olympus BX60, Olympus, Center Valley, 
PA). 
Immunohistochemical analysis was performed to evaluate collagen distribution and the presence 
of fibrocartilage-related proteins[2].  Specifically, monoclonal antibodies against type I collagen (1:20 
dilution, Abcam, Cambridge, MA), type II collagen (1:100 dilution, Santa Cruz Biotechnology, Santa Cruz, 
CA), type I pro-collagen (1:50 dilution, Developmental Studies Hybridoma Bank, Iowa City, IA), aggrecan 
(1:100 dilution, Santa Cruz Biotechnology) and TGF-β3 (1:100, Abcam) were applied to serial sections 
after retrieval with 1% hyaluronidase for 30 minutes (aggrecan and type II collagen) or hot citrate buffer 
(pH = 6.0) for 20 minutes (type I procollagen and TGF-β3)  at 37˚C. All sample sections were incubated 
with primary antibody overnight at 4˚C. Following a rinse with PBS, FITC-conjugated secondary antibody 
(1:200 dilution, Abcam) was added for one hour at 25˚C. Propidium iodide (Invitrogen) was used as a 
nuclear counterstain. Images were obtained using a confocal microscope (Leica TCS-SP5, Leica, 
Bannockburn, IL).  
 
7.2.4 Mineralization 
Mineral distribution with the tibial and femoral bone tunnels was determined using micro-
computed tomography (micro-CT, n=2/group). Briefly, following fixation for 96 hours in 10% neutral 
buffered formalin, histological samples were scanned with a micro-computed tomography system (VivaCT 
40, Scanco Medical, Switzerland). The length of the tibia and femur surrounding the bone tunnel was 
scanned with a 17μm voxel size. Three-dimensional reconstructions were then performed by tracing the 
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edges of the bone and using a mineral density of 268 mg HA/cm3.  Tunnel diameter was measured by 
taking measurements in tripliciate down the length of each tunnel in the resulting three-dimensional 
figures. 
 Bone volume surrounding the tunnel was quantified by performing volumetric reconstruction of a 
uniform cylinder of bone including the tibial bone tunnel. A 2.0cm circular contour surrounding the bone 
tunnel was placed on 315 slices as acquired via micro-CT and reconstructed at a density of 268 mg 
HA/cm3, the bone volume and bone volume fraction were quantified using the vivaCT software. 
Samples for calcified histology were dehydrated in serial alcohol concentrations (70%–100%). 
Rat tibiae were embedded in poly(methylmethacrylate) using a modification of the methods of Erben et 
al.[248]. Seven-micrometer-thick sections were cut perpendicular to the bone tunnels and von Kossa 
staining was used to visualize mineralized tissue[249]. Images were obtained using a light microscope 
(Zeiss Axiovert 25, Zeiss, Germany). 
 
7.2.5 Biomechanical Properties 
Biomechanical testing (n=10) was performed to evaluate the strength of the reconstruction after 8 
weeks[38;247]. Limbs used for biomechanical testing were disarticulated at the hip and all muscles were 
removed leaving the joint capsule and the ligaments intact to protect the ACL graft until testing. 
Specimens were stored in a freezer at −80°C until testing. Prior to testing, each limb was defrosted 
overnight at 4°C and thawed at room temperature. The joint capsule, tendons, ligaments (except the 
ACL) and the suture material at the graft ends were excised prior to testing. The bony ends were potted in 
bonding cement at the proximal femur and the distal tibia to allow secure fixation in the testing machine. 
The specimen was positioned on a custom device for rat knees. Knee flexion was maintained at 45° with 
the tensile load passing parallel to the ACL graft and the bone tunnels. A preload of 15 g was applied to 
the graft for five cycles, following which a tensile load to failure test was performed at a displacement rate 
of 0.17 mm/second. The load-deformation curve was recorded on a personal computer. Results are 
reported in terms of the ultimate load-to-failure (N) and stiffness (N/mm) which were calculated from the 
linear portion of the load-deformation curve. The site of failure was recorded as pull-out from the bone 




7.2.6 Statistical Analysis  
Results are presented in the form of mean ± standard deviation, with n equal to the number of 
samples per group. Two-way analysis of variance (ANOVA) was performed to evaluate the effect of time 
and composition on collar contraction and also to assess the effect of time and collar composition on 
tunnel diameter. One-way ANOVA was used to evaluate the effect of the bi-phasic collar on bone volume 
and biomechanical properties. The Tukey-Kramer post-hoc test was used for pair-wise comparisons. 




7.3.1 Matrix Deposition & Fibrocartilage Formation 
 A vascularized bone tunnel was evident surrounding the collagenous tendon graft in the control, 
PLGA and PGLA-HA groups as shown in the series of trichrome stains (Fig. 7.2), in which the 
collagenous matrix appears green, erythrocytes in red and cell nuclei in black. After 4 weeks, similar 
collagen distribution was displayed within and surrounding the grafts in all groups with vascularized tissue 
evident within the mid-substance of grafts wrapped with the PLGA-HA. After 8 weeks, the presence of 
vascularized tissue was more prominent in the PLGA-HA group and a statistically significant decrease in 
tunnel diameter (Fig. 7.2) was also observed in this group. Histological sections of the PLGA and PLGA-
HA regions of specimens wrapped with the bi-phasic collar also displayed vasculature present within the 
graft at both 4 and 8 weeks.  
Visualization of the collagenous matrix via picrosirius red staining revealed similar collagen 
distribution within grafts of all groups at both week 4 and week 8 (Fig. 7.3). Evaluation of collagen 
orientation, as shown with polarized light microscopy, indicated minimal differences in collagen orientation 
in the control and PLGA groups at both week 4 and week 8. Interestingly, collagen fibers appearing green 
under polarized light, indicative of smaller diameter fibers, were distinctly present within the graft in both 
the PLGA-HA and HA region of the bi-phasic collar after 8 weeks. Fibers appearing green were also 
evident surrounding the grafts in all groups, corresponding to the outline of the bone tunnel.  
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 Collagen distribution was further evaluated using immunohistochemistry. At 4 weeks, type I 
collagen was uniformly distributed in all groups and similar findings were observed after 8 weeks. 
Additionally, intracellular type I procollagen was stained to determine regions of new collagen synthesis 
and neo-tissue formation[250] (Fig. 7.4). Type I procollagen was revealed to be present surrounding all 
grafts and was most abundant around grafts wrapped with a collar at 4 weeks. After 8 weeks, type I 
procollagen was similarly uniform in all groups. Type II collagen was found to be present only within the 
grafts of experimental groups (PGLA, PLGA-HA and bi-phasic collars) at 4 weeks and was found in all 
groups after 8 weeks, though most abundantly in the groups wrapped with nanofiber collars (Fig. 7.4). 
 The deposition of proteoglycans and the formation of fibrocartilage were evaluated with Alcian 
Blue staining as well as immunohistochemical staining for type II collagen and aggrecan. In addition, the 
presence of TGF-β3 was also evaluated as it has been shown to be an important factor related to 
proteoglycan production in tendons[230]. At 4 weeks, Alcian Blue staining revealed glycosaminoglycans 
(GAG) present surrounding grafts in all groups but only within the midsubstance of grafts wrapped with a 
PLGA-HA collar. No substantial GAG content was observed within the grafts of any group after 8 weeks 
(Fig. 7.5). Aggrecan was found only within the adjacent cartilaginous tissue in the control group at week 4 
but was present in the midsubstance of all grafts wrapped with a collar. Minimal regions of aggrecan 
deposition were found within the graft of the control group at 8 weeks and it was more abundantly present 
within the PLGA, PLGA-HA and bi-phasic groups at this time point (Fig. 7.5). TGF-β3 deposition was 
found to correlate with aggrecan deposition as it was not present in the control group graft at 4 weeks and 
only minimally present in the control after 8 weeks. More abundant TGB-β3 deposition was observed in 
the PLGA, PLGA-HA and bi-phasic groups after 8 weeks (Fig. 7.6). 
 
7.3.2 Mineralization 
In terms of mineral distribution, micro-CT analysis revealed that mineralized tissue was present 
within grafts wrapped with collars containing HA at 4 weeks (PLGA-HA and bi-phasic groups, Fig. 7.7). 
The most abundant mineral was detected within the tunnels of the PLGA-HA and bi-phasic groups as a 
cylindrical ring of mineral evident in the tunnel of both groups. The presence of mineralized tissue within 
the graft was confirmed with von Kossa staining, which stained positive for mineral within grafts wrapped 
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with HA and bi-phasic collars. Nodules of mineralized tissue formation were found to be larger after 8 
weeks in these groups.  
Mineralized tissue formation was further evaluated by quantifying the amount of bone present 
surrounding and within the tibial bone tunnels of each specimen. This analysis revealed that a greater 
amount of mineral was present after 8 weeks with the bi-phasic collar in comparison with the control 
group (Fig. 7.8). The total bone volume (9.36±1.31 mm3 vs. 7.58±1.67 mm3) and bone volume fraction 
(0.27±0.03 vs. 0.22±0.05) of the analyzed region were significantly greater with the bi-phasic collar as 
compared to the control group. 
 
7.3.3 Biomechanical Properties 
 Uniaxial tensile testing of reconstructed knees revealed no significant difference in stiffness or 
failure load between the bi-phasic group and the control group. The failure load of grafts in the control 
group was measured as 11.10±5.97N as compared to 10.17±3.94N with the bi-phasic collar. Similarly, the 
stiffness in the control group was 8.27±4.79 N/mm as compared to 7.92±3.30 with the bi-phasic collar. 
Samples in both groups failed at both the mid-substance of the graft as well as at the tibial and femoral 
bone tunnels.  
 
7.4 Discussion 
 Our long-term goal is to facilitate biological fixation by engineering a functional and anatomical 
fibrocartilage interface directly on soft tissue and synthetic grafts used in orthopaedic repair 
techniques[251]. To this end, this study focused on the in vivo evaluation of a mechanoactive and 
osteointegrative collar system, guided by the working hypothesis that compression applied to tendon 
grafts via the inherent contraction of the polymeric nanofiber meshes would result in matrix remodeling 
and fibrocartilage formation while the addition of a ceramic component would enhance bone formation 
and tendon-to-bone integration. Specifically, the primary objective of this study was to evaluate this graft 
collar system in vivo to test the hypothesis that a composite nanofiber collar will promote fibrocartilage 
formation, enhance osteointegration and increase graft fixation strength.   
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 We previously reported that the PLGA nanofiber collar induced the upregulation of fibrocartilage-
related markers in vitro after 24 hours when applied to bovine patellar tendon samples, as compared to 
samples with pre-contracted PLGA collars[36]. This study extended the collar system to an in vivo rat 
model and indicates that tendon graft compression via collar contraction resulted in the acceleration of 
type II collagen, aggrecan and TGF-β3 formation after 4 weeks in vivo and also increased the production 
of these proteins after 8 weeks. As the native enthesis of tendons is largely comprised of types I and II 
collagen and proteoglycans[22;35;227] and native fibrocartilage formation from tendon and ligament 
tissue has been shown to correlate with the expression and production of these proteins[252], these 
results indicate that compressive loading can initiate matrix remodeling. It should be noted however, that 
no in situ monitoring of tendon compression was performed and that physical loads at the graft-bone 
interface may also have played a role due to the fact that knee motion was not constrained. However, 
these findings demonstrate the potential of the nanofiber collar system for use in vivo to induce 
fibrocartilage-like tissue formation on tendon grafts following ACL reconstruction.   
 The incorporation of hydroxyapatite nanoparticles within the PLGA-HA and bi-phasic graft collars 
resulted in the formation of calcified tissue within the bone tunnels of these groups. In addition, an 
increase in total bone volume surrounding the graft was measured with in bi-phasic collar group as 
compared to the control group. These findings are likely due to the presence of a physiological mineral 
within the collar as several groups have reported similar results when evaluating calcium phosphate-
based cements to augment tendon-to-bone integration. For example, Wen et al. applied a calcium 
phosphate-based brushite within the tendon-to-bone interface of the bone tunnels in a rabbit ACL 
reconstruction model[253]. It was reported that the application of the cement resulted in increased peri-
tendon bone volume and also promoted bone growth into the healing interface. Additionally, Ishikawa et 
al. studied the effect of a collagen gel mixed with a hydroxyapatite powder on tendon-to-bone integration 
in a rabbit model[62]. The gel, applied between the grafted Achilles tendon and bone in a femoral bone 
tunnel, resulted in greater bone volume and Sharpey-like fibers integrating the tendon with bone. Our 
results are in agreement with these findings and demonstrate the potential of a ceramic component within 
the graft collar to enhance bone formation and tendon-to-bone integration. 
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The functional outcomes of the nanofiber collar were evaluated with uniaxial tensile testing of the 
bi-phasic collar as compared to the control group[38;247]. No significant difference in stiffness or failure 
load was measured between the two groups. This finding may be due to the relatively short 8-week study 
duration as compared to the traditional 6 to 12 month healing process following ACL reconstruction. It is 
anticipated that future studies may need to be extended beyond the 8-week time point to allow for 
sufficient healing and interface formation to impact biomechanical outcomes. 
We reported on the evaluation of three collar systems (PLGA, PLGA-HA and bi-phasic) for 
enhancing ligament-to-bone integration. The PLGA collar demonstrated the potential of collar-mediated 
compression to initiate the formation of fibrocartilage-like tissue while the PLGA-HA collar included a 
mineral component and resulted in mineralized tissue formation throughout the length of the bone 
tunnels. The bi-phasic collar, extending upon these designs, resulted in region-specific mineralized tissue 
formation and demonstrates the potential of a multi-phase collar to recapitulate the inherent complexity of 
the ligament-to-bone interface. It is anticipated that this system would result in long-term enhancement of 
bone formation within the tunnel and also induce fibrocartilage formation, thereby regenerating the 
anatomical transition between ligament and bone.  
 While the rat ACL reconstruction model is well established in the literature, interpretations of 
these results must take into account the limitation of this model. Specifically, due to the fact that the rat 
growth plate does not close during the lifetime of the animal[254], further evaluation is necessary in a 
larger, skeletally mature animal model. Therefore, future studies will focus on extending the use of our 
system to more clinically relevant animal models, such as a caprine model. 
 
7.5 Conclusions 
 In summary, a mechanoactive nanofiber collar was evaluated to assess the efficacy of applying 
mechanical loading to tendon grafts in situ. Collar-induced compression of the flexor digitorum tendon 
graft accelerated and increased the formation of key components of fibrocartilage, including type II 
collagen, aggrecan and TGF-β3. In addition, the inclusion of a physiological mineral component within the 
collar resulted in bone formation within the graft midsubstance. These promising results demonstrate the 
clinical potential of a multi-phasic mechanoactive polymer-ceramic collar, as it is envisioned that the collar 
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can be used to apply both biochemical and mechanical stimuli to induce the formation of a 
fibrocartilaginous interface on tendon grafts. Based on these results, the bi-phasic nanofiber collar system 
will be used to induce interface tissue formation on the multi-phased synthetic ACL graft. In addition, this 
approach has the potential for immediate clinical translation in order to augment current ACL 
reconstruction methods by enhancing graft osteointegration and stimulating the formation of native 
ligament-to-bone interfacial tissue. In the next chapter, a multi-phased scaffold comprised of all three 




Figure 7.1. Mechanoactive nanofiber collar application. The ACL reconstruction procedure was 
performed on Lewis rats. Rats in the experimental groups received either a PLGA, PLGA-HA, or a bi-
phasic collar on each end of the flexor tendon graft, corresponding to the regions inserted within the bone 
tunnels.  






















Figure 7.2. Effect of nanofiber collar on matrix deposition. A modified Goldner’s Masson Trichrome 
Stain of histological sections. Collagen is stained in green, erythrocytes in red and cell nuclei in black (5x, 
scale bar = 500μm) to delineate the bone (B) from the graft (G). Similar collagen distribution is evident in 
all groups over time, with vascularized tissue formation most evident within the graft of the PLGA-HA and 

















Figure 7.3. Effect of nanofiber collar on collagen distribution and orientation. Picrosirius red staining 
of histological specimens with corresponding polarized light micrographs showing that collagen 
distribution is uniform in all groups (5x, scale bar = 500μm). Polarized light microscopy revealed the 
presence of smaller diameter fibers (green, arrow) within the grafts of the PLGA-HA group and the HA 













































Figure 7.4. Effect of nanofiber collar on neo-tissue formation. Type I procollagen (red; cell nuclei: 
blue; 63x, scale bar = 50μm) was found to be most abundant surrounding the experimental groups at 
week four. Type II collagen (yellow; blue: cell nuclei; 20x, bar = 200μm) was present only within the graft 
of experimental groups at week four and was present within all grafts at week eight.  
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Figure 7.5. Effect of nanofiber collar on cartilaginous tissue formation. Alcian Blue staining indicated 
the presence of GAG (blue) only within grafts wrapped with a PLGA-HA collar after four weeks (5x, scale 
bar = 500μm). No positive staining was indicated within the graft of any groups after eight weeks. 
Aggrecan (yellow; cell nuclei: blue; 63x, scale bar = 50μm) was present within the graft of all experimental 
groups at week four but absent in the control group. After eight weeks, aggrecan was present within all 
grafts but was more abundantly evident in the experimental groups.  
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Figure 7.6. Effect of nanofiber collar on fibrocartilage formation. Staining for TGF-β3 (yellow; cell 
nuclei: blue; 63x, scale bar = 50μm) indicated that it was present near regions of aggrecan. Similarly, it 
was only present in experimental groups at week four and absent in the control group. It was most 
abundantly evident in the experimental groups at week eight.  
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Figure 7.7. Effect of nanofiber collar on mineralized tissue formation and tunnel diameter. Three-
dimensional reconstructions (bar = 500μm) of tibiae via μCT revealed the presence of mineralized tissue 
within the tunnels of grafts wrapped with the PLGA-HA and BP scaffold after four weeks. More abundant 
mineralized tissue was found within the grafts of these groups after eight weeks. Both the PLGA-HA and 
Bi-Phasic collar groups measured a significant decrease in tunnel diameter between weeks four and eight 
(#p<0.05). A significant decrease in tunnel diameter was observed with the PLGA-HA collar after four 







































Figure 7.8. Effect of nanofiber collar on tunnel mineralization. Bone volume surrounding the bone 
tunnel was analyzed using μCT. Total bone volume (BV) and bone volume fraction (BVF) of uniform 
cylindrical sections of bone surrounding the bone tunnel was assessed using the vivaCT software. A 
significant increase in BV and BVF were measured in the bi-phasic collar group as compared to the 
control group. Similar tissue morphology was evident with the bi-phasic collar as compared to the control 
group. Regions of cartilage-like tissue were found within the tendon substance with the bi-phasic collar 
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CHAPTER 8: IN VITRO EVALUATION OF THE 





 The previous chapters focused on optimizing the individual phases of the synthetic ACL graft to 
enable bone, interface and ligament regeneration. The focus of this chapter is the incorporation of all 
three phases in order to produce a single construct to induce the formation of an integrated bone-
ligament-bone complex in vitro. In this chapter, the three phases will be incorporated, the cell seeding 
density will be optimized and the optimal construct will be cultured under in a physiologically-relevant 
bioreactor system to evaluate the formation of a pre-integrated ligament tissue in vitro. 
 
8.1.1 Background and Motivation 
Optimization of cell seeding density of tissue engineered scaffolds is necessary to maximize the 
utility of donor cells and provide a basis for uniform tissue regeneration[255]. In particular, higher cell-
seeding densities have been reported to be desirable due to increased matrix production[256], likely due 
to the increased cell-cell contact and enhanced cell-matrix interactions[257-259]. Previous studies 
investigating cell-seeded synthetic ligament grafts have been performed using a range of cell seeding 
densities. For example, Cooper et al. and Fan et al. seeded ligament scaffolds at a density of 3 million 
cells per scaffold[18;108] and 4 million cells[109] per scaffold prior to implantation in a rabbit model and 
goat model, respectively. Therefore, prior to in vivo implantation, the cell seeding density for the synthetic 
ligament graft must be optimized.     
 
8.1.2 Objectives 
The objectives of this study are three-fold: the first objective is to optimize the architecture of the 
ligament phase of the scaffold as that phase is responsible for its bulk mechanical properties, the second 
is to determine the optimal seeding density for the synthetic ACL graft and the last is to the culture the 
system to evaluate the formation of a pre-integrated bone-ligament-bone complex in vitro. Grafts seeded 
at the optimal seeding density, as determined by matrix deposition and cell phenotype, will then be 
cultured in a bioreactor to simulate the physiological environment and evaluate the formation of an 
integrated bone-ligament-bone complex in vitro. It is hypothesized that a multi-bundle architecture, similar 
to the characterization of the structure of the native ligament will be necessary for optimal mechanical 
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characteristics. In addition, it is hypothesized that increasing initial cell seeding density will result in 
accelerated differentiation of MSCs towards specific phenotypes and increased matrix deposition.  
 
8.2 Materials and Methods 
8.2.1 Synthetic ACL Phase Fabrication 
Each phase of the nanofiber-based synthetic ACL was fabricated via electrospinning. For the 
ligament phase, a mixture of 18% (w/v) poly(ε-caprolactone) (PCL, Sigma-Aldrich, Mw=70,000-90,000) 
and PLGA (85:15, Mw=123.6 kDa; Lakeshore Biomaterials) was dissolved in a mixture of 60/40 
dichloromethane (DCM, Sigma-Aldrich, St. Louis, MO) and DMF. The polymer solution was loaded into a 
5 mL syringe with a 18.5-gauge stainless steel blunt tip needle, and electrospun at 8-10kV using a 
custom electrospinning device.  The polymer solution was deposited (1 mL/hour) using a syringe pump 
(Harvard Apparatus, Holliston, MA) onto a custom rotating mandrel (20 m/s) to produce aligned fibers.  
For the interface phase, bi-phasic nanofiber collars were fabricated. Briefly, a polymer solution 
consisting of 35% PLGA (w/v, 85:15, Lakeshore Biomaterials) in 55% N,N-dimethylformamide (Sigma-
Aldrich) and 10% ethanol (Pharmco-AAPER, Brookfield, CT) was loaded into a syringe fitted with an 18.5-
gauge blunt tip needle (Becton Dickinson, Franklin Lakes, NJ). Composite PLGA-hydroxyapatite (PLGA-
HA) nanofibers were fabricated similarly by adding a suspension of HA nanoparticles immersed in DMF to 
the PLGA solution, resulting in a 15% HA (w/w) polymer-ceramic suspension. Aligned fibers were 
obtained using an aluminum mandrel rotating at a velocity of 20m/s with a constant polymer flow rate of 1 
mL/hr maintained via a syringe pump (Harvard Apparatus, Holliston, MA)[233]. An electrical potential was 
applied between the needle and the drum using a high-voltage DC power supply (Spellman, Hauppauge, 
NY). The bi-phasic collar system was fabricated by electrospinning parallel regions of PLGA and PLGA-
HA nanofibers. After depositing a layer of aligned PLGA nanofibers on the mandrel, a custom masking 
system was applied upon which a layer of PLGA-HA nanofibers was deposited. The resulting multi-phase 
collar consisted of a PLGA region, a PLGA/PLGA-HA overlapping region (1mm in length) and a PLGA-HA 
region. 
For the bone phase, composite polymer-ceramic nanofibers were fabricated. Briefly, a 5:1 mixture 
of PLGA and PCL was dissolved in a 60:40 mixture of dichloromethane and dimethyl formamide (DMF) 
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and mixed for one hour. Simultaneously, a suspension of HA nanoparticles (Nanocerox, Ann Arbor, MI) 
and DMF was sonicated for one hour. The nanoparticle suspension and polymer solution were then 
mixed rigorously to produce an 18% (wt%) polymer solution containing 35% (wt ceramic/wt polymer) HA. 
To produce the nanofibers, the polymer solution was loaded into a 5 mL syringe with a 18.5-gauge 
stainless steel blunt tip needle, and electrospun at 8-10kV using a custom electrospinning device. The 
polymer solution was deposited (1 mL/hour) using a syringe pump (Harvard Apparatus, Holliston, MA) 
onto a rotating mandrel (20m/s) to produce the aligned fibers.   
 
8.2.2 Cells and Cell Culture 
 Mesenchymal stem cells were obtained from the long bones of Lewis rats. Rats were euthanized 
by carbon dioxide inhalation, and the femurs and tibiae were harvested under sterile conditions. The 
MSCs were harvested by lavaging the intramedullary canals of the long bones into 50mL conical tubes 
using DMEM containing 10% fetal bovine serum (FBS), 1% penicillin-streptomycin, 1% non-essential 
amino acids, 0.1% amphotericin B and 0.1% gentamicin. Harvested cells were plated directly into 150cm2 
culture dishes for 48 hours in an incubator at 37°C, humidified with 5% CO2. After 2 days, the contents of 
the flask were removed and washed with phosphate buffered saline (PBS), leaving behind MSCs that 
adhered to the bottom of the flask. Once confluent, the MSCs were detached with 0.25% trypsin (Cellgro) 
and serially sub-cultured. Cells from passages three and four were used for all studies. 
Grafts were seeded dynamically using an orbital shaker. Briefly, after sterilization, grafts were 
placed in conical tubes (BD Biosciences, Franklin Lakes, NJ) containing cell suspension with a density of 
1 million MSC/ml. Tubes containing grafts were placed on an orbital shaker, rotating at a rate of 100 
RPM, while placed in a cell culture incubator. It was determined through previous optimization studies 
that cell seeding density could be controlled by varying the amount of time that scaffolds were agitated in 
the cell suspension. Seeding for 2 hours resulted in 2.5x105 cells per scaffold, 3 hours resulted in 5x105 




8.2.3 Cell Proliferation 
Total DNA content was measured using the PicoGreen dsDNA assay (Invitrogen).  At each time 
point, the samples (n=5/group) were homogenized in 0.1% Triton-X (Sigma-Aldrich) and subjected to 20 
seconds of ultrasonication at 5W.  Fluorescence was measured using a microplate reader (Tecan, 
Research Triangle Park, NC) at an excitation wavelength of 485 nm and an emission wavelength of 535 
nm.  A standard curve was derived and used to correlate DNA concentration to fluorescence intensity, 
and cell number was determined based on a conversion factor of 8pg DNA/cell[104].  
 
8.2.4 Cell Biosynthesis 
Total collagen content per sample (n=5/group) was calculated using the hydroxyproline 
assay[142].  Briefly, the samples were first desiccated for 24 hours and then digested for 16 hours at 
60oC with papain (600 µg protein/ml) in 0.1M sodium acetate (Sigma), 10 mM cysteine HCl (Sigma), and 
50 mM ethylenediaminetetraacetate (Sigma).  A 40 µl aliquot of the digest was hydrolyzed with 10 µl 10 M 
sodium hydroxide and autoclaved for 25 minutes.  The hydrolyzate was then oxidized by a buffered 
chloramine-T reagent for 25 minutes before the addition of Ehrlich’s reagent.  Sample absorbance was 
measured at 550nm (Tecan), and the collagen content was obtained by interpolation along a standard 
curve of bovine type I collagen (Sigma). 
Mineralization potential was determined by measuring ALP activity (n=5) using an colorimetric 
assay based on the hydrolysis of p-nitrophenyl phosphate (pNP-PO4) to p-nitrophenol (pNP)[202].  
Briefly, the samples were lysed in 0.1% Triton-X solution, then added to pNP-PO4 solution (Sigma) and 
allowed to react for 30 min at 37°C. Sample absorbance was measured at 415nm using a microplate 
reader (Tecan).   
Sample glycosaminogylcan content (GAG, n=5) was determined with a modified 1, 9-
dimethylmethylene blue (DMMB) binding assay[234-236], with chondrotin-6-sulfate (Sigma) as the 
standard.  To account for the anionic nature of the carboxyl groups on the alginate hydrogel, the pH of the 
DMMB dye solution was adjusted to 1.5 with concentrated formic acid (Sigma) so that only the sulfated 
GAG-DMMB complexes were detectable.  Additionally, the absorbance difference between 540nm and 




8.2.5 Cell Differentiation 
 The phenotype of MSCs was assessed quantitative real-time reverse transcriptase polymerase 
chain reaction (n=5/group). Total RNA was isolated using the Trizol extraction method (Invitrogen). 
Isolated RNA was then reverse-transcribed into complementary DNA using the SuperScript First-Strand 
Synthesis System (Invitrogen), and the cDNA product was amplified using recombinant Taq DNA 
polymerase (Invitrogen). Phase-specific gene expression analysis was performed using the primers listed 
in Table 8.1. GAPDH served as the house-keeping gene. All primer sequences are listed in Table 2. All 
genes were amplified for 50 cycles in a thermocycler (Bio-Rad iCycler, Hercules, CA) with a fluorescent 
probe (SYBR Green, Invitrogen). Quantitative analysis of gene expression was performed using the delta-
delta CT method. 
 
8.2.6 Tensile Mechanical Properties 
For tensile testing, the scaffolds were secured with custom clamps and mounted on an Instron 
(Model 8841, Norwood, MA), equipped with a 250 lb load cell. The samples had an average gauge length 
of 3.5 cm and were tested to failure along the scaffold long axis at a strain rate of 5 mm/min. Scaffold 
yield strength, ultimate tensile stress and ductility were determined, and elastic modulus was calculated 
from the linear region of the stress-strain curve. 
    
8.2.7 Effect of Architecture on Graft Mechanical Properties and Integrity 
 The effect of ligament phase architecture was first evaluated to select the optimal configuration 
for the ligament phase in terms of mechanical properties. Ligament phase nanofibers were rolled into 
cylindrical bundles to mimic the organization of the native ACL. To standardize the amount of fibers in 
each bundle, ligament phase nanofibers were fabricated by electrospinning for 45 minutes to create a 
20μm-thick nanofiber mesh. The resulting meshes were rolled into bundles 0.8mm in diameter. 
Five architecture configurations were tested. Single, double and triple parallel bundle designs 
were evaluated, which consisted of one, two or three ligament phase bundles in parallel (Fig. 8.1). 
Additionally, two braided structures were assessed, the first consisted of three fibrous bundles were then 
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braided together while the second was made up of three triple bundles braided together (Fig 8.1). Once 
fabricated, the ends of the ligament phase constructs were melted to maintain integrity.  
Once the ligament phase architecture was optimized, a multi-phased scaffold incorporating the 
ligament, bone and interface phases was constructed. To incorporate the ligament and bone phases, 
multi-phased bundles were first constructed. To standardize the number of fibers in each phase, 
composite polymer-ceramic bone phase nanofibers were first electrospun onto a mandrel for 45 minutes. 
Subsequently, a region of fibers 0.5mm in width was excised from the mandrel and ligament phase 
nanofibers were electrospun over the remaining bone phase fibers for 45 minutes. The resulting mesh 
consisted of a region with a layer of bone phase fibers over a layer of ligament phase fibers and a central 
region of ligament phase-only fibers. The meshes were then rolled into cylindrical bundles and interface 
phase collars were secured to these ligament/bone phase bundles using a 7-0 Prolene suture (Ethicon, 
Somerville, NJ). The resulting multi-phased scaffold consisted of a 1cm bone phase at each end, 0.5cm 
interface phases and a central 0.5cm ligament phase. Tensile testing was performed on multi-phased 
ACL scaffold to ensure construct integrity between phases. 
 
8.2.8 Effect of Cell Density 
Following validation of the multi-phased ACL scaffold, cell seeding density on the scaffold was 
optimized. Multi-phased ACL scaffolds were fabricated and seeded with rat MSCs. Three densities were 
evaluated: 2.5x105 cells per scaffold, 5x105 cells per scaffold and 1x106 cells per scaffold. The effect of 
culture duration on cell proliferation, biosynthesis, and differentiation was determined over the course of 7 
days. For end point analyses, the scaffolds were carefully separated into bone, ligament and interface 
phases to perform phase-specific analyses.  
 
8.2.9 Bioreactor Culture 
After optimizing cell density, the multi-phased ACL construct was cultured in vitro at the optimal 
cell density using a bioreactor to apply mechanical stimulation and simulate the in vivo environment. The 
bioreactor system and mechanical loading parameters were identical to those used in a previously 
published study[176]. The effect of bioreactor culture duration on cell proliferation, biosynthesis, and 
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differentiation as well as scaffold tensile mechanical properties was assessed over 21 days. Similar to the 
cell density optimization study, for end point analyses, the scaffolds were carefully separated into bone, 
ligament and interface phases to perform phase-specific analyses. 
 
8.3 Results 
8.3.1 Effect of Architecture on Mechanical Properties 
 A parallel-bundle and a braid design were evaluated to determine the optimal architecture for the 
ligament phase of the graft. Three different parallel bundle designs, ranging from one to three parallel 
bundles, were tested to simulate the architecture of the native ACL. No difference in tensile mechanical 
properties was measured by changing the parameters of the parallel-bundle design (Fig. 8.1). In contrast, 
braiding resulted in a significant increase in the length of the toe region of the ligament phase as well as a 
significant decrease in elastic modulus. No significant difference was measured between the single-
bundle braid system and the triple-bundle braid.   
 The tensile properties of the synthetic graft were also evaluated after incorporating all three 
phases to ensure that no delamination occurred once the phases were combined. No significant 
difference in tensile properties was measured between a single ligament-phase-only graft and the multi-
phased graft incorporating the bone and interface phases (Fig. 8.2). 
 
8.3.2 Effect of Cell Density on Cell Proliferation and Biosynthesis 
 A seven day study was conducted to evaluate the effect of cell density on MSC response. In 
terms of cell attachment and proliferation, a significantly greater number of cells was measured on all 
phases of grafts seeded with 1M cells as compared to the 250K and 500K cell seeded group at day 1 (Fig 
8.3). On the bone phase, a significantly greater number of cells was measured in the 1M cell seeded 
group as compared to the 500K cell seeded group, which also had significantly more cells than the 250K 
cell seeded group. After seven days, no significant difference in cell number was measured between the 
250K and 500K cell seeded groups though the 1M cell seeded group had significantly greater cells than 
both. On the interface and ligament phases, the 250K and 500K cell seeded groups had similar numbers 
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of cells at day 3 with significantly greater cells attached in the 1M cell seeded group. At day 7, the 1M cell 
seeded group had a significantly greater number of cells than the 250K cell seeded group only.  
 A significant increase in ALP activity per cell was measured on the bone phase of grafts seeded 
with 1M cells at day 7, as compared to grafts seeded with 250K cells (Fig. 8.4). In addition, this increase 
was significant as compared to the ALP activity for the same group at day 3. No significant difference in 
ALP activity was measured for the other groups on the bone phase nor was any difference measured 
between groups or over time on the interface or ligament phases. 
 Total collagen content on each phase was also quantified and normalized per cell with no 
significant difference measured between groups or over time on any of the phases (Fig. 8.5). A mean 
increase, however, was observed over time for the 1M cell seeded group on all phases. 
 A significant increase in sulfated GAG content per cell was measured on the interface phase of 
grafts seeded with 1M cells at day 7, as compared to grafts seeded with 250K cells (Fig. 8.6). No 
significant difference in total GAG content was measured for the other groups on the interface phase nor 
was any difference measured between groups or over time on the bone or ligament phases. 
 
8.3.3 Effect of Cell Density on Cell Differentiation 
 The effect of cell density on MSC differentiation was assessed at day 1 (Fig. 8.7). On the bone 
phase, no difference in osteocalcin or osteopontin expression was measured as a function of seeding 
density. On the interface phase, type II collagen and aggrecan were upregulated at day 1 with a 1M 
cells/scaffold seeding density, as compared to the 250K cell seeded group. No difference in type X 
collagen expression was observed between groups.  For the ligament phase, several ligament-specific 
markers were measured including types I and III collagen, fibronectin, tenascin-C, scleraxis and 
tenomodulin. However, cell density had no significant effect on the expression of any of these markers. 
 
8.3.4 Effect of Bioreactor Culture on Cell Proliferation and Biosynthesis 
 Based on the results of the cell-density study, synthetic grafts seeded with 1M cells were cultured 
for 21 days in a bioreactor which applied controlled tensile stimulation to mimic the in vivo environment. 
Evaluating cell attachment and proliferation, a significantly greater number of cells was measured on the 
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bone phase at day 7 as compared to day 1. No difference in cell number was measured over time on the 
interface or ligament phases. 
 A significant increase in ALP activity was only measured on the bone phase with a significant 
increase at day 7 as compared to day 1. The ALP activity remained elevated at day 21 on the bone 
phase. No difference in ALP activity was measured over time on the interface or ligament phases. 
Collagen content per cell was significantly greater on the ligament phase after 21 days of culture as 
compared to day 1 and day 7. No difference was measured over time on the bone phase or interface 
phase. Lastly, GAG content was measured over time and normalized per cell. A significant increase in 
GAG content was measured at day 7 as compared to day 1 and remained elevated at day 21. No 
significant difference was measured over time on the bone or ligament phases. 
 
8.3.5 Effect of Bioreactor Culture on Cell Differentiation 
 Cell differentiation was assessed by measuring the expression of relevant genes for each phase 
at day 21 as compare to day 1. On the bone phase, a significant increase in osteocalcin and osteopontin 
expression was measured at day 21. On the interface phase, type II collagen and aggrecan were 
significantly upregulated at day 21. However, no difference in type X collagen was observed as compared 
to day 1. Similarly, the expression of several fibroblastic markers was measured for the ligament phase. It 
was observed that types I and III collagen, fibronectin, tenascin-C, and tenomodulin were all upregulated 
at day 21 as compared to day 1. No difference in scleraxis expression was measured over time.  
 
8.3.6 Effect of Bioreactor Culture on Tensile Properties 
 Tensile mechanical properties of the cell-seeded synthetic grafts were measured at day 1, 7 and 
21. No significant difference in mechanical properties was observed over time though a mean decrease in 
elastic modulus and ultimate tensile strength was measured beginning at day 7 (Fig. 8.10). Conversely, a 





 The goal of this study is to optimize the architecture and seeding density of synthetic ACL 
scaffold and subsequently evaluate the optimized scaffold for the formation of an integrated bone-
ligament-bone complex in vitro. To address the first objective, five different configurations for the ligament 
phase of the scaffold were evaluated. It was determined that a multi-bundle braided structure was optimal 
for this phase based on the physiologically relevant mechanical properties that it exhibited, specifically an 
elongated toe-region similar to the native ligament. Following optimization of the architecture, the cell 
seeding density for the scaffold was optimized. Three densities were evaluated: 2.5x105, 5x105 and 1x106 
cells per scaffold. It was demonstrated that the highest seeding density, 1x106 cells per scaffold, resulted 
in increased ALP activity and GAG production on the bone and ligament phases, respectively, at day 7 as 
well as an upregulation of type II collagen and aggrecan on the interface phase at day 1. No such 
response was observed at the other seeding densities indicating that the 1x106 cells per scaffold density 
was optimal for further investigation. Lastly, the scaffold incorporating the optimal architecture and cell 
density was culture in vitro using a bioreactor system to apply physiologically relevant mechanical 
loading. A phase-specific response was measured over 21 days with increase ALP activity and 
osteogenic marker expression on the bone phase, increase GAG production on the interface phase and 
increased collagen synthesis and fibroblastic marker expression on the ligament phase. 
Controlling the bundle architecture of the ligament phase was shown to enable control of scaffold 
bulk mechanical properties. All scaffold configuration displayed elastic mechanical properties within the 
range of the native ACL in terms of the elastic modulus, which is reportedly between 49-163 MPa[186], 
yield strength (13.7-36.4MPa in humans[186]), and ductility (19-36% [186]). However, in addition to 
elastic mechanical properties, the viscoelastic properties of soft tissue grafts are critical for long-term 
functionality. In particular, the low stiffness region known was the ‘toe region’ of the stress-strain cure 
reported to be approximately 5% for the native human ACL. This mechanical behavior is due to the 
straightening of collagen fibrils that occurs and enables the tissue to lengthen without damaging the fiber 
structure[185;260;261]. In this study, it was demonstrated that using a braided structure resulted in a toe 
region upwards of 5% enabling the same viscoelastic behavior as the native ligament. Previous efforts in 
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ligament tissue engineering have similarly focused on a braided design due to mechanical 
considerations[18;19;100;103;104]. 
 For in vitro culture, the highest cell seeding density evaluated in this study was found to be 
optimal as increased ALP activity and GAG content was only measured on the bone and interface 
phases, respectively, after 7 days of culture with 1x106 cells per scaffold. Previous studies investigating 
the effect of seeding density on ligament tissue engineered constructs have similarly found that greater 
cell density enhances biosynthetic activity. For example, Awad et al. reported that collagen gel constructs 
seeded at 4 million cells per ml resulted in greater cell alignment and contractile properties[262]. Studies 
investigating cell seeding density for bone and cartilage tissue engineering construct have also reported 
that a minimum number of cells is required for an optimal response, beyond which additional cells have 
little effect on biosynthesis and tissue formation[255;262;263]. Increased cell density is thought to lead to 
an enhanced response due to greater cell-cell and cell-material interactions that occur with higher cell 
number[255]. 
 Using the optimized parameters, the scaffold was cultured in vitro using a bioreactor to apply 
mechanical stimulation similar to that experienced when the scaffold is used for ACL reconstruction. The 
scaffold supported the formation of distinct tissue types on each phase. On the interface phase, increased 
GAG production was measured after 7 days of culture. These proteins are indicative of a cartilage-like 
phenotype as proteoglycans and type II collagen make up cartilaginous tissues as well as the 
fibrocartialginous insertion sites between soft and hard tissues[75]. The expression of types II and X 
collagen as well as aggrecan, however, was not upregulated in this study suggesting that additional 
chemical or mechanical factors may be necessary to induce long-term interface formation. Type X 
collagen is of particular importance because it is has been identified at the ACL-bone interface and is 
thought to play a role in the attachment of ligament to bone[220]. A bone-specific response was 
measured on the bone phase, including an increase in ALP activity at day 7 and the upregulation of 
osteocalcin and osteopontin after 21 days which are early and late markers of bone formation, 
respectively[264;265]. Lastly, similar to previous studies performed on an aligned PLGA nanofiber system 
using human MSCs[176], collagen production was increased and the expression of several fibroblastic 
markers was upregulated indicating that the rat MSC differentiated towards a fibroblastic phenotype. 
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Collectively, these findings suggest that the physical and chemical parameters of each phase coupled 
with the tensile mechanical loading resulted in the formation of a heterogeneous tissue similar to the 
native bone-ACL-bone complex. 
 
8.5 Conclusions 
 The results of this study demonstrate that a braided architecture seeded at a density of 1 million 
cells per graft is the optimal seeding density for the synthetic nanofiber graft. In addition, these findings 
show that a phase-specific response is elicited at this density when cultured under physiologically 
relevant mechanical conditions and that a bone-ligament-bone complex containing distinct yet continuous 
regions of bone, interface and ligament tissue can be formed in vitro on the synthetic nanofiber graft. 




Table 8.1. List of rat PCR primers. 
Gene Sense Anti-Sense 
GAPDH 5’-TGTATCCGTTGTGGATCTGACATGC-3’ 5’-CCCTGTTGCTGTAGCCATATTCATTGT-3’ 
Osteocalcin 5’-AGGGCAGTAAGGTGGTGAAT-3’ 5’-CTAAACGGTGGTGCCATAGA-3’ 
Osteopontin 5’-TGTGTCCTCTGAAGAAACGG-3’ 5’-AGAATCCTCGCTCTCTGCAT-3’ 
Type II Collagen 5’-GGACATAGGGCCTGTCTGTT-3’ 5’-CCGGACTGTGAGGTTAGGAT-3’ 
Aggrecan 5’-CAGATCTGCATGGAATCACC-3’ 5’-AAGTGCCTGCATCTATGTCG-3’ 
Type X Collagen 5’-CTCCTGGTGTGAATGGACAG-3’ 5’-TCACCTCTTCTTCCCACTCC-3’ 
Type I Collagen 5’-CTGCTGGTCCTAAGGGAGAG-3’ 5’-GACAGCACCATCGTTACCAC-3’ 
Type III Collagen 5’-GATGCTGGTGCTGAGAAGAA-3’ 5’-GGCTGGAAAGAAGTCTGAGG-3’ 
Fibronectin 5’-AGAAATTGACAAGCCATCCC-3’ 5’-CACAGGAGAAGTTGAAGGCA-3’ 
Tenascin C 5’-CAGAAGCTGAACCGGAAGTTG-3’ 5’-GGCTGTTGTTGCTATGGCACT-3’ 
Scleraxis 5’-AACACGGCCTTCACTGCGCTG-3’ 5’-CAGTAGCACGTTGCCCAGGTG-3’ 






Figure 8.1. Effect of ligament phase architecture. No difference in tensile properties was measured 
with multiple parallel bundles. Braiding of the bundles resulted in a significantly elongated toe region and 
decreased construct elastic modulus. Similarly, no difference in mechanical properties was observed 
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Figure 8.2. Multi-phased ACL scaffold fabrication. The multi-phased ACL scaffold was fabricated via 
electrospinning the bone and ligament phases together and then attaching the bi-phasic collars as the 
interface phase. Incorporating the ligament and bone phases had no effect on scaffold mechanical 
properties.  
Multi-Phased Scaffold


















































Figure 8.3. Cell attachment and proliferation. A significantly greater number of cells was measured on 
all phases of grafts seeded with 1M cells as compared to the 500K and 250K cell group at day 1. A 














































































Figure 8.4. Effect of cell density on ALP activity. Increased ALP activity was measured on the bone 
phase of grafts seeded with 1M cells at day 7, as compared to grafts seeded with 250K cells. No effect of 












































































Figure 8.5. Effect of cell density on collagen synthesis. Cell density had no significant effect on 























































Figure 8.6. Effect of cell density on GAG production. Increased sulfated GAG was measured on the 
interface phase of grafts seeded with 1M cells, as compared to grafts seeded with 250K cells. No effect of 


















































Figure 8.7. Effect of cell density on cell differentiation at day 1. Type II collagen and aggrecan 
expression was significantly upregulated on the interface phase only in the 1M cell seeded group at day 
1. Cell density had no effect on the expression of osteogenic or fibroblastic markers on the bone and 










































































Figure 8.8. Cell proliferation and biosynthesis over time with bioreactor culture. A significant 
increase in cell number was only measured on the bone phase at day 7 compared to day 1. A phase-
specific response was measured in terms of biosynthesis with increase ALP activity per cell on the bone 
phase beginning at day 7, increased collagen per cell on the ligament phase at day 21 and increased 



































































































Figure 8.9. Cell differentiation on each phase with bioreactor culture. A phase-specific differentiation 
response was observed on the graft. On the bone phase, osteocalcin and osteopontin were upregulated 
at day 21 as compared to day 1. On the interface phase, type II collagen and aggrecan were upregulated 
at day 21. On the ligament phase, types I and III collagen, fibronectin, tenascin-C, and tenomodulin were 












































































Figure 8.10. Effect of bioreactor culture on tensile mechanical properties. No significant difference in 
























































































CHAPTER 9: IN VIVO EVALUATION OF THE 





 The previous chapters of this thesis focused on the design and optimization of the multi-phased 
synthetic scaffold for the formation of an integrated bone-ligament-bone complex in vitro. While the 
results from Chapter 8 demonstrate the ability of the scaffold to induce the formation of distinct regions of 
bone, ligament and interface tissue in vitro, an animal model will be used in Chapter 9 to assess the 
formation of an integrated bone-ligament-bone complex in vivo.  In this study, the three different scaffold 
modalities will be evaluated. The first modality consists of a multi-phased scaffold pre-cultured with cells 
in vitro prior to implantation into the patient.  The second modality is an acellular multi-phased scaffold 
which is implanted to direct the response of host cells. Lastly, a single-phase scaffold consisting of the 
ligament phase only will be implanted to assess how the multi-phased design affects subsequent tissue 
formation. 
 
9.1.1 Background and Motivation 
The development of scaffold systems for tissue engineering necessitates the use of relevant in 
vivo models to account for the presence of vasculature, the full complement of in vivo cytokines, 
hormones, growth factors, cell types, and physiologic loading which are essential for graft-to-host 
interaction. In vitro models alone are not adequate to evaluate the full spectrum of the biologic response 
due to the complexity of the processes being studied. Moreover, there is insufficient data available for the 
design of non-living models. This in vivo evaluation will provide invaluable feedback for future scaffold 
optimization and guidelines for implant evaluation in larger animal models. 
 
9.1.2 Objectives 
 The goal of this study is to test the multi-phased scaffold in vivo by assessing bone, fibrocartilage 
and ligament formation and integration. It is hypothesized that the multi-phased design of the synthetic 
ACL scaffold will enable for the regeneration of distinct-yet-continuous bone, interface and ligament 
tissue. Specifically, the bone phase will support mineralized bone tissue formation and scaffold 
osteointegration, the nanofiber collar interface phase will support fibrocartilaginous tissue and the 
ligament phase will maintain joint stability and promote collagenous ligament tissue formation. In addition, 
 157 
 
it is hypothesized that the seeding of cells on the multi-phased scaffold prior to implantation result in more 
abundant tissue formation. To this end, ACL reconstruction will be performed using a control soft tissue 
graft, a single phase (ligament phase only) scaffold to demonstrate the effect of the multi-phased design, 
as well as an acellular and cell-seeded multi-phased scaffold. 
Several animal models have been developed for ACL reconstruction including the rodent[266], 
rabbit[18], canine[12], porcine[267] and goat[268] models. While large animal models provide a more 
accurate representation of human anatomical size and biomechanical loads, they are significantly more 
costly to obtain and maintain. These animals are also quadrupeds with differences in anatomy and joint 
biomechanics as compared to bipedal humans. The rodent model is a well-developed model of ACL 
reconstruction that has been extensively studied to assess tendon-to-bone healing[11;56;57;266;269]. A 
syngeneic rodent model, in particular, is optimal for this study as it allows for the use of primary rodent 
stem cells without the need to harvest cells from each animal, a procedure that would increase study 
complexity and time. The rat is also the smallest animal and lowest species in which the response can be 
evaluated in vivo, but is much larger compared to mice, making the technically-challenging ACL 
reconstruction procedure feasible. 
 
9.2 Materials and Methods 
9.2.1 Synthetic ACL Scaffold Fabrication 
Each phase of the nanofiber-based synthetic ACL was fabricated via electrospinning. For the 
ligament phase, a mixture of 18% (w/v) poly(ε-caprolactone) (PCL, Sigma-Aldrich, Mw=70,000-90,000) 
and PLGA (85:15, Mw=123.6 kDa; Lakeshore Biomaterials) was dissolved in a mixture of 60/40 
dichloromethane (DCM, Sigma-Aldrich, St. Louis, MO) and DMF. The polymer solution was loaded into a 
5 mL syringe with a 18.5-gauge stainless steel blunt tip needle, and electrospun at 8-10kV using a 
custom electrospinning device.  The polymer solution was deposited (1 mL/hour) using a syringe pump 
(Harvard Apparatus, Holliston, MA) onto a custom rotating mandrel (20 m/s) to produce aligned fibers.  
For the interface phase, bi-phasic nanofiber collars were fabricated. Briefly, a polymer solution 
consisting of 35% PLGA (w/v, 85:15, Lakeshore Biomaterials) in 55% N,N-dimethylformamide (Sigma-
Aldrich) and 10% ethanol (Pharmco-AAPER, Brookfield, CT) was loaded into a syringe fitted with an 18.5-
 158 
 
gauge blunt tip needle (Becton Dickinson, Franklin Lakes, NJ). Composite PLGA-hydroxyapatite (PLGA-
HA) nanofibers were fabricated similarly by adding a suspension of HA nanoparticles immersed in DMF to 
the PLGA solution, resulting in a 15% HA (w/w) polymer-ceramic suspension. Aligned fibers were 
obtained using an aluminum mandrel rotating at a velocity of 20m/s with a constant polymer flow rate of 1 
mL/hr maintained via a syringe pump (Harvard Apparatus, Holliston, MA)[233]. An electrical potential was 
applied between the needle and the drum using a high-voltage DC power supply (Spellman, Hauppauge, 
NY). The bi-phasic collar system was fabricated by electrospinning parallel regions of PLGA and PLGA-
HA nanofibers. After depositing a layer of aligned PLGA nanofibers on the mandrel, a custom masking 
system was applied upon which a layer of PLGA-HA nanofibers was deposited. The resulting multi-phase 
collar consisted of a PLGA region, a PLGA/PLGA-HA overlapping region (1mm in length) and a PLGA-HA 
region. 
For the bone phase, composite polymer-ceramic nanofibers were fabricated. Briefly, a 5:1 mixture 
of PLGA and PCL was dissolved in a 60:40 mixture of dichloromethane and dimethyl formamide (DMF) 
and mixed for one hour. Simultaneously, a suspension of HA nanoparticles (Nanocerox, Ann Arbor, MI) 
and DMF was sonicated for one hour. The nanoparticle suspension and polymer solution were then 
mixed rigorously to produce an 18% (wt%) polymer solution containing 35% (wt ceramic/wt polymer) HA. 
To produce the nanofibers, the polymer solution was loaded into a 5 mL syringe with a 18.5-gauge 
stainless steel blunt tip needle, and electrospun at 8-10kV using a custom electrospinning device. The 
polymer solution was deposited (1 mL/hour) using a syringe pump (Harvard Apparatus, Holliston, MA) 
onto a rotating mandrel (20m/s) to produce the aligned fibers.   
 A multi-phased scaffold incorporating the ligament, bone and interface phases was constructed. 
To incorporate the ligament and bone phases, multi-phased bundles were first constructed. To 
standardize the number of fibers in each phase, composite polymer-ceramic bone phase nanofibers were 
first electrospun onto a mandrel for 45 minutes. Subsequently, a region of fibers 0.5mm in width was 
excised from the mandrel and ligament phase nanofibers were electrospun over the remaining bone 
phase fibers for 45 minutes. The resulting mesh consisted of a region with a layer of bone phase fibers 
over a layer of ligament phase fibers and a central region of ligament phase-only fibers. The meshes 
were then rolled into cylindrical bundles and interface phase collars were secured to these ligament/bone 
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phase bundles using a 7-0 Prolene suture (Ethicon, Somerville, NJ). The resulting multi-phased scaffold 
consisted of a 1cm bone phase at each end, 0.5cm interface phases and a central 0.5cm ligament phase.  
Single phase (ligament phase only) scaffolds were similarly fabricated using the layering technique 
though both layers consisted of ligament phase fibers and no interface phase collar was attached. 
 
9.2.2 Cells and Cell Culture 
 Mesenchymal stem cells were obtained from the long bones of Lewis rats. Rats were euthanized 
by carbon dioxide inhalation, and the femurs and tibiae were harvested under sterile conditions. The 
MSCs were harvested by lavaging the intramedullary canals of the long bones into 50mL conical tubes 
using DMEM containing 10% fetal bovine serum (FBS), 1% penicillin-streptomycin, 1% non-essential 
amino acids, 0.1% amphotericin B and 0.1% gentamicin. Harvested cells were plated directly into 150cm2 
culture dishes for 48 hours in an incubator at 37°C, humidified with 5% CO2. After 2 days, the contents of 
the flask were removed and washed with phosphate buffered saline (PBS), leaving behind MSCs that 
adhered to the bottom of the flask. Once confluent, the MSCs were detached with 0.25% trypsin (Cellgro) 
and serially sub-cultured. Cells from passages three were used for implantation. 
 
9.2.3 Cell Seeding 
 For rats receiving cell-seeded synthetic scaffolds, the scaffolds were seeded dynamically using 
an orbital shaker. Briefly, after sterilization, scaffolds were placed in conical tubes (BD Biosciences) 
containing cell suspension with a density of 1 million MSC/mL. Tubes containing scaffolds were placed on 
an orbital shaker, rotating at a rate of 100 RPM, for four hours in a cell culture incubator. It was 
determined through previous optimization studies that this technique resulted in the adhesion of 
approximately 1 million cells per scaffold. The scaffolds were pre-cultured with cells for one day prior to 
implantation.  
 
9.2.4 Surgical Procedure 
The ACL reconstruction procedure was performed on male Lewis rats (weight, 275–325 g) 
following approval by the Institutional Animal Care and Use Committee. The rats were kept in soft-
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bedding cages with free access to food and water. Animals were anesthetized with a mixture of 80 mg/kg 
ketamine hydrochloride and 5 mg/kg xylazine administered intraperitoneally through a 25-gauge needle.  
For the control group, the flexor digitorum longus (FDL) tendon was harvested and used as a 
graft[247]. Briefly, a longitudinal incision was made on the medial aspect of the right distal leg and ankle. 
The FDL tendon was identified and cut just distal to the ankle in order to harvest the full length of the 
flexor digitorum longus tendon (average length, 30 mm). The experimental groups received either a 
single-phase synthetic scaffold, acellular multi-phased synthetic scaffold, or a cell-seeded multi-phased 
synthetic scaffold. 
To perform the ACL reconstruction, an incision was made over the knee and a medial 
parapatellar arthrotomy was performed to open the joint and excise the ACL. Bone tunnels 1.4mm in 
diameter were made in the proximal tibia and the distal femur by entering the joint at the attachment sites 
of the ACL. The graft or scaffold was passed through the bone tunnels to replace the ACL and the 
proximal and distal ends were secured to the femur and tibia, respectively. Wounds were closed in 
standard fashion. No negative effects of the autologous graft harvest were observed other than expected 
swelling and all animals resumed normal gait by 2 to 3 days after surgery. The animals remained healthy 
and infection-free throughout the duration of the study. All animals resumed normal cage activity by the 
first postoperative day. Careful inspection of the articular surfaces after euthanasia revealed no arthritis or 
advanced joint degeneration. 
 
9.2.5 Mineralization 
Mineral distribution with the tibial and femoral bone tunnels was determined using micro-
computed tomography (micro-CT, n=3/group). Briefly, following fixation for 96 hours in 10% neutral 
buffered formalin, histological samples were scanned with a micro-computed tomography system (VivaCT 
40, Scanco Medical, Switzerland). The length of the tibia and femur surrounding the bone tunnel was 
scanned with a 17μm voxel size. Three-dimensional reconstructions were then performed by tracing the 
edges of the bone and using a mineral density of 268 mg HA/cm3.  Tunnel diameter was measured by 




Bone volume surrounding the tunnel was quantified by performing volumetric reconstruction of a 
uniform cylinder of bone including the tibial bone tunnel. A 2.0cm circular contour surrounding the bone 
tunnel was placed on 315 slices as acquired via micro-CT and reconstructed at a density of 268 mg 
HA/cm3, the bone volume and bone volume fraction were quantified using the vivaCT software. 
Samples for calcified histology were dehydrated in serial alcohol concentrations (70%–100%). 
Rat tibiae were embedded in poly(methylmethacrylate) using a modification of the methods of Erben et 
al.[248]. Seven-micrometer-thick sections were cut perpendicular to the bone tunnels and von Kossa 
staining was used to visualize mineralized tissue[249]. Images were obtained using a light microscope 
(Zeiss Axiovert 25, Zeiss, Germany). 
 
9.2.6 Matrix Deposition 
Three animals per group were euthanized at 4 and 10 weeks after surgery via carbon dioxide 
inhalation and prepared for histologic analysis. At each time point, two specimens were decalcified and 
embedded in paraffin for histology and immunohistochemistry. The remaining specimen for each time 
point was embedded in methacrylate.  
Harvested tissues for decalcified histology were fixed for two days in 10% neutral buffered 
formalin and then decalcified for 48 hours in a solution of formalin, formic acid and ion exchange beads 
(Dowex HCS-5, Dow Chemical, Midland, MI). Excess bone and soft tissue surrounding the femoral and 
tibial tunnels was removed and the tissues were dehydrated in serial alcohol concentrations (70%–
100%), cleared thrice in xylenes and then embedded in paraffin (Fisher Scientific) at 60ºC. Seven-
micrometer-thick sections were cut perpendicular to the axes of the bone tunnels and stained with a 
Modified Goldner’s Masson trichrome stain and picrosirius red to visualize collagen distribution, and 
safranin-O to visualize glycosaminoglycans (GAG). Images were obtained using a light microscope (Zeiss 





9.2.7 Biomechanical Testing 
Biomechanical testing (n=10) was performed to evaluate the strength of the reconstruction after 
10 weeks[38;247]. Limbs used for biomechanical testing were disarticulated at the hip and all muscles 
were removed leaving the joint capsule and the ligaments intact to protect the ACL graft/scaffold until 
testing. Specimens were stored in a freezer at −80°C until testing. Prior to testing, each limb was 
defrosted overnight at 4°C and thawed at room temperature. The joint capsule, tendons, ligaments 
(except the ACL) and the suture material at the graft/scaffold ends were excised prior to testing. The bony 
ends were potted in bonding cement at the proximal femur and the distal tibia to allow secure fixation in 
the testing machine. The specimen was positioned in a tensile testing system (Instron 8800) with custom 
clamps to maintain knee flexion at 45° with the tensile load passing parallel to the ACL graft/scaffold and 
the bone tunnels. A preload of 15 g was applied to the graft/scaffold for five cycles, following which a 
tensile load to failure test was performed at a displacement rate of 0.17 mm/second. The load-
deformation curve was recorded on a personal computer. Results are reported in terms of the ultimate 
load-to-failure (N) and stiffness (N/mm) which were calculated from the linear portion of the load-




 The surgery was well tolerated by rats regardless of the graft or scaffold utilized for the 
procedure. All animals regained mobility within 24 hours of surgery and had resumed normal gait within 7 
days of the procedure. Inspection of the joints after euthanasia showed that control grafts and synthetic 
scaffolds remained intact. The articular cartilage surfaces appeared normal with no evidence of advanced 
joint degeneration. 
 
9.3.1 Reconstruction with Flexor Tendon Graft 
 Reconstruction with the flexor digitorum longus graft served as a positive control for the scaffold 
groups in terms of joint stability and surrounding tissue integrity, as well as negative control in terms of 
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graft osteointegration and interface formation. Analysis of mineral formation via micro-CT at 4 weeks 
revealed a cylindrical bone tunnel (Fig. 9.2), as expected. Similarly, histological analysis demonstrated 
that the graft was intact as a dense collagenous structure and surrounded by bone within the bone 
tunnels, as shown via trichrome and picrosirius red staining. A disorganized fibrovascular interface was 
evident between the graft and the bone with no cartilage damage was noted to the surfaces of the tibia or 
femur, as evidenced via safranin-O staining. After 4 weeks, a mineralization front was noted extending 
from the periphery of the bone tunnel and surrounding the graft indicating the formation of new bone 
tissue (Fig 9.3). 
 
9.3.2 Reconstruction with Single Phase Synthetic Scaffold 
 Reconstruction was performed with a single phase scaffold as a negative control for interface 
formation and osteointegration, as compared to the multi-phased scaffold. Analysis of mineralization via 
micro-CT demonstrated a bone tunnel similar in structure to that of the FDL graft control surrounding the 
scaffold (Fig. 9.2). Histologically, neo-collagenous tissue was evident surrounding the single-phase 
scaffold within the joint and the bone tunnels (Fig 9.4). Similar activity as the FDL graft control group 
surrounding the bone tunnel in terms of bone formation (Fig 9.4) was noted and no evidence of cartilage 
damage or degeneration was visible histologically. 
 
9.3.3 Reconstruction with Acellular Multi-Phased Scaffold 
 The acellular multi-phased scaffold was similarly well-tolerated as the single-phased grafts. 
Nodules indicative of new bone formation were present within the bone tunnels when visualized via 
micro-CT corresponding to the location of the bone phase of the scaffold (Fig. 9.2). Histologically, 
abundant collagenous tissue was evident surrounding each phase of the scaffold. Collagenous tissue 
was also evident around the individual bundles of the synthetic scaffold (Fig 9.5). Tissue staining positive 
for proteoglycans, via safranin-O, was visible adjacent to the interface phase. Qualitatively more 
accelerated bone formation, as compared to the FDL graft and single phase controls, was noted from the 
periphery of the bone tunnel towards the scaffold indicating more rapid bone formation (Fig 9.5).  No 




9.3.4 Reconstruction with Cell-seeded Multi-Phased Graft 
 The cell-seeded scaffold performed similarly at 4 weeks as the acellular multi-phased scaffold. As 
shown via micro-CT, mineralized tissue was present within the bone tunnels thereby indicating new bone 
formation on the bone phase of the scaffold (Fig. 9.2). Histologically, similarly, abundant collagenous 
tissue was evident surrounding the bone phase of the scaffold within the bone tunnels and spanning the 
individual bundles of the ligament phase of the cell-seeded scaffold (Fig 9.6). Small regions of tissue 
staining positive for proteoglycans, via safranin-O, were visible adjacent to the interface phase. Again, 
similar to the corresponding acellular scaffold, qualitatively more accelerated bone formation was visible 
as compared to the FDL graft and single phase controls (Fig 9.6). All joint surfaces appeared intact and 
no cartilage damage was noted. 
 
9.4 Discussion 
The long-term research goal of this thesis is to facilitate integrative anterior cruciate ligament 
regeneration, by engineering a multi-phased synthetic scaffold that mimics the native structure and 
composition characteristic of bone, ligament and bone-ligament interfaces. Specifically, this study 
assesses the efficacy of a biomimetic multi-phased scaffold to promote ACL regeneration and integration.  
The ACL reconstruction procedure was performed in a rat model with groups evaluating an acellular and 
cell-seeded multi-phased scaffold as well as a single-phased scaffold and tendon graft to serve as 
controls. While all synthetic scaffold systems supported joint stability and ligament-like tissue formation, it 
was found that the multi-phased design accelerated bone formation and enabled the formation of 
interface-like tissue.  
The implantation of tissue engineered scaffolds into animal models is a pre-requisite for further 
clinical development and eventual regulatory approval. While the in vivo response can be evaluated using 
a simple subcutaneous model, the synovial environment of the knee is a unique environment due to its 
low vascularity[18]. As a result, an intra-articular model provides a more accurate representation of 
scaffold performance. In this study, a histological analysis was performed to observe any inflammatory 
response the biomechanical response of the scaffold to maintain normal knee function was tested. The 
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synthetic ACL scaffold tested in this study was well-tolerated by all animals and reduced the duration of 
the reconstruction procedure. A histological evaluation showed minimal inflammatory response and no 
scaffolds ruptured nor was any cartilage damage observed, indicating that joint stability was maintained. 
Hydroxyapatite presence within the bone phase of the multi-phased scaffold resulted in 
accelerated mineralization surrounding the scaffold as well as the formation of mineralized tissue within 
the scaffold. Several groups have reported similar results when evaluating the use of composite polymer-
ceramic scaffolds for bone tissue regeneration[224;270;271]. For example, Hasegawa et al. reported that 
porous poly(D,L)-lactide/hydroxyapatite composite scaffold induced bone formation by rat MSCs in 
subcutaneous rodent model which did not occur when the same scaffold was implanted without HA 
particles[271]. In addition, calcium phosphate-based cements have also been shown to be effective in 
augmenting tendon-to-bone integration[62;253]. Our results are in agreement with these findings and 
demonstrate the potential of a ceramic component within the scaffold to enhance bone formation 
osteointegration. 
The multi-phased scaffold supported the formation of heterogeneous tissue, localized to the 
phases of the scaffold. Bone formation was limited to within the bone tunnels, with no ectopic bone 
formation on interface or ligament phases. Collagenous tissue was observed within the joint cavity 
indicating neo-ligament tissue formation on the ligament phase and regions of cartilaginous interface-like 
tissue were observed surrounding the interface-phase of the scaffold. These findings validate the multi-
phased design as compared to the single-phase synthetic graft, in which no interface-like tissue formation 
was observed nor was significant bone formation displayed within the bone tunnels. 
In summary, the findings of this study demonstrate that a synthetic nanofiber-based scaffold can 
effectively regenerate the ACL. As compared to the single-phase scaffold, the multi-phased design 
accelerated the formation of bone tissue, likely due to the presence of hydroxyapatite within the bone 
phase, and displayed evidence of preliminary interface-like tissue formation. Cell-seeding was shown to 
have minimal effects on tissue formation at 4 weeks.  While the rat ACL reconstruction model has 
been well developed in the literature, interpretations of these findings must take into account the 
limitations of this model. Specifically, due to the fact that the rat growth plate does not close during the 
lifetime of the animal[254], further evaluation is necessary in a larger, skeletally mature animal model. To 
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better evaluate the scaffold for long-term ligament regeneration, future studies should focus on longer 
time points and also the use of larger animal models that more closely parallel the biomechanical loads 
experienced by the human knee. 
 
9.5 Conclusions 
 The results of this study collectively demonstrate that the multi-phased ACL scaffold is an 
effective replacement for conventional soft tissue grafts and is capable of supporting joint stability and 
driving the formation of a bone, ligament and interface tissues. Further evaluation at longer time points 
and in larger animal models is necessary to evaluate long-term tissue formation, scaffold degradation and 




Figure 9.1. Schematic of scaffold design and ACL reconstruction. A multi-phased ACL scaffold was 
developed for ACL regeneration and ACL reconstruction was performed on Lewis rats. Rats received 
either a flexor tendon graft, a single phase scaffold, an acellular multi-phased scaffold or a MSC-seeded 
multi-phased scaffold. Animals were sacrificed after 4 or 10 weeks for histological analysis and 
biomechanical testing. 
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Figure 9.2. Mineralization within the tibial bone tunnels. Mineralization within the bone tunnels was 
evaluated via micro-CT. Bone formation was evident within the bone tunnels only for animals that 
received the multi-phased synthetic ACL. 
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Figure 9.3. Control reconstruction with flexor tendon graft. Histological analysis demonstrated that 
the graft (G) was intact as a dense collagenous structure and surrounded by bone within the bone 
tunnels. A disorganized fibrovascular interface was evident between the graft and the bone. After 4 
weeks, a mineralization front was noted extending from the periphery of the bone tunnel and surrounding 
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Figure 9.4. Reconstruction with single-phase graft. Neo-collagenous tissue was evident surrounding 
synthetic (S) graft and spanning the bone tunnels, surrounding the individual bundles of the scaffold. 
Similar activity as the FDL graft control group surrounding the bone tunnel in terms of bone formation was 
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Figure 9.5. Reconstruction with acellular multi-phased graft. Collagenous tissue was evident 
surrounding the ligament phase (L) of the graft and within the individual bundles of the synthetic scaffold. 
Qualitatively more accelerated bone formation was noted from the periphery of the bone tunnel towards 
the bone phase (B) of the graft indicating more rapid bone formation. Small regions of tissue staining 
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Figure 9.6. Reconstruction with MSC-seeded multi-phased graft. Similar to the aceullular multi-
phased scaffold, collagenous tissue was evident surrounding the ligament (L) phase of the scaffold. Small 
regions of tissue staining positive for proteoglycans, via safranin-O were visible adjacent to the interface 
phase (I). Qualitatively more accelerated bone formation was visible around the bone phase (B) as 
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 The objective of this thesis was to design a multi-phased integrative scaffold for anterior cruciate 
ligament regeneration. As this integrative scaffold was intended to replace traditional soft tissue grafts 
used for ACL reconstruction, there are several key design criteria for the ideal system. First, it must be 
able to withstand the functional demands of the native tissue by demonstrating physiologically equivalent 
viscoelastic and elastic mechanical properties as immediate joint stability is required following 
reconstruction. Second, the scaffold must be comprised of compositionally varying phases in order to 
recapitulate the inherent heterogeneity of the native ligament to bone transition. Lastly, the scaffold must 
be biodegradable such that it is gradually replaced by the regenerated tissue following implantation. It 
was hypothesized that a biomimetic, multi-phased scaffold comprised of optimized bone, interface and 
ligament regions coupled with controlled chemical and/or mechanical stimulation in vitro will guide phase-
specific mesenchymal stem cell differentiation and result in a biologically integrated bone-ligament-bone 
complex in vivo. To evaluate these hypotheses, studies were designed to address five specific aims. 
The first three aims focused on individually optimizing each phase of the multi-phased scaffold to 
enable MSC-mediated integrative ACL reconstruction. Aim 1 focused on the formation of a ligament-like 
tissue on polymeric nanofibers by inducing the differentiation of MSC into the ligament fibroblast-like 
phenotype. To this end, the effect of mechanical stimulation and nanofiber architecture were assessed to 
determine the optimal parameters to induce fibroblastic differentiation (Chapter 2). It was demonstrated 
that both physiologically-relevant mechanical stimulation and an aligned nanofiber substrate were 
required for the upregulation of fibroblastic markers and the production of a ligament-like extracellular 
matrix. Next, the addition of fibrogenic growth factors[28] was evaluated to determine if concurrent 
chemical and mechanical stimulation was necessary(Chapter 3). Lastly, the effect of nanofiber 
composition was assessed to select the optimal material based on mechanical properties, degradation 
and cell response for the ligament phase (Chapter 4).  
Following development of the ligament phase, Aim 2 addressed the optimization of the bone 
phase by guiding MSC-mediated bone formation. To accomplish this, hydroxyapatite (HA) particles, the 
primary mineral identified in bone[32], were incorporated into nanofibers to induce MSC differentiation 
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towards an osteoblastic phenotype[33]. The osteogenic differentiation of MSCs was evaluated as a 
function of nanofiber mineral content to determine the optimal nanofiber mineral content (Chapter 5). 
Aim 3 focused on optimizing the interface phase. As fibrocartilage formation has been shown to 
be induced by compressive loading[35], this aim incorporated the application of compression to induce 
MSC-mediated formation of a matrix rich in types I and II collagen and proteoglycans. To this end, a 
mechanoactive, nanofiber-based collar composed of PLGA was used to apply compression to MSCs as it 
contracts when placed in a physiological environment. Compressive loading via a nanofiber collar system 
has previously been shown to induce upregulation of fibrocartilage-related markers when applied to soft 
tissue in vitro[36]. Similarly, compression has also been shown to enhance MSC chondrogenesis[30;37]. 
The effect of compression via nanofiber scaffold contraction on MSCs was first assessed in vitro (Chapter 
6) and the  system was further validated by assessing its ability to induce fibrocartilage formation on 
biological grafts in vivo (Chapter 7).   
Incorporating the outcomes of the first three aims, Aim 4 encompassed the design, 
characterization and in vitro evaluation of a stratified scaffold that incorporates all three optimized phases 
to form an integrated bone-ligament-bone complex. This multi-phased scaffold was designed to guide 
MSC differentiation in order to form distinct-yet-continuous regions of bone, interface and ligament tissues 
in vitro. Graft architecture and seeding density were optimized and the optimal multi-phased graft was 
evaluated in vitro (Chapter 8) to assess the formation of bone, interface and ligament tissue. 
Subsequently, in Aim 5, the system was evaluated in vivo using a well-established rodent model of ACL 
reconstruction[38] to assess its efficacy for integrative ACL reconstruction (Chapter 9) in terms of 
biomechanical properties and matrix formation, focusing on regenerating a biologically integrated bone-
ligament-bone complex. The major findings of each chapter are briefly highlighted below. 
 
10.1.1 Nanofiber Phase Design and Optimization for MSC-Mediated Ligament Formation 
 The first aim focused on optimization of the ligament phase of the multi-phased ACL scaffold. As 
this system uses MSCs to produce three different tissue types, it was necessary to identify the 
parameters required to differentiate MSCs into fibroblasts, the primary cell type of ligaments. In Chapter 
2, the effects of nanofiber alignment and mechanical stimulation on fibroblastic differentiation of MSCs 
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were assessed. A custom built bioreactor was used to apply physiological levels of dynamic tensile 
stimulation to MSCs seeded on aligned and unaligned nanofibers. It was demonstrated that fibroblastic 
differentiation of MSCs only, in terms of type III collagen production and the expression of several key 
fibroblast-related markers, occurs with a combination of aligned nanofibers and mechanical strain. These 
findings established the architecture for the scaffold and demonstrated that mechanical stimulation alone 
could differentiate these cells. 
 In Chapter 3, the effect of combined mechanical and chemical stimulation was investigated to 
determine if chemical stimulation could synergistically enhance fibroblastic differentiation of MSCs. Cells 
were stimulated with bFGF prior to the application of mechanical stimulation as this growth factor has 
been shown to promoted fibrogenesis of MSCs. It was shown that sequential chemical and mechanical 
stimulation enhanced MSC proliferation and collagen synthesis and established bFGF stimulation as a 
viable method to enhanced cell response if necessary. 
 Optimization of nanofiber composition was the focus Chapter 4. Nanofibers were fabricated from 
a blend of two degradable polymers, PLGA and PCL as these both have mechanical properties within 
range of the native ACL with differing degradation characteristics. It was demonstrated that nanofibers 
with controlled mechanical and degradation properties could be generated by blending the two polymers 
at various ratios. The response of human ACL fibroblasts on each composition was studied to select the 
optimal parameters based on cell response. Fibroblast proliferation, matrix production and fibroblast gene 
expression were shown to be greatest on scaffolds with higher PCL content, including pure PCL 
nanofibers and 1:5 PLGA:PCL blend nanofibers. Based on these findings, the 1:5 PLGA:PCL nanofibers 
were selected as the composition of the ligament phase. Collectively, these findings provide the rationale 
for the parameters of the ligament phase of the integrative ACL graft.  
 
10.1.2 Nanofiber Phase Design and Optimization for MSC-Mediated Bone Formation 
 The focus of Aim 2 was to optimize the bone phase of the graft to induce osteogenic 
differentiation of MSCs. In Chapter 5, Composite polymer-ceramic nanofibers were fabricated by 
incorporating hydroxyapatite, as HA is the primary mineral found in bone and has been shown to enhance 
both osteoblast response and osteogenesis of stem cells[33;196;197]. The response of MSCs, in terms of 
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mineralized matrix formation and osteogenic marker expression, was studied as a function of nanofiber 
HA content. The production of ALP was increased on nanofibers containing 25% and 35% HA and the 
expression of several osteogenic markers was greatest on the 35% HA nanofibers. These findings 
established that the optimal ceramic content of the bone phase as 35% HA.  
  
10.1.3 Mechanoactive Nanofiber Collar Design and Optimization for MSC-mediated Interface Formation 
 The focus of Aim 3 shifted to the design and optimization of a nanofiber collar system to induce 
fibrocartilage formation by MSCs on the multi-phased ACL scaffold. A system to apply compression was 
investigated as this mode of stimulation has been shown to be responsible for fibrocartilage formation in 
vivo and has been shown to enhance cartilage-like tissue production by MSCs. To this end, a nanofiber 
collar system was designed and evaluated in vitro (Chapter 6) to induce cartilage formation by MSCs, as 
this system had been previously shown to enhance proteoglycan production and fibrocartilage-related 
marker production on tendon grafts in vitro. It was demonstrated that compressive stimuli enhanced the 
expression of fibrocartilage-related markers by MSCs thereby indicating that the collar system could be 
used to promote interface formation by these cells when seeded on the multi-phased ACL scaffold. This 
system was further validated in vivo using a rodent ACL reconstruction model (Chapter 7). It was shown  
that the multi-phased nanofiber collar, composed of parallel regions of polymer and polymer-ceramic 
nanofibers, enhanced graft osteointegration and increase the production of fibrocartilage-related proteins. 
These findings established the ability of the collar system to promote fibrocartilage formation.  
 
10.1.4 Fabrication and In Vitro Evaluation of the Multi-Phased ACL Scaffold 
 Based on the phases optimized in the first seven chapters, in Aim 4, a multi-phased nanofiber-
based graft for integrative ACL reconstruction was fabricated and optimized in terms of architecture and 
cell seeding density (Chapter 8). The architecture of the ligament phase was optimized by designing a 
braided three-bundle system that mimicked the organization of the native ACL while also mimicking the 
elastic and viscoelastic properties of the native ligament tissue.  The system was cultured in vitro with 
rodent MSCs at three different densities, 2.5x105, 5x105 and 1x106 cells per scaffold, to evaluate the 
effect of cell seeding density and determine the optimal cell density for further evaluation (Chapter 8). A 
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seeding density of 1 million cells/scaffold resulted in increased ALP activity and GAG production on the 
bone and ligament phase, respectively, at day 7 as compared to the other groups thereby indicating that 
this seeding density was optimal. The optimized multi-phased graft was then cultured in vitro using a 
bioreactor to simulate the in vivo mechanical environment (Chapter 8).  Over 21 days, a phase-specific 
response by cells was measured with distinct regions of bone, interface and ligament tissue formed in 
vitro.   
 
10.1.5 In Vivo Evaluation of the Multi-Phased ACL Scaffold 
 To address Aim 5, the final chapter of this thesis focused on establishing the efficacy of the multi-
phased ACL scaffold in vivo using a rodent model of ACL reconstruction. A cell-seeded multi-phased 
scaffold was compared with an acellular multi-phased scaffold, acellular single-phase scaffold, consisting 
of the ligament phase only, and a flexor tendon graft. All scaffold configurations were well tolerated in vivo 
and no cartilage damage in any animals, indicating that the joint stability was maintained. As compared to 
the single phase scaffold, accelerated bone formation was noted surrounding the multi-phased scaffold. 
These findings demonstrate the efficacy of the multi-phased ACL scaffold for ligament reconstruction.   
 
10.2 Future Directions 
 The findings of this thesis demonstrate the feasibility of using a multi-phased scaffold to 
regenerate the ACL, ACL-to-bone interface and subchondral bone. However, to realize the clinical 
translation of the scaffold system, several areas of further study are needed as described below. 
 
10.2.1 Large Animal Model 
 Although the rat model has been well-established for ACL reconstruction, it is still necessary to 
evaluate scaffold designs in large animal models for clinical translation. Compared to the rat, larger 
animal models such as the rabbit[18], canine[12], porcine[267] or goat[268] models would provide a more 
physically demanding environment with dimensions and biomechanical loads more closely approximating 




10.2.2 Growth Factor Delivery for Interface Formation  
 Due to the complexity of the current multi-phased graft design, future work may require 
simplifying the structure of the graft for high-throughput fabrication. One potential approach is the 
incorporation of chemical factors into the interface phase of the graft, as opposed to using the nanofiber 
collar system. In particular, TGF-β3 has been shown to induce chondrogenic differentiation of MSCs[272] 
and can enhance cartilage formation on tissue engineered scaffolds[273;274].  In addition, growth factor 
release from nanofibers has been well investigated[131;275;276] .      
 
10.2.3 Alternative Stem Cell Source 
 While MSCs can be readily obtained and have been well characterized in the literature, other 
sources of stem cells such as tendon-derived stem cells and synovium-derived stem cells may be better 
suited for musculoskeletal tissue regeneration. In addition, the recent development of induced pluripotent 
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